nevirapine has been researched along with zidovudine in 645 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 127 (19.69) | 18.2507 |
2000's | 234 (36.28) | 29.6817 |
2010's | 260 (40.31) | 24.3611 |
2020's | 24 (3.72) | 2.80 |
Authors | Studies |
---|---|
Bamberger, DL; Fisher, TE; Goldman, ME; Hoffman, JM; Jones, JH; Rooney, CS; Saari, WS; Smith, AM; Thomas, CM; Wai, JS | 1 |
Behnke, ML; Cullen, E; Fuchs, VU; Grozinger, KG; Hargrave, KD; Kapadia, SR; Mauldin, SC; Patel, UR; Proudfoot, JR; Vitous, J | 1 |
Bethell, RC; Cammack, N; Green, DV; Hancock, AP; Hann, MM; Lamont, RB; Livermore, DG; Noble, SA; Orr, DC; Payne, JJ | 1 |
Alvarez, R; Aquaro, S; Balzarini, J; Camarasa, MJ; De Clercq, E; Karlsson, A; Perno, CF; San-Félix, A; Velázquez, S | 1 |
Fujiwara, M; Hanasaki, Y; Ijichi, K; Katsuura, K; Konno, K; Sakai, S; Shirakawa, S; Takayama, H; Watanabe, H; Yamaguchi, K | 1 |
Artico, M; La Colla, P; Loi, AG; Mai, A; Massa, S; Sbardella, G; Scano, P; Tramontano, E | 1 |
Balani, SK; Ciccarone, TM; Condra, JH; Emini, EA; Goldman, ME; Greenlee, WJ; Kauffman, LR; MacTough, SC; Rooney, CS; Williams, TM | 1 |
Althaus, IW; Biles, C; Busso, M; Genin, MJ; Morge, RA; Resnick, L; Reusser, F; Romero, DL; Tarpley, WG; Thomas, RC | 1 |
Bell, FW; Cantrell, AS; Högberg, M; Jaskunas, SR; Johansson, NG; Jordan, CL; Kinnick, MD; Lind, P; Morin, JM; Noréen, R | 1 |
Artico, M; Corrias, S; La Colla, P; Loi, AG; Massa, S; Piras, G; Silvestri, R | 1 |
Altamura, S; Campiani, G; De Filippis, MP; Di Renzo, L; Fiorini, I; Garofalo, A; Greco, G; Nacci, V; Novellino, E | 1 |
Artico, M; De Montis, A; La Colla, P; Loi, AG; Mai, A; Massa, S; Putzolu, M; Quartarone, S; Sbardella, G; Scintu, F | 1 |
Arranz, E; Balzarini, J; De Clercq, E; Díaz, JA; Ingate, ST; Pannecouque, C; Vega, S; Witvrouw, M | 1 |
Mao, C; Sudbeck, EA; Uckun, FM; Venkatachalam, TK | 1 |
Maher, D; Mao, C; Pendergrass, S; Tuel-Ahlgren, L; Uckun, FM; Venkatachalam, TK; Zhu, D | 2 |
Topliss, JG; Yoshida, F | 1 |
Andreola, ML; Aubertin, AM; Bisagni, E; Dollé, V; Kirn, A; Legraverend, M; Nguyen, CH; Tarrago-Litvak, L; Ventura, M | 1 |
Aiello, F; Armaroli, S; Bergamini, A; Bolacchi, F; Bongiovanni, B; Caccia, S; Campiani, G; Capozzi, M; Coletta, M; Fabbrini, M; Garofalo, A; Greco, G; Guiso, G; Maga, G; Marini, S; Morelli, E; Nacci, V; Novellino, E; Ramunno, A; Spadari, S; Ventura, L | 1 |
Buckheit, RW; Burrier, J; Cushman, M; Hartman, TL; Micklatcher, M; Osterling, MC; Silvestri, MA; Turpin, JA; Wargo, H; Xu, G | 1 |
Singh, SK; Yadav, A | 1 |
Bergamini, A; Butini, S; Campiani, G; Catalanotti, B; Coletta, M; De Angelis, M; Fattorusso, C; Fiorini, I; Gemma, S; Greco, G; Huleatt, P; Maga, G; Marini, S; Nacci, V; Novellino, E; Persico, M; Ramunno, A; Rodriquez, M; Spadari, S | 1 |
Alongi, M; Armand-Ugón, M; Bernardini, C; Botta, M; Cancio, R; Carmi, C; Clotet-Codina, I; Corelli, F; Crespan, E; Esté, JA; Maga, G; Manetti, F; Massa, S; Mugnaini, C; Petricci, E; Togninelli, A | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Botta, M; Cancio, R; Clotet-Codina, I; Corelli, F; Esté, JA; Maga, G; Manetti, F; Mugnaini, C | 1 |
Baba, M; De Clercq, E; Shi, M; Takao, S; Wang, X | 1 |
Baba, M; Cheng, YC; Dutschman, GE; Grill, SP; Hu, R; Lam, W; Paintsil, E; Tanaka, H | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
De Clercq, E; Li, J; Lin, Y; Liu, X; Pannecouque, C; Witvrouw, M; Yan, R | 1 |
Alongi, M; Angeli, L; Armand-Ugón, M; Bellucci, L; Bernardini, C; Botta, M; Brizzi, A; Clotet-Codina, I; Corelli, F; Esté, JA; Facchini, M; Gevariya, H; Maga, G; Manetti, F; Massa, S; Mugnaini, C; Samuele, A; Tafi, A; Togninelli, A | 1 |
De Maeyer, M; Debyser, Z; Desadeleer, C; Hombrouck, A; Van Remoortel, B; Voet, A; Witvrouw, M | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Cao, Y; De Clercq, E; Liu, X; Pannecouque, C; Wang, Y; Zhan, P | 1 |
Cecchetti, V; Daelemans, D; Manfroni, G; Massari, S; Pannecouque, C; Sabatini, S; Tabarrini, O | 1 |
Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E | 1 |
Bergamini, A; Borrelli, G; Brindisi, M; Butini, S; Campiani, G; Coccone, SS; Cosconati, S; Di Mattia, M; Galletti, B; Gemma, S; Giorgi, G; Lalli, S; Maga, G; Marinelli, L; Novellino, E; Ramunno, A; Samuele, A; Zanoli, S | 1 |
Bachmann, MH; Fessel, WJ; Kagan, RM; Mitsuya, Y; Shafer, RW; Shahriar, R; Varghese, V | 1 |
Chen, YC; Dumond, JB; Fiscus, SA; Horton, AL; Kashuba, AD; Patterson, KB; Rezk, NL; Tappouni, HL; Tien, HC; Vourvahis, M; Yeh, RF | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
De Clercq, E; Fang, Z; Li, Z; Liu, X; Pannecouque, C; Zhan, P | 1 |
Clercq, ED; Fang, Z; Li, Z; Liu, X; Pannecouque, C; Zhan, P; Zhu, J | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Bharate, SB; Bhutani, KK; Chauthe, SK; Mitra, D; Sabde, S; Singh, IP | 1 |
Fransen, S; Gupta, S; Huang, W; Paxinos, EE; Petropoulos, CJ; Stawiski, E | 1 |
Asaftei, S; De Clercq, E | 1 |
Barbault, F; Chen, CH; Huang, L; Huang, R; Jiang, S; Jiang, X; Lee, KH; Lu, H; Qian, K; Qin, B; Tian, X; Xie, L | 1 |
Azas, N; Casano, G; Dumètre, A; Hutter, S; Pannecouque, C; Robin, M | 1 |
Corbau, R; Fishburn, L; Irving, S; Knöchel, T; Martin, A; Mori, J; Mowbray, C; Panton, W; Perros, M; Phillips, C; Ringrose, H; Smith-Burchnell, C; Thornberry, A; Westby, M; Wood, A | 1 |
Engelman, A; Haim, H; Koh, Y | 1 |
Cai, QQ; He, YP; Lai, CC; Li, C; Li, DX; Long, J; Wang, H; Zhang, CS; Zhang, DH; Zhang, SS; Zheng, YT | 1 |
Bhutani, KK; Bodiwala, HS; Mitra, D; Sabde, S; Singh, IP | 1 |
Balestrieri, E; Chiacchio, MA; Ferlazzo, A; Giofrè, SV; Iannazzo, D; Macchi, B; Mastino, A; Piperno, A; Pizzimenti, F; Romeo, R | 1 |
Coltart, DM; Garnsey, MR; Kwiek, JJ; Matous, JA | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
De Clercq, E; Ge, W; Jiang, Y; Li, Z; Liu, X; Pannecouque, C; Wu, J; Zhan, P; Zhang, J | 1 |
Balzarini, J; Chen, FE; De Clercq, E; Gu, SX; He, QQ; Ma, XD; Pannecouque, C; Yang, SQ | 1 |
Chen, W; Chen, X; De Clercq, E; Li, D; Li, X; Liu, X; Pannecouque, C; Tian, Y; Zhan, P | 1 |
Balzarini, J; Chen, FE; Clercq, ED; Dai, HF; Gu, SX; He, QQ; Ma, XD; Pannecouque, C; Yang, SQ | 1 |
Balzarini, J; Chen, X; De Clercq, E; Liu, X; Pannecouque, C; Zhan, P | 1 |
Balzarini, J; Chen, FE; De Clercq, E; Gu, SX; He, QQ; Li, ZM; Ma, XD; Pannecouque, C; Yang, SQ | 1 |
Chen, X; Cheng, Z; De Clercq, E; Liu, X; Meng, C; Pannecouque, C; Shao, S; Zhan, P | 1 |
Borrell, JI; Clotet, B; Esté, JA; Giménez, L; Gonzalo, E; Pascual, R; Pettersson, S; Puig-de-la-Bellacasa, R; Teixidó, J | 1 |
Brancale, A; Clotet, B; Coluccia, A; Cosconati, S; Esté, JA; Famiglini, V; Gonzalez, E; La Regina, G; Maga, G; Novellino, E; Piscitelli, F; Samuele, A; Schols, D; Silvestri, R | 1 |
Balzarini, J; Chen, X; De Clercq, E; Li, D; Li, X; Liu, H; Liu, X; Pannecouque, C; Wang, L; Zhan, P | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, W; Chen, X; De Clercq, E; Li, X; Li, Z; Liu, X; Pannecouque, C; Tian, Y; Zhan, P | 1 |
Chen, W; Chen, X; Clercq, ED; Li, X; Li, Z; Liu, X; Pannecouque, C; Tian, Y; Zhan, P | 1 |
Briñón, MC; Daelemans, D; Dehaen, W; Leen, V; Madrid, M; Pannecouque, C; Ribone, SR | 1 |
Akkarawongsapat, R; Jariyawat, S; Kasisit, J; Kongkum, N; Napaswad, C; Piyachaturawat, P; Pohmakotr, M; Reutrakul, V; Suksen, K; Tuchinda, P | 1 |
Chen, FE; Daelemans, D; De Clercq, E; Liu, Y; Ma, XD; Pannecouque, C; Yang, S | 1 |
Asada, E; Baba, M; Demizu, Y; Hamasaki, T; Irie, K; Iwai, M; Kato, Y; Kurihara, M; Maruyama, T; Sakakibara, N | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Balzarini, J; Chen, FE; Chen, WX; Daelemans, D; De Clercq, E; He, QQ; Pannecouque, C; Wu, HQ; Yan, ZH | 1 |
Balzarini, J; Chen, X; De Clercq, E; Li, Z; Liu, H; Liu, X; Pannecouque, C; Xie, Z; Zhan, P; Zhang, L; Zhao, T | 1 |
Ba, M; Gu, Q; Guo, Y; Li, D; Li, G; Li, L; Ma, X; Zhu, T | 1 |
De Clercq, E; Li, Z; Liu, H; Liu, X; Pannecouque, C; Wang, J; Zhan, P | 1 |
Chen, FE; Chen, WX; De Clercq, E; He, QQ; Huang, XY; Pannecouque, C; Wu, HQ; Yan, ZH | 1 |
Badia, R; Brancale, A; Cirilli, R; Clotet, B; Coluccia, A; Crespan, E; Esté, JA; Famiglini, V; La Regina, G; Maga, G; Novellino, E; Pelliccia, S; Silvestri, R | 1 |
Chen, FE; Chen, WX; De Clercq, E; He, QQ; Pannecouque, C; Piao, HR; Wu, HQ; Wu, Y; Yan, ZH | 1 |
Collu, G; Giliberti, G; La Colla, P; Loddo, R; Loksha, YM; Pedersen, EB; Sanna, G | 1 |
Costa, J; Dumontet, V; Leyssen, P; Litaudon, M; Neyts, J; Nothias-Scaglia, LF; Pannecouque, C; Paolini, J; Retailleau, P; Roussi, F | 1 |
Balzarini, J; Chen, F; Chen, W; De Clercq, E; Liu, Y; Meng, G; Pannecouque, C; Zheng, A | 1 |
Ba, M; Cao, Y; Guo, C; Guo, Y; He, R; Li, Z; Liang, Y; Tang, C; Xu, Z; Yang, Y; Zhang, X; Zhou, H; Zhu, L | 1 |
Chen, W; De Clercq, E; Liu, X; Liu, Z; Pannecouque, C; Zhan, P | 1 |
Chen, FE; Chen, WX; Daelemans, D; De Clercq, E; He, QQ; Pannecouque, C; Wu, HQ; Yao, J | 1 |
Balzarini, J; Chen, W; De Clercq, E; Fu, L; Huang, B; Li, C; Liu, H; Liu, T; Liu, X; Pannecouque, C; Sun, Y; Yu, M; Zhan, P | 1 |
Ashok, P; Balzarini, J; Chander, S; Murugesan, S; Pannecouque, C | 1 |
Chen, W; De Clercq, E; Fu, L; Huang, B; Li, C; Li, X; Liang, X; Liu, H; Liu, T; Liu, X; Pannecouque, C; Sun, Y; Zhan, P | 1 |
Chen, FE; Chen, WX; Daelemans, D; De Clercq, E; He, QQ; Mao, TQ; Pannecouque, C; Tang, GF; Wan, ZY | 1 |
Girard-Valenciennes, E; Grondin, I; Leyssen, P; Litaudon, M; Neyts, J; Olivon, F; Palenzuela, H; Pannecouque, C; Roussi, F | 1 |
Bagnoli, L; Desantis, J; Iraci, N; Marini, F; Mariotti, A; Pannecouque, C; Sancineto, L; Santi, C; Tabarrini, O | 1 |
Chen, W; Daelemans, D; De Clercq, E; Huang, B; Kang, D; Li, X; Liu, X; Liu, Z; Lu, X; Pannecouque, C; Yang, J; Zhan, P | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Chen, X; Daelemans, D; De Clercq, E; Huang, B; Kang, D; Li, W; Liu, X; Meng, Q; Pannecouque, C; Zhan, P | 1 |
Bhatt, HG; Pannecouque, C; Patel, BD; Patel, SB | 1 |
Chizhov, AO; Geisman, AN; Khandazhinskaya, AL; Kochetkov, SN; Naesens, L; Novikov, MS; Ozerov, AA; Pannecouque, C; Seley-Radtke, KL; Valuev-Elliston, VT | 1 |
Bingöl Özakpınar, Ö; De Clercq, E; Küçükgüzel, İ; Kulabaş, N; Özsavcı, D; Pannecouque, C; Tatar, E | 1 |
Buckheit, RW; Cushman, M; Hartman, TL; Hoshi, A; Okazaki, M; Pannecouque, C; Sakamoto, T; Takayama, J; Xuan, M | 1 |
Chen, W; Daelemans, D; De Clercq, E; Huang, B; Liu, X; Pannecouque, C; Yang, J; Zhan, P | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Daelemans, D; De Clercq, E; Ding, X; Fang, Z; Huang, B; Kang, D; Li, Z; Liu, X; Lu, X; Pannecouque, C; Xu, H; Zhan, P; Zhang, H; Zhou, Z | 1 |
Al-Masoudi, NA; Hamdy, AM; Hering-Junghans, C; Khaddour, Z; Langer, P; Rahman, Q; Villinger, A | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
De Clercq, E; Huo, Z; Kang, D; Liu, H; Liu, X; Pannecouque, C; Tian, Y; Zhan, P; Zhang, H; Zhou, Z | 1 |
Altieri, A; Belov, DS; Curreli, F; Debnath, AK; Kurkin, AV; Kwon, YD; Kwong, PD; Ramesh, RR | 1 |
Gu, SX; Ju, XL; Li, TT; Lu, HH; Pannecouque, C; Xiao, T; Xue, P; Zhang, X; Zheng, XJ; Zhu, YY | 1 |
Gu, SX; Ju, XL; Liu, GY; Lu, HH; Pannecouque, C; Xue, P; Zhang, XL; Zheng, XJ; Zhu, YY | 1 |
Cai, Z; Cosford, NDP; Heil, ML; Mattmann, ME; Pagano, N; Snyder, BA; Teriete, P; Yang, L | 1 |
Daelemans, D; De Clercq, E; Ding, X; Fang, Z; Huang, B; Huo, Z; Kang, D; Liu, X; Lu, X; Meng, Q; Pannecouque, C; Tian, Y; Wu, G; Xu, H; Yu, Z; Zhan, P; Zhang, H; Zhou, Z | 1 |
Cuong, NM; Fong, HHS; Guan, YF; Li, WF; Liu, KL; Nguyen, VH; Rong, L; Rumschlag-Booms, E; Soejarto, DD; Wang, DY; Zhang, HJ | 1 |
Badia, R; Brambilla, A; Brancale, A; Catalano, M; Cirilli, R; Coluccia, A; Crespan, E; Esté, JA; Famiglini, V; Formica, FR; La Regina, G; Limatola, C; Maga, G; Masci, D; Novellino, E; Riveira-Muñoz, E; Silvestri, R | 1 |
Daelemans, D; De Clercq, E; Huang, B; Kang, D; Liu, J; Liu, X; Liu, Z; Pannecouque, C; Tian, Y; Zhan, P | 1 |
Daelemans, D; De Clercq, E; Ding, X; Feng, D; Huo, Z; Kang, D; Liu, X; Pannecouque, C; Tian, Y; Wang, Z; Wu, G; Zhan, P; Zhao, T; Zhou, Z | 1 |
Chen, F; De Clercq, E; Jin, K; Meng, G; Pannecouque, C; Yin, H | 1 |
Daelemans, D; De Clercq, E; Gao, P; Kang, D; Liu, X; Lu, X; Pannecouque, C; Yang, J; Zhan, P | 1 |
Chen, CH; Daelemans, D; De Clercq, E; Huang, B; Kang, D; Lee, KH; Liu, J; Liu, X; Liu, Z; Pannecouque, C; Tian, Y; Zhan, P; Zhang, H | 1 |
Daelemans, D; De Clercq, E; Desta, S; Ding, X; Huo, Z; Jing, L; Kang, D; Liu, X; Pannecouque, C; Wang, Z; Wu, G; Zhan, P; Zhang, H; Zhou, Z; Zuo, X | 1 |
Clercq, E; Daelemans, D; Ding, X; Feng, D; Guma, S; Huang, B; Huo, Z; Jing, L; Kang, D; Liu, X; Luo, W; Pannecouque, C; Wang, Z; Wu, G; Zhan, P; Zhang, H; Zhang, J; Zhao, T; Zhou, Z; Zuo, X | 1 |
Byrareddy, SN; Kongsted, J; Kramer, VG; Kurup, S; Liu, X; Namasivayam, V; Vanangamudi, M; Zhan, P | 1 |
Abadi, LF; Bhutani, KK; Desai, D; Gaikwad, S; Gupta, S; Kulkarni, S; Kumar, S; Singh, IP | 1 |
Bal, C; Mitra, A; Mitra, D; Parveen, A; Rozy, F; Sharon, A; Trivedi, J | 1 |
Chen, FE; Gu, SX; Liu, GY; Meng, G; Pannecouque, C; Tang, JF; Wu, FS; Xiao, T; Xu, ZQ; Zhu, YY | 1 |
Armijos Rivera, JI; Badia, R; Brambilla, A; Catalano, M; Cinquina, E; Coluccia, A; Crespan, E; Esté, JA; Falasca, F; La Regina, G; Limatola, C; Maga, G; Masci, D; Nalli, M; Riveira-Muñoz, E; Silvestri, R; Turriziani, O | 1 |
Cherukupalli, S; De Clercq, E; Feng, D; Fu, Z; Jiang, X; Kang, D; Liu, X; Pannecouque, C; Wang, Z; Zhan, P | 1 |
De Clercq, E; Huang, B; Jiang, X; Kang, D; Li, J; Liu, X; Olotu, FA; Pannecouque, C; Soliman, MES; Wang, Z; Zhan, P | 1 |
Chen, CH; De Clercq, E; Feng, D; Jing, L; Kang, D; Lee, KH; Lin, H; Liu, X; Olotu, FA; Pannecouque, C; Soliman, M; Zhan, P; Zuo, X | 1 |
De Clercq, E; Gao, P; Liu, X; Pannecouque, C; Song, S; Sun, L; Wang, Z; Zhan, P; Zhang, J | 1 |
Cherukupalli, S; De Clercq, E; Fu, Z; Gao, S; Kang, D; Liu, X; Pannecouque, C; Sun, L; Zhan, P; Zhang, T; Zhou, Z | 1 |
Chen, FE; De Clercq, E; Jin, X; Pannecouque, C; Piao, HR; Zhuang, C | 1 |
Cheng, Y; De Clercq, E; Gao, P; Gao, S; Kang, D; Liu, X; Pannecouque, C; Song, L; Song, S; Sun, L; Xu, S; Zhan, P; Zhao, F | 1 |
Chen, FE; Clercq, E; Hao, QQ; Ling, X; Pannecouque, C | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Larder, BA | 1 |
Cheng, YC; Dutschman, GE; Im, GJ; Mellors, JW; Tramontano, E; Winkler, SR | 1 |
Cheng, YC; Tramontano, E | 1 |
Chou, TC; Eckner, RJ; Merluzzi, VJ; Richman, D; Rosenthal, AS; Sabo, JP; Skoog, M | 1 |
Barringer, K; Cheeseman, S; Corbeil, J; Havlir, D; Ignacio, C; Looney, D; Pauletti, D; Richman, DD; Spector, SA; Sullivan, J | 1 |
Connell, EV; Hsu, MC; Richman, DD | 1 |
Boone, LR; Borroto-Esoda, K | 1 |
Bakhanashvili, M; Boyer, PL; Hizi, A; Hughes, SH; Loya, S; Tal, R | 1 |
Cheeseman, SH; Greenough, TC; Hall, D; Hattox, SE; Havlir, D; McLaughlin, MM; Myers, M; Spector, SA; Stein, DS; Sullivan, JL | 1 |
López-Galíndez, C; Nájera, I; Nájera, R; Olivares, I; Peinado, MA; Perucho, M; Richman, DD; Rojas, JM | 1 |
Chavan, SJ; Prochaska, HJ | 1 |
Bader, JP; Boyer, PL; Buckheit, RW; Chu, SH; Fliakas-Boltz, V; Hughes, SH; Mayers, DL; Pan, BC; Weislow, O; Yeagy-Bargo, S | 1 |
Brennan, TM; Bridges, CG; Leyda, JP; Taylor, DL; Tyms, AS | 1 |
Barry, DW; Pennington, KN; Rooney, J; St Clair, MH | 1 |
Bechtel, LJ; Chow, YK; D'Aquila, RT; Eron, JJ; Hirsch, MS; Kaplan, JC; Merrill, DP | 1 |
Rennie, J | 1 |
Cohen, J | 3 |
Kellam, P; Kemp, SD; Larder, BA | 1 |
Brewster, F; Grob, P; Koup, RA; Sullivan, JL | 1 |
Richman, DD | 1 |
Boucher, CA; de Jong, MD; Hall, D; Imrie, A; Kauffmann, RH; Koster, R; Loewenthal, M; Schipper, P; van der Ende, I; Weigel, HM | 1 |
Jäger, H | 1 |
Arts, EJ; Gu, Z; Li, Z; Quan, Y; Wainberg, MA | 1 |
Basgoz, N; D'Aquila, RT; Fischl, MA; Hirsch, MS; Hughes, MD; Johnson, VA; Liou, SH; Myers, M; Niu, M; Sommadossi, JP; Timpone, J | 1 |
Gu, Z; Li, X; Parniak, MA; Quan, Y; Wainberg, MA | 1 |
Chou, TC; Polsky, B; Scarborough, A; Zhu, QY | 1 |
Boucher, CA; Carr, A; Cooper, DA; de Jong, MD; Imrie, A; Sorice, F; Vella, S | 1 |
Baba, M; Makino, M; Nakade, K; Okamoto, M; Yamada, K; Yuasa, S | 1 |
Anderson, B; Farley, M; Fox, C; Luzuriaga, K; Mueller, BU; Pizzo, PA; Schwartzentruber, DJ; Sei, S; Sullivan, JL; Tudor-Williams, G; Venzon, DJ | 1 |
Canon, J; Chen, IS; Krogstad, P; Rey, O | 1 |
Charpiot, B; Datema, R; Hincenbergs, M; Kaneshima, H; Linquist, V; McCune, JM; Moreno, MB; Rabin, L; Seifert, J; Warren, S | 1 |
Baba, M; Hashimoto, KI; Okamoto, M; Shigeta, S; Tsunoda, R | 1 |
Hirschel, B; Rutschmann, O | 1 |
Corbeil, J; Gervaix, A; Leoni, LM; Richman, DD; West, D; Wong-Staal, F | 1 |
Iversen, AK; Merigan, TC; Shafer, RW; Winters, MA | 1 |
Bryson, Y; Cort, S; Krogstad, P; Lamson, M; Luzuriaga, K; Robinson, J; Stechenberg, B; Sullivan, JL | 1 |
Beveridge, A; Cooper, DA; Genn, W; Imrie, A; Vizzard, J | 1 |
Basgoz, N; Bremer, JW; D'Aquila, RT; Elbeik, T; Erice, A; Fischl, MA; Hirsch, MS; Hughes, MD; Johnson, VA; Kuritzkes, DR; Scott, WA; Spector, SA | 1 |
Eisen, JA; Katzenstein, DA; Merigan, TC; Shafer, RW | 1 |
Collins, DO; Sakamoto, A | 1 |
Boucher, CA; de Boer, RJ; de Jong, MD; de Wolf, F; Foudraine, NA; Goudsmit, J; Lange, JM | 1 |
Danner, SA; de Jong, MD; Koot, M; Lange, JM; Miedema, F; Pakker, NG; Reiss, P; Roos, MT; Schellekens, PT; van Leeuwen, R | 1 |
Alaeus, A; Albert, J; Cox, S; Palmer, S | 1 |
Gómez-Cano, M; Soriano, V | 1 |
Balzarini, J; De Clercq, E; Kleim, JP; Pelemans, H; Riess, G; Roesner, M; Winkler, I | 1 |
Arranz, ME; Balzarini, J; De Clercq, E; Declercq, R; Desmyter, J; Diaz, JA; Esnouf, R; Ingate, ST; Jonckheere, H; Pannecouque, C; Schmit, JC; Van Meervelt, L; Vandamme, AM; Vega, S; Witvrouw, M | 1 |
Conway, B; Cooper, D; Hall, D; Harris, M; Lange, JM; Montaner, JS; Myers, M; Reiss, P; Robinson, P; Smith, D; Vella, S; Wainberg, MA | 1 |
Amacker, M; Hübscher, U | 1 |
Conway, B; Cooper, D; Dohnanyi, C; Hall, DB; Lange, J; Montaner, JG; Myers, M; Reiss, P; Vella, S | 1 |
Chen, IS; Grovit-Ferbas, K; Poon, B; Stewart, SA | 1 |
Danner, SA; de Wolf, F; Goudsmit, J; Hoetelmans, RM; Jurriaans, S; Lange, JM; Lukashov, VV; Notermans, DW; Prins, JM; Roos, M; Schuitemaker, H; Weverling, GJ | 1 |
Harrigan, PR; Harris, M; Mo, T; Montaner, JS | 1 |
Conway, B; Cooper, D; Hall, D; Harris, M; Lange, J; Montaner, JS; Myers, M; Raboud, JM; Rae, S; Reiss, P; Robinson, P; Vella, S; Wainberg, MA | 2 |
Saag, MS; Schooley, RT | 1 |
Chan, KC; Ho, TT; Lee, SS; Wong, KH | 1 |
Balfour, HH; Erice, A; Fischl, MA; Henry, K; Hirsch, MS; Kahn, JO; Kenton, A; Kmack, A; Liou, SH; Martinez, A; Phair, J; Tierney, C | 1 |
Brew, BJ; Markus, R | 1 |
D'Aquila, RT; Fischl, MA; Hirsch, MS; Hughes, MD; Johnson, VA; Myers, M; Sheiner, LB; Sommadossi, JP; Zhou, XJ | 1 |
Clay, PG; Rathbun, RC; Slater, LN | 1 |
Haubrich, R; Richman, D | 1 |
Amacker, M; Faraj, A; Gosselin, G; Hübscher, U; Imbach, JL; Maga, G; Mathé, C; Sommadossi, JP; Spadari, S | 1 |
Alberici, F; Andreotti, M; Bucciardini, R; Cargnel, A; De Rienzo, B; Fiaccadori, F; Floridia, M; Fragola, V; Francisci, D; Galluzzo, CM; Giannini, G; Grillone, W; Leoncini, F; Nigra, E; Ortona, L; Piazza, M; Pirillo, MF; Ricciardulli, D; Scalzini, A; Tomino, C; Tumietto, F; Vella, S; Weimer, LE | 1 |
Amacker, M; Hübscher, U; Tasara, T | 1 |
Bazmi, HZ; La Colla, P; Mellors, JW; Piras, G; Putzolu, M; Tramontano, E | 1 |
Baba, M; Okamoto, M; Okamoto, T | 1 |
Claessen, FA; Hall, D; Hamann, D; Kauffmann, RH; Koopmans, PP; Kroon, ED; Kroon, FP; Lange, JM; Miedema, F; Montaner, JS; Otto, SA; Pakker, NG; Reiss, P; Roos, MT; Schellekens, PT; Sprenger, HG; ten Napel, CH; van der Ende, ME; Weigel, HM; Wit, FW | 1 |
Liang, C; Quan, Y; Rong, L; Wainberg, MA | 1 |
Brown, AJ; D'Aquila, RT; Günthard, HF; Johnson, VA; Kuritzkes, DR; Richman, DD; Wong, JK | 1 |
Allen, M; Bagenda, D; Bakaki, P; Bray, D; Deseyve, M; Dransfield, K; Ducar, C; Emel, L; Fleming, T; Fowler, MG; Guay, LA; Jackson, JB; Miotti, P; Mirochnick, M; Mmiro, F; Mofenson, L; Musoke, P; Nakabiito, C; Sherman, J | 1 |
Simonds, RJ | 1 |
Lurie, P; Wolfe, SM | 1 |
Cherry, M | 2 |
Temesgen, Z; Wright, AJ | 1 |
Simon-Meyer, J | 1 |
D'Aquila, RT; Günthard, HF; Johnson, VA; Kuritzkes, DR; Leigh Brown, AJ; Precious, HM; Richman, DD; Wong, JK | 1 |
Arens, M; Heyden, NA; Pirounaki, M; Ratner, L | 1 |
Brown, AJ; D'Aquila, RT; Hanna, GJ; Hazelwood, JD; Johnson, VA; Kuritzkes, DR; Richman, DD; Savara, AV | 1 |
Howse, J | 1 |
Bucciardini, R; Fragola, V; Harrigan, PR; Montaner, JS; Raboud, JM; Rae, S; Ricciardulli, D; Vella, S | 1 |
Butler, KM; Clarke, SM; Condon, S; Healy, CM; Mulcahy, F | 1 |
Allende, MC; Belloso, WH; Benetucci, JA; Cahn, PE; Davey, RT; Emery, S; Lane, HC; Lasala, MC; Law, MG; Lopardo, G; Losso, MH; Nelson, E; Salomon, H; Saracco, M | 1 |
King, P; Masland, T | 1 |
Burger, DM; Hoetelmans, RM; Jurriaans, S; Lange, JM; Portegies, P; Prins, JM; Sommadossi, JP; Turner-Foisy, ML; van Praag, RM; Weverling, GJ; Zhou, XJ | 1 |
Hayashi, T | 1 |
Ahmed, PS; Bedard, J; Bowlin, TL; Chambers, P; Clarke, J; Kelly, LA; Rando, RF; Taylor, DL; Tyms, AS; Wood, LJ | 1 |
Andreotti, M; Binelli, A; Bucciardini, R; Floridia, M; Fragola, V; Galluzzo, MC; Giannini, G; Pirillo, MF; Ricciardulli, D; Tomino, C; Vella, S; Weimer, LE | 1 |
Chen, F; Pau, AK; Piscitelli, SC | 1 |
Cooper, PA; Gray, GE; Jivkov, BI; Lala, SG; Schorn, MC | 1 |
Badia, X; Benavides, A; Coma, A; López Lavid, C; Pinto, JL | 1 |
Bower, M; Gazzard, BG; Mandalia, S; Matthews, GV; Moyle, GJ; Nelson, M | 1 |
Escolano, C; Gregori, J; Gutiérrez, F; Moltó, J; Mora, A; Nogueira, E; Pasquau, F | 1 |
Andreotti, M; Bucciardini, R; Floridia, M; Fragola, V; Galluzzo, CM; Giannini, G; Marzi, M; Massella, M; Mirra, M; Pirillo, MF; Ricciardulli, D; Tomino, C; Vella, S; Weimer, LE; Wu, AW | 1 |
Mirochnick, M | 1 |
Fernandez, AD; McNeeley, DF | 1 |
Genka, I; Kikuchi, Y; Oka, S; Tachikawa, N; Teruya, K; Yamamoto, Y; Yasuoka, A; Yasuoka, C | 1 |
Babaki, P; Barré-Sinoussi, F; Charpak, N; de Thé, G; Dovie Akue, JP; Ferreira Rea, M; Huraux, C; Ndiaye, B; Pratomo, H; Samuel, NM; Wilfert, C; Zetterström, R | 1 |
Gosselin, G; Hübscher, U; Maga, G; Pregnolato, M; Spadari, S; Ubiali, D | 1 |
Gilden, D | 1 |
Benson, M; Shannon, M | 1 |
James, JS | 1 |
Mascolini, M | 1 |
Bowersox, J | 1 |
Doepel, L; Folkers, G | 1 |
MacDougall, DS | 2 |
Landry, S | 1 |
Wool, M | 1 |
Kasper, T | 1 |
Sax, PE | 1 |
Lindsay, MK | 1 |
Beijnen, JH; Cooper, DA; Hall, D; Hoetelmans, RM; Lange, JM; Montaner, JS; Reiss, P; Veldkamp, AI; Vella, S; Weverling, GJ | 1 |
Conway, B; Cooper, D; Curry, R; Hall, D; Harris, M; Lange, JM; Montaner, JS; Reiss, P; Robinson, P; Vella, S; Wainberg, MA | 1 |
Newell, ML | 1 |
Goldenberg, RL; Rouse, DJ; Sinkala, M; Stringer, JS; Vermund, SH | 1 |
Brocklehurst, P; Volmink, J | 2 |
Hudson, CP; Moodley, J; Smith, AN | 1 |
Broadhead, R; Fiscus, S; Gibbons, A; Hoover, D; Kumwenda, N; Lema, V; Liomba, G; Mukiibi, J; Taha, TE | 1 |
Delfraissy, JF; Glaziou, P; Kruy, LS; Leng, C; Min, DC; Rekacewicz, C; Saman, M | 1 |
de Wolf, F; Jurriaans, S; Lange, JM; Prins, JM; van Praag, RM; Wit, FW | 1 |
Nattrass, N; Skordis, J | 1 |
Fan, B; Stewart, JT | 2 |
Brenner, B; Detorio, M; Loemba, H; Ma'ayan, S; Moisi, D; Oliveira, M; Parniak, MA; Spira, B; Wainberg, MA | 1 |
Marchei, E; Pacifici, R; Pellegrini, M; Tossini, G; Valvo, L; Zuccaro, P | 1 |
Anderson, JR | 1 |
Flexner, C; Gandhi, R | 1 |
Gallant, JE | 1 |
Aranda, M; Badía, X; Barrufet, P; Cahn, P; Casado, A; Casiró, A; Consiglio, E; Estela, J; Ferrer, E; Gatell, JM; González, A; Llibre, JM; Lozano, L; Luna, E; Lupo, S; Maños, M; Martínez-Lacasa, J; Miró, JM; Ocaña, I; Pedrol, E; Perez, JL; Perez, P; Podzamczer, D | 1 |
Volmink, J | 2 |
Nachega, J | 1 |
Mandel, L; Surattanont, F | 1 |
Becker-Pergola, G; Eshleman, SH; Fleming, T; Guay, LA; Jackson, JB; Mmiro, F; Mracna, M; Musoke, P; Mwatha, A | 1 |
Almond, LM; Back, DJ; De Vries, C; Gould, J; Hoggard, PG; Kewn, S; Khoo, SH; Lou, Y; Maherbe, A; Sales, SD; Wood, R | 1 |
John-Stewart, GC; Kiarie, JN; Kreiss, JK; Richardson, BA | 1 |
Klosinski, L | 1 |
Baldanti, F; Galloni, D; Gerna, G; Lilleri, D; Piccinini, G; Seminari, E | 1 |
Boshoff, L; Coovadia, H; Gigliotti, M; Gray, G; Hall, D; Hofmyer, J; McIntyre, J; Moodley, D; Moodley, J; Nikodem, C; Robinson, P; Sullivan, JL | 1 |
Arnedo, M; Barberá, MJ; Ferrer, E; Fumero, E; Gatell, JM; Gudiol, F; McKenna, P; Pérez, JL; Podzamczer, D; Pumarola, T; Rinehart, A | 1 |
Baldanti, F; Blanca, G; Gerna, G; Hübscher, U; Maga, G; Paolucci, S; Skoblov, AY; Spadari, S; Victorova, L | 1 |
Everall, IP; Foster, R; Olajide, D | 1 |
Oka, S; Teruya, K | 1 |
Kahn, JG; Marseille, E | 1 |
Meldrum, J | 1 |
Das, P | 1 |
Avila-Figueroa, C; Bertozzi, SM; Guijarro, MT; Rely, K | 1 |
Andréola, M; Cruchaga, C; Dollé, V; Martínez-Irujo, JJ; Nguyen, CH; Odriozola, L; Pérez-Mediavilla, A; Tarrago-Litvak, L | 1 |
Bruun, JN | 1 |
Allen, M; Bagenda, D; Bakaki, P; Bray, D; Deseyve, M; Ducar, C; Duefield, C; Emel, L; Fleming, T; Fowler, MG; Gigliotti, M; Guay, LA; Jackson, JB; Miotti, P; Mirochnick, M; Mmiro, F; Mofenson, L; Musoke, P; Mwatha, A; Nakabiito, C; Owor, M; Sherman, J | 1 |
Bertolli, J; Hu, DJ; Macalalad, A; Nieburg, P; Simonds, RJ | 1 |
Broadhead, RL; Fiscus, S; Gibbons, A; Hoover, DR; Kumwenda, NI; Lema, V; Liomba, G; Miotti, PG; Nkhoma, C; Taha, TE | 1 |
Bethel, J; Fowler, MG; Harris, DR; Lambert, JS; Meyer, WA; Mofenson, LM; Moye, J; Stiehm, ER | 1 |
Danner, SA; Gruzdev, B; Jurriaans, S; Lange, JM; Peeters, M; Prins, JM; Rakhmanova, A; Sankatsing, SU; van't Klooster, G; Weverling, GJ | 1 |
Jackson, B; Mmiro, F | 1 |
Boyle, BA | 1 |
Gerntholtz, L | 1 |
Garry, RF; Jaspan, HB | 1 |
Smart, T | 1 |
Barberá, MJ; Barceló, JJ; Ferrer, E; Gallart, T; García, A; García, F; Gatell, JM; Lacarcel, M; Maleno, MJ; Martínez, C; Miró, JM; Plana, M; Podzamczer, D | 1 |
Becquet, R; Bequet, L; Dabis, F; Ekouevi, DK; Inwoley, A; Leroy, V; Rouet, F; Tonwe-Gold, B; Viho, I | 1 |
Beliaeva, VV; Bogoslovskaia, EV; Kravchenko, AV; Miroshnichenko, AV; Serebrovskaia, LV; Sitdykova, IuR | 1 |
Coovadia, H | 1 |
Jourdain, G; Kanshana, S; Koetsawang, S; Lallemant, M; Le Coeur, S; Mary, JY; McIntosh, K; Ngo-Giang-Huong, N; Thaineua, V | 1 |
Ariyadej, S; Bowonwatanuwong, C; Hammer, S; Jourdain, G; Kantipong, P; Lallemant, M; Le Coeur, S; Leechanachai, P; Leenasirimakul, P; Ngo-Giang-Huong, N | 1 |
Broadhead, RL; Chen, S; Fiscus, SA; Hoover, DR; Kafulafula, G; Kumwenda, NI; Liomba, G; Miotti, PG; Nkhoma, C; Nour, S; Taha, TE | 1 |
Beckerman, K; Chavers, S; Covington, DL; Dominguez, K; Garcia, P; Ross, B; Sacks, S; Scheuerle, A; Tilson, H; Watts, DH | 1 |
Herzmann, C; Karcher, H | 1 |
Feinberg, J | 1 |
Gerber, JG; Wyles, DL | 1 |
Byrne, CM; Coughlan, S; Hall, WW; Hopkins, SM; Lyons, FE; Mulcahy, FM | 1 |
Alexander, G; Christie, CD; Figueroa, JP; Harvey, KM; Johnson, N; McDonald, D; Mullings, AA; Palmer, P; Smikle, MF; Whorms, S; Williams, E | 1 |
Christie, CD; Evans-Gilbert, T; Figueroa, JP; Hambleton, I; Palmer, P; Pierre, R; Rodriquez, B; Smikle, MF; Steel-Duncan, JC; Whorms, S | 1 |
Hudson, CP | 1 |
Musoke, P | 1 |
Arts, EJ; Asiimwe, S; Bajunirwe, F; Kamya, MR; Massaquoi, I; Whalen, CC | 1 |
Becquet, R; Bequet, L; Dabis, F; Dequae-Merchadou, L; Ekouevi, DK; Fassinou, P; Horo, A; Leroy, V; Rouet, F; Rouzioux, C; Sakarovitch, C; Viho, I; Welffens-Ekra, C | 1 |
Broadhead, R; Chen, S; Chitale, R; Hoover, D; Kafulafula, G; Katundu, P; Kumwenda, J; Kumwenda, N; Mukiibi, J; Nkhoma, C; Taha, TE | 1 |
Capparelli, E; Cressey, TR; Jackson, JB; Jourdain, G; Kunkeaw, S; Lallemant, MJ; Mirochnick, M; Musoke, P | 1 |
Andréola, M; Cruchaga, C; Martínez-Irujo, JJ; Odriozola, L; Tarrago-Litvak, L | 1 |
Fleming, T; Jackson, B | 1 |
Andrieux-Meyer, I; Bourgeois, A; Calmy, A; Ciaffi, L; Delaporte, E; Lactuock, B; Laurent, C; Liégeois, F; Mougnutou, R; Mpoudi-Ngolé, E; Nkoué, N; Zekeng, L | 1 |
Qazi, S; Uckun, FM; Venkatachalam, TK | 1 |
Baker, SG; Fitzmaurice, GM; Freedman, LS; Kramer, BS | 1 |
Bonjoch, A; Clotet, B; De la Torre, J; Galvez, J; Martínez, E; Miralles, C; Miranda, J; Muñoz-Moreno, JA; Paredes, R; Prieto, A; Videla, S; Vilades, C | 1 |
Bolton, C; Chersich, MF; Gray, GE; McIntyre, JA; Stevens, W; Urban, M; van Niekerk, R; Violari, A | 1 |
Capparelli, E; Connor, JD; Essex, M; Holland, DT; Lockman, S; Mirochnick, M; Peter, T; Shapiro, RL; Stevens, L; Thior, I; Wester, C | 1 |
Chung, MH; John-Stewart, GC; Kiarie, JN; Lehman, DA; Overbaugh, J; Richardson, BA | 1 |
Mahlat, U; Volmink, J | 1 |
Eley, B | 1 |
Abdullah, F; Boulle, A; Coetzee, D; Draper, B; Goemaere, E; Hilderbrand, K | 1 |
Brown, CR; Hong-Brown, LQ; Lang, CH | 1 |
Billaud, E; Bugnon, F; Cua, E; Cuzin, L; Dellamonica, P; Delpierre, C; Massip, P; Pugliese, P; Raffi, F | 1 |
Nolan, D | 1 |
Girault, V | 1 |
Galeano, V; Galli, A; Gutiérrez, S; Lioni, M; Maturo, M; Quian, J; Serra, M; Visconti, A | 1 |
Balfour, HH; Brundage, RC; Cavert, W; Fox, K; Henry, K; Kurpad, AV; Raj, TD; Ravindran, GD; Vezina, HE; Weller, D | 1 |
Averitt, D; Kumar, PN; Pakes, GE; Pappa, KA; Rodriguez-French, A; Shaefer, MS; Tashima, KT; Thompson, MA; Wannamaker, PG; Williams, VC | 1 |
Chen, S; Eshleman, SH; Fiscus, SA; Hoover, DR; Hudelson, SE; Jackson, JB; Kumwenda, NI; Piwowar-Manning, E; Taha, TE | 1 |
Bequet, L; Chaix, ML; Dabis, F; Ekouevi, DK; Leroy, V; Menan, H; Peytavin, G; Rouet, F; Rouzioux, C; Tonwe-Gold, B; Toure, H; Viho, I | 1 |
Greiner, T | 1 |
Alexander, L; Collins, JA; Margolis, A; Paintsil, E | 1 |
Koh, MT | 1 |
Eilers, E; Feiterna-Sperling, C; Obladen, M; Schmitz, T; Weizsaecker, K | 1 |
Besser, M; Bulterys, M; Fowler, MG; Sansom, S; Soorapanth, S; Theron, G | 1 |
Hemanthkumar, AK; Kumaraswami, V; Ramachandran, G; Swaminathan, S | 1 |
Essex, M; Gaseitsiwe, S; Gilbert, PB; Heymann, SJ; Lagakos, S; Lockman, S; Makhema, J; Ndung'u, T; Novitsky, V; Shapiro, RL; Smeaton, LM; Stevens, L; Thior, I; Wester, C | 1 |
Acheampong, E; Argyris, EG; Dornadula, G; Mehlman, K; Nunnari, G; Pomerantz, RJ; Zhang, C; Zhang, H | 1 |
Dabis, F; Nightingale, S | 1 |
Arimi, P; Essex, M; Gilbert, PB; Heymann, SJ; Kebaabetswe, P; Kim, S; Lagakos, S; Lee, TH; Lockman, S; Makhema, J; Marlink, R; Mazonde, P; McIntosh, K; Moffat, C; Ndase, P; Novitsky, V; Peter, T; Shapiro, RL; Smeaton, LM; Stevens, L; Thior, I; van Widenfelt, E; Wester, C | 1 |
de Bethune, MP; Figueiredo, A; Mak, J; Moore, KL; Sluis-Cremer, N; Tachedjian, G | 1 |
Arbess, G; Boyle, E; Chipato, T; Chitsike, I; Glazier, RH; Gottesman, M; Pilon, R; Silverman, M; Simor, A; Spitzer, RF; Thistle, P | 1 |
Andreotti, M; Ceffa, S; Cusato, M; Germano, P; Giuliano, M; Guidotti, G; Liotta, G; Loureiro, S; Mancini, MG; Marazzi, MC; Palombi, L; Pirillo, MF; Regazzi, M; Vella, S; Villani, P | 1 |
Gu, SM | 1 |
Cecelia, AJ; Kumarasamy, N; Mayer, K; Saghayam, S; Solomon, S; Wanke, C | 1 |
Arimi, P; Asmelash, A; Chand, F; Essex, M; Lagakos, S; Lockman, S; Makhema, J; Mazhani, L; Moffat, C; Ndase, P; Novitsky, V; Shapiro, RL; Smeaton, LM; Stevens, L; Thior, I; van Widenfelt, E; Wester, C | 1 |
Becquet, R; Bedikou, G; Bequet, L; Dabis, F; Ekouevi, DK; Fassinou, P; Leroy, V; Sakarovitch, C; Timite-Konan, M; Viho, I | 1 |
Brocklehurst, P; Siegfried, NL; van der Merwe, L; Volmink, J | 1 |
Niamba, P; Taïeb, A; Traoré, A | 1 |
Gibb, DM; Grosskurth, H; Khoo, S; Kikaire, B; Mugyenyi, P; Munderi, P; Namale, L; Reid, A; Ssali, F; Walker, AS | 1 |
Chi, BH; Chintu, N; Lee, A; Sinkala, M; Stringer, EM; Stringer, JS | 1 |
Ket-Aim, S; Poolsup, N; Suksomboon, N | 1 |
Bethel, J; Dharmarajan, S; Jacob, SM; Junankar, V; Parameshwari, S; Read, JS; Samuel, NM; Stoszek, SK; Van Hook, HM; Xu, J | 1 |
Broadhead, RL; Chen, S; Fiscus, SA; Hoover, DR; Jackson, JB; Kafulafula, G; Kumwenda, NI; Miotti, PG; Nkhoma, C; Piwowar, E; Taha, TE | 1 |
Abdoulaye, D; André, C; André, E; Bernard, L; Sandrine, PF; Sylvie, A | 1 |
Baldanti, F; Belfiore, A; Campanini, G; Cancio, R; Gerna, G; Maga, G; Paolucci, S | 1 |
Abdel-Megeed, MF; Kashuba, AD; Rezk, NL | 1 |
Abrams, EJ; Amani-Bosse, C; Becquet, R; Coffie, PA; Dabis, F; Ekouevi, DK; El-Sadr, WM; Leroy, V; Rouet, F; Tonwe-Gold, B; Toure, S; Viho, I | 1 |
Adile, SL; Chandrakar, AK; Garg, ML; Pandey, N; Patel, S | 1 |
Dzombo, D; Essajee, S; Jelagat, J; Mandaliya, K; Mwalimu, M; Shikely, K; Song, R | 1 |
D'costa, GF; Khadke, K; Patil, YV | 1 |
Bharucha, KE; Bhosale, R; Bollinger, RC; Gupta, A; Gupte, N; Kulkarni, P; Nayak, U; Phadke, M; Sastry, J; Tripathy, S | 1 |
Dimarco, M; Dodard, C; Guilbaud, R; Marier, JF; Monif, T; Morelli, G; Singla, AK; Thudi, NR; Tippabhotla, SK | 1 |
Fahey, J; Harrigan, PR; Kuiper, M; Lima, VD; Sheen, CW; Sluis-Cremer, N; Tachedjian, G; Tyssen, D; Wynhoven, B; Yap, SH; Zanin, M | 1 |
Götte, M | 1 |
Chhum, V; Fleury, HJ; Glaziou, P; Koum, K; Kruy, LS; Ly, N; Min, DC; Phoung, V; Reynes, JM; Srey, C | 1 |
Abrams, EJ; Becquet, R; Chaix, ML; Clarisse, AB; Coffie, PA; Dabis, F; Ekouevi, DK; Leroy, V; N'dri-Yoman, T; Rouzioux, C; Tonwe-Gold, B; Viho, I | 1 |
Arts, EJ; Bajunirwe, F; Demers, KR; Fraundorf, E; Kyeyune, F; Lalonde, MS; Mugyenyi, P; Syed, A; Troyer, RM; Whalen, CC | 1 |
Becquet, R; Dabis, F; Dequae-Merchadou, L; Ekouevi, DK; Horo, A; Leroy, V; Rouet, F; Rouzioux, C; Sakarovitch, C; Timité-Konan, M; Tonwe-Gold, B; Viho, I | 1 |
Doerries, R; Drechsler, H; Gass, A; Hardmeier, M; Kuhle, J; Mehling, M; Ruegg, S | 1 |
Bourgeois, A; Calmy, A; Ciaffi, L; Delaporte, E; Kouanfack, C; Koulla-Shiro, S; Laurent, C; Mougnutou, R; Mpoudi-Ngolé, E; Nkoué, N | 1 |
Gomutbutra, V | 1 |
Cheng, J; Han, N; Liu, YN; Liu, ZY; Wei, HS; Zhang, FJ; Zhao, HX; Zhao, Y | 1 |
Anglaret, X; Dabis, F; Dakoury-Dogbo, N; Diakite, N; Duvignac, J; Grundmann, C; Karcher, S; Kouadio, B; Marlink, R; Seyler, C; Toure, S; Traore, M | 1 |
Claassen, M; Cotton, MF; Engelbrecht, S; Laten, JD; Preiser, W; Theron, GB; van Zyl, GU | 1 |
Bulterys, M; Fowler, MG; Hoover, DR; Kafulafula, G; Kumwenda, NI; Li, Q; Mebrahtu, T; Mipando, L; Mofenson, LM; Nkanaunena, K; Taha, TE; Thigpen, MC | 1 |
Gray, GE; Saloojee, H | 1 |
Basseila, GB; Bokilo, AD; Dokekias, AE; Galiba, FO; Malanda, F; Nsitou, MB; Ntsimba, P | 1 |
Chung, MH; John-Stewart, GC; Kiarie, J; Kinuthia, J; Lehman, DA; Overbaugh, J; Richardson, BA | 1 |
Aleyamma, TK; Buck, J; Chaguturu, S; Cu-Uvin, S; Gopalakrishnan, G; Lionel, J; Mayer, K; Varghese, L | 1 |
Bae, WH; Essex, M; Lockman, S; Onyait, K; Shapiro, RL; Smeaton, LM; Thior, I; Wester, C | 1 |
Abdullah, F; Draper, B | 1 |
Abrams, EJ; Becquet, R; Blanche, S; Coffie, PA; Dabis, F; Ekouevi, DK; Horo, A; Leroy, V; Thiebaut, R; Tonwe-Gold, B | 1 |
Chung, MH; John-Stewart, GC; Kiarie, JN; Kinuthia, J; Lehman, DA; Njiri, F; Overbaugh, J; Richardson, BA | 1 |
Mills, J | 1 |
Arimi, P; Asmelash, A; Essex, M; Leidner, J; Lockman, S; Makhema, J; Moffat, C; Ndase, P; Novitsky, V; Rossenkhan, R; Shapiro, RL; Smeaton, L; Stevens, L; Thior, I; Wester, C | 1 |
Capparelli, E; Fowler, MG; Holland, D; Masaba, R; Mirochnick, M; Odhiambo, P; Thigpen, MC; Thomas, T; Weidle, PJ; Zeh, C | 1 |
George, C; Jayakumar, B; Lal, L; Yesoda, A | 1 |
Patel, AK; Patel, JA; Patel, KK; Ranjan, RR; Sharma, R; Shukla, RK | 1 |
Allavena, C; Cahn, P; Clotet, B; Côté, H; Harris, M; Montaner, J; Negredo, E; Ochoa, C; Raffi, F; Singer, J; Thorne, A; Zala, C | 1 |
Barré-Sinoussi, F; Faye, A; Gomuthbutra, V; Lallemant, M; Le Coeur, S; Leechanachai, P; Limtrakul, A; Mary, JY; Matanasaravoot, W; Menu, E; Ngo-Giang-Huong, N; Pornprasert, S; Rugpao, S; Sirivatanapa, P | 1 |
Berzins, B; Evans, S; Forand, J; Hafner, R; Murphy, R; Owens, S; Shevitz, A; Tashima, K; Tebas, P; Yarasheski, K; Zhang, J | 1 |
Fang, L; Han, J; Jiang, Y; Wang, L; Wang, Q; Yao, J; Zhang, Q | 1 |
Black, V; Guidozzi, F | 1 |
Brinkman, K; Danner, SA; Geerlings, SE; Hassink, EA; Lips, P; Reiss, P; Ristola, M; Sutinen, J; van Agtmael, MA; van Vonderen, MG | 1 |
Foster, C; Gibb, DM; Lyall, H; Olmscheid, B; Pearce, G; Zhang, S | 1 |
Chung, MH; John-Stewart, GC; Kiarie, J; Kinuthia, J; Lehman, DA; Mabuka, JM; Overbaugh, J | 1 |
Ammann, AJ | 1 |
Asavapiriyanont, S; Chalermchockcharoenkit, A; Chotpitayasunondh, T; Culnane, M; Leelawiwat, W; McConnell, MS; McNicholl, JM; Mock, PA; Tappero, JW; Teeraratkul, A; Vanprapa, N | 1 |
Agmon-Levin, N; Asher, I; Chowers, M; Cohen, Y; Elbirt, D; Gottesman, G; Gradestein, S; Levi, I; Maayan, S; Risenberg, K; Sthoeger, Z; Torten, D; Turner, D; Werner, B | 1 |
Cao, YL; Chen, H; Guo, Y; Li, SX | 1 |
Christie, CD; Evans-Gilbert, T; Moore, J; Palmer, P; Pierre, RB; Rodriguez, B; Steel-Duncan, J; White, YR | 1 |
Aizire, J; Donnell, D; Eshleman, SH; Fowler, MG; Guay, LA; Jackson, JB; Mmiro, FA; Musoke, PM; Mwatha, AK; Nakabiito, C | 1 |
Averbuch, D; Engelhard, D; Jaouni, T; Pe'er, J | 1 |
Bisseye, C; Buelli, F; Castelli, F; Gnoula, C; Ilboudo, D; Karou, D; Nikiema, JB; Odolini, S; Ouermi, D; Pietra, V; Pignatelli, S; Sagna, T; Sanou, DS; Sia, DJ; Simpore, J | 1 |
Cole, SR; Fowler, MG; Hoover, DR; Kafulafula, G; Kumwenda, J; Kumwenda, NI; Li, Q; Mofenson, L; Taha, TE; Thigpen, MC | 1 |
Fowler, MG; Hoover, DR; Kafulafula, G; Kumwenda, NI; Li, Q; Mipando, L; Mofenson, LM; Nkanaunena, K; Taha, TE; Thigpen, M | 1 |
Eklund, M; Gray, GE; Hall, DB; Hopley, M; Martinson, NA; Mayers, D; McIntyre, JA; Moodley, D; Robinson, P | 1 |
John-Stewart, GC; Lehman, DA; Overbaugh, J | 1 |
Cheng, I; Kuritzkes, DR; Paredes, R; Tuomala, RE | 1 |
Burke, A; Dunn, DT; Gibb, DM; Gilks, CF; Goodall, RL; Kaleebu, P; Katundu, P; Kityo, C; Lyagoba, F; McCormick, A; Munderi, P; Ndembi, N; Pillay, D; Robertson, V; Walker, AS; Yirrell, DL | 1 |
Amuron, B; Birungi, J; Bunnell, R; Coutinho, A; Foster, S; Grosskurth, H; Jaffar, S; Kyomuhangi, R; Levin, J; Mermin, J; Nabiryo, C; Namara, G; Ndembi, N; Opio, A; Tappero, JW | 1 |
Asahchop, EL; Brenner, BG; Moisi, D; Ntemgwa, M; Toni, TA; Wainberg, MA | 1 |
Eshleman, SH; Fowler, MG; Hoover, DR; Kafulafula, G; Kumwenda, N; Li, Q; Lidström, J; Mofenson, LM; Taha, TE; Thigpen, MC | 1 |
Essex, M; Hagan, JE; Kim, S; Lockman, S; Makhema, J; Mitchell, R; Moyo, SM; Musonda, R; Ndung'u, T; Novitsky, V; Rossenkhan, R; Sebunya, TK; Shapiro, R; Thior, I; van Widenfelt, E | 1 |
Abaine, D; Aber, M; Ahimbisibwe, F; Akao, J; Akuma, S; Amuron, B; Amurwon, J; Angweng, E; Anywar, W; Atwiine, D; Atwiine, S; Awio, P; Babiker, A; Babiker, AG; Bafana, T; Bagaya, L; Bahendeka, S; Bakeinyaga, GT; Barungi, G; Bassett, M; Bohannon, J; Boocock, K; Borok, M; Bray, D; Breckenridge, A; Bulaya-Tembo, R; Buluma, E; Burke, A; Burke, C; Byakwaga, H; Byamukama, A; Byaruhanga, R; Chakonza, L; Chidziva, E; Chigwedere, E; Chimanzi, J; Chimbetete, C; Chirairo, H; Chirara, M; Chirema, O; Chitsungo, S; Chivhunga, T; Coutinho, A; Darbyshire, JH; Drasiku, A; Dunn, D; Enzama, R; Etukoit, B; Fadhiru, K; Ferrier, A; Florence, A; Foster, S; Gazzard, B; Generous, L; Gibb, DM; Gilks, C; Gilks, CF; Goodall, R; Grosskurth, H; Grundy, C; Haguma, W; Hakim, J; Hill, C; Hughes, P; Jamu, A; Jangano, M; Jones, S; Kabanda, J; Kabuye, G; Kagina, G; Kajungu, D; Kaleebu, P; Kambungu, A; Kankunda, R; Karungi, J; Kasirye, R; Katabira, E; Katabira, H; Katundu, P; Khauka, P; Kigozi, J; Kikaire, B; Kityo, C; Komugyena, J; Kulume, R; Kusiima, A; Kyomugisha, H; Labeja, O; Lara, AM; Latif, A; Levin, J; Lubwama, E; Lutwama, F; Lyagoba, F; Machingura, I; Machingura, J; Makota, S; Mambule, I; Mapinge, F; Mapuchere, C; Massa, R; Matenga, J; Matongo, M; Maweni, C; Mawora, A; McCormick, A; McLaren, A; Mdege, N; Moyo, K; Muchabaiwa, L; Mudzingwa, S; Mufuka-Kapuya, C; Muganzi, A; Mugisha, A; Mugurungi, O; Mugyenyi, P; Muhweezi, D; Muhwezi, A; Mukiibi, S; Mukose, A; Mulindwa, G; Mulindwa, M; Munderi, P; Murungi, S; Musana, H; Musoro, G; Mutowo, J; Mutsai, S; Muvirimi, C; Muyingo, S; Muzambi, M; Mwebesa, D; Mwesigwa, P; Nabankema, E; Nabongo, P; Naidoo, B; Nairuba, R; Nakahima, W; Nakazibwe, M; Nakiyingi, J; Nalumenya, R; Namale, L; Namara, W; Namata, I; Namazzi, A; Namuli, T; Namyalo, M; Nanfuka, A; Nanfuka, R; Nassuna, G; Ndembi, N; Newland, C; Ngorima, N; Nimwesiga, E; Nsibambi, D; Nyachwo, L; Nyiraguhirwa, D; Ochai, R; Ojiambo, H; Ojiambo, W; Oketta, F; Omony, W; Otim, T; Oyugi, J; Palfreeman, A; Pascoe, M; Pearce, G; Peto, L; Peto, T; Phiri, M; Pillay, D; Pozniak, A; Puddephatt, C; Rahim, S; Rauchenberger, M; Reid, A; Robertson, V; Ronald, A; Rooney, J; Ruberantwari, A; Rutikarayo, N; Sabiiti, J; Sadik, F; Sematala, F; Serwadda, D; Sheehan, S; Simango, M; Smith, M; Snowden, W; Spencer-Drake, C; Spyer, M; Ssali, F; Steens, JM; Svovanapasis, P; Takubwa, J; Taylor, K; Taziwa, F; Tinago, G; Todd, J; Tugume, S; Tukamushaba, J; Tumukunde, D; Tumusiime, C; Twijukye, C; Vere, L; Waita, R; Wakholi, BN; Walker, AS; Walusimbi, J; Wangati, K; Wanyama, J; Wapakhabulo, AC; Warambwa, C; Warara, R; Wavamunno, P; Weller, I; Whitworth, J; Wilkes, H; Winogron, D; Yirrell, D; Zalwango, A; Zalwango, E; Zawedde, C; Zengeza, E | 1 |
Battegay, M; Bernasconi, E; Cavassini, M; Elzi, L; Furrer, H; Hirschel, B; Ledergerber, B; Marzolini, C; Vernazza, P; Weber, R | 1 |
Hou, T; Liu, JS; Wang, W; Zhang, J | 1 |
Babiker, AG; Darbyshire, JH; Gibb, DM; Gilks, CF; Grosskurth, H; Kityo, C; Mugyenyi, P; Munderi, P; Reid, A; Ssali, F; Walker, AS | 1 |
Achalapong, J; Ariyadej, S; Chotivanich, N; Collins, IJ; Cressey, TR; Frenkel, LM; Hemvuttiphan, J; Jarupanich, T; Jourdain, G; Kanchana, S; Kanjanasing, A; Kengsakul, K; Koetsawang, S; Lallemant, M; Le Coeur, S; Liampongsabuddhi, P; McIntosh, K; Ngo-Giang-Huong, N; Pornkitprasarn, W; Ratanakosol, J; Sabsanong, P; Sittipiyasakul, V; Sukhumanant, T; Traisaithit, P; Van Dyke, RB; Wannapira, W; Winiyakul, N | 1 |
Cotton, MF; Rabie, H; van Zyl, GU | 1 |
Deshpande, A; Fleury, HJ; Jeannot, AC; Pinson, P; Schrive, MH; Wittkop, L | 1 |
Asboe, D; Dunn, D; Fearnhill, E; Gazzard, B; Pillay, D; Pozniak, A; Price, H | 1 |
Butini, L; Cirioni, O; Costantini, A; Giacometti, A; Montroni, M; Scalise, G | 1 |
Aparna, P; Badarinadh Gupta, P; Mukkanti, K; Narayan, GK; Rangarao, K; Rao, SV; Sandip, T; Thomas, KM; Upendra, K | 1 |
Bryan, G; Bweupe, M; Colebunders, R; Kabaso, M; Kasonde, P; Mukonka, V; Mwale, F; Torpey, K; Weaver, MA; Zimba, C | 1 |
Ahmed, YI; Chasela, CS; Chigwenembe, M; Ellington, SR; Fiscus, SA; Hoffman, IF; Hosseinipour, MC; Hudgens, MG; Jamieson, DJ; Kacheche, Z; Kamwendo, DD; Kayira, D; Kazembe, P; Knight, RJ; Kourtis, AP; Martinson, F; Mofolo, IA; Sichali, DS; Soko, A; Tegha, G; van der Horst, CM; Wiener, JB | 1 |
Akhtar, M; Asmelash, A; Essex, M; Handelsman, E; Hughes, MD; Jayeoba, O; Kitch, D; Leidner, J; Lockman, S; Lubega, E; Makhema, J; Martinez-Tristani, M; Mazhani, L; Mburu, K; McIntosh, K; Moffat, C; Moko, E; Moyo, S; Ogwu, A; Powis, K; Shapiro, RL; Sharma, U; Snowden, W; Souda, S; Thior, I; Tumbare, E; Tuomola, R; van Widenfelt, E; Wester, C; Zwerski, S | 1 |
Cisse, M; Doulougou, B; Kouanda, S; Ouedraogo, CM; Ouedraogo, G; Pietra, V; Simpore, J; Sondo, B; Soudre, R; Tougri, H | 1 |
Banda, HN; Chasela, C; Eron, JJ; Farr, SL; Fiscus, SA; Jamieson, DJ; Johnson, JA; Kashuba, AD; Kourtis, AP; Lipscomb, J; Matiki, C; Mpaso, M; Nelson, JA; Ng'ombe, TJ; Tegha, GL; van der Horst, C; Wiener, J | 1 |
Abrams, EJ; Amani-Bosse, C; Chaix, ML; Coffie, PA; Dabis, F; Ekouevi, DK; Leroy, V; Tonwe-Gold, B | 1 |
Bancheno, WM; Mareverwa, J; Mwanyumba, F | 1 |
Castelnuovo, B; Kamya, MR; Kiragga, A; Manabe, Y | 1 |
Bachani, D; Chan, PL; Deshpande, A; Rajasekaran, S; Rewari, BB; Srikantiah, P | 1 |
Rutherford, GW; Siegfried, N; Spaulding, A | 1 |
De Bruyn, G; Gray, GE; Harwell, JI; Lurie, MN; McGarvey, ST; Triche, EW; Venkatesh, KK | 1 |
Arrivé, E; Avit, D; Benaboud, S; Blanche, S; Dabis, F; Ekouévi, DK; Gray, G; Hirt, D; McIntyre, J; Nerrienet, E; Rey, E; Sim, KL; Tréluyer, JM; Urien, S | 1 |
Biwolé-Sida, M; Bork, K; Coudray, M; Cournil, A; Delaporte, E; Essomba, CN; Kouanfack, C; Laurent, C; Tonfack, CA | 1 |
Delaporte, E; Diouf, A; Etard, JF; Girard, PM; Landman, R; Laurent, C; Molinari, N; Ndoye, I; Ngom Guèye, NF; Sow, PS; Tchatchueng Mbougua, JB | 1 |
Bitarakwate, E; Byamugisha, J; Fowler, MG; Galla, M; Kayma, S; Kekitiinwa, A; Maganda, A; Matovu, J; Mubiru, M; Mudiope, P; Musoke, P; Namukwaya, Z; Salmond, W | 1 |
de Vincenzi, I | 1 |
Basu, S; Das, BK; Kumar, A | 1 |
Alvarez, A; Azcoaga-Lorenzo, A; del Amo, J; Ferreyra, C; Palma, PP; Velilla, E | 1 |
Baumann, J; Delviks-Frankenberry, KA; Lengruber, RB; Nikolenko, GN; Pathak, VK; Santos, AF; Soares, MA | 1 |
Albert, J; de Rivera, IL; Karlsson, AC; Largaespada, N; Murillo, W; Naver, L; Parham, L | 1 |
Fowler, MG; Hoover, DR; Kumwenda, J; Kumwenda, NI; Li, Q; Mipando, L; Mofenson, LM; Nkanaunena, K; Taha, TE; Taylor, A; Thigpen, MC | 1 |
Eshleman, SH; Fogel, J; Fowler, MG; Hoover, DR; Kumwenda, N; Mofenson, LM; Sun, J; Taha, TE; Taylor, AW | 1 |
Blevins, M; Burlison, JR; Ciampa, PJ; Moon, TD; Rothman, RL; Sidat, M; Vermund, SH | 1 |
Chu, J; Ciaranello, AL; Dabis, F; Engelsmann, B; Freedberg, KA; Keatinge, J; Maruva, M; Mugwagwa, R; Mushavi, A; Perez, F; Walensky, RP | 1 |
Arendt, V; Gras, A; Henry, AP; Karasi, JC; Karasi-Omes, C; Sauvageot, N; Schmit, JC; Schneider, S; Seguin-Devaux, C; Ternes, AM | 1 |
Dia, AT; Diallo, PD; Gaye, AM; Sow, PG | 1 |
Brocklehurst, P; Siegfried, N; Sint, TT; van der Merwe, L | 1 |
Atun, R; Ben-Smith, A; Chimbwandira, F; Chirwa, Z; Gilks, CF; Harries, AD; Jahn, A; Lynen, L; Makombe, SD; Meguid, T; Midiani, D; Mnthambala, A; Schouten, EJ; Shawa, M; Van Damme, W; van Oosterhout, JJ; Zachariah, R; Zolfo, M | 1 |
Bacheler, L; Dunn, DT; Gilks, C; Goodall, RL; Kaleebu, P; Kityo, C; Munderi, P; Pillay, D; Ranopa, M; Van Houtte, M | 1 |
Chen, S; Fowler, MG; Hoover, DR; Kumwenda, NI; Mipando, L; Mofenson, LM; Nkanaunena, K; Taha, TE; Taylor, A; Thigpen, MC | 1 |
Claassen, M; Preiser, W; van der Merwe, L; van Zyl, GU; Zeier, M | 1 |
Calis, JC; de Wit, TF; Geelen, SP; Sigaloff, KC; van Vugt, M | 1 |
Davis, CA; Hughes, SH; Parniak, MA | 1 |
Dawson, L; Dixon, DO; Lie, RK; Shah, SK | 1 |
Gibb, DM; Gilks, CF; Grosskurth, H; Hakim, J; Kityo, C; Mambule, I; Munderi, P; Reid, A; Ssali, F; Stöhr, W; Walker, AS | 1 |
Beck-Engeser, GB; Eilat, D; Wabl, M | 1 |
Achalapong, J; Beck, IA; Britto, P; Chotivanich, N; Cressey, TR; Frenkel, L; Jourdain, G; Maupin, R; Mirochnick, M; Ngo-Giang-Huong, N; Prommas, S; Puthanakit, T; Rasri, W; Roongpisuthipong, A; Shapiro, DE; Van Dyke, RB; Yuthavisuthi, P | 1 |
Drake, AL; Emery, S; Farquhar, C; Hitti, J; John-Stewart, G; Kiarie, J; Ongecha-Owuor, F; Overbaugh, J; Richardson, BA; Roxby, AC; Wald, A | 1 |
Back, DJ; Else, LJ; Khoo, SH; Taylor, S | 1 |
Aurpibul, L; Capparelli, E; Chokephaibulkit, K; Cressey, TR; Eksaengsri, A; Hongsiriwon, S; Kabat, B; Limwongse, C; McIntosh, K; Muresan, P; Ngampiyaskul, C; Sirisanthana, V; Smith, ME; Toye, M; Wittawatmongkol, O; Yogev, R | 1 |
Beck-Sagué, CM; Fernandez, AD; Leonardo-Guerrero, J; Nicholas, SW; Roman-Pouriet, J; Schmidt, NC | 1 |
Boltz, VF; Chow, JY; Coffin, JM; Gray, GE; Hall, DB; Hopley, MJ; Maldarelli, F; Martinson, NA; Mayers, D; McIntyre, JA; Mellors, JW; Palmer, S; Robinson, P | 1 |
Balzarini, J; Derudas, M; Grivel, JC; Introini, A; Lisco, A; Margolis, L; McGuigan, C; Merbah, M; Munawwar, A; Schinazi, RF; Vanpouille, C | 1 |
Anastos, K; Burger, H; Foley, B; Hamy, F; Kemal, KS; Klimkait, T; Mayers, D; Minin, VN; Petrovic, K; Ramirez, CM; Suchard, MA; Weiser, B | 1 |
Agu, KA; Akpoigbe, KJ; Badru, T; Chabikuli, O; Eluwa, GI; Hamelmann, C | 1 |
Choudhury, H; Das, A; Gorain, B; Nandi, U; Pal, TK; Roy, B | 1 |
Dugange, F; Harms, G; Hauser, A; Kuecherer, C; Kunz, A; Lau, I; Mbezi, P; Sewangi, J; Theuring, S; Ziske, J | 1 |
Beck, IA; Blanco, AJ; Carlsson, J; Dross, S; Frenkel, LM; Gantt, S; Gloyd, S; Jamisse, L; Matediana, E; Matunha, L; Micek, MA; Montoya, P; Seidel, K | 1 |
Adair, LS; Chasela, CS; Ellington, SR; Fiscus, SA; Hoffman, I; Hosseinipour, MC; Hudgens, MG; Jamieson, DJ; Kacheche, Z; Kamwendo, DD; Kayira, D; King, CC; Knight, RJ; Kourtis, AP; Martinson, F; Mofolo, IA; Sichali, DS; Soko, A; Tegha, G; van der Horst, C; Wiener, JB | 1 |
Chen, Z; Chu, Y; Qiu, M; Song, H; Wang, Q; Wu, Z; Yuan, Z | 1 |
Drake, AL; Emery, S; Farquhar, C; John-Stewart, GC; Kiarie, JN; Matemo, DN; Ongecha-Owuor, F; Overbaugh, J; Richardson, B; Roxby, AC; Wald, A | 1 |
Bastos, FI; Bethel, J; Bryson, YJ; Camarca, M; Ceriotto, M; Dickover, R; Fonseca, R; Gray, G; Grinsztejn, B; Joao, EC; Kreitchmann, R; Machado, D; Mirochnick, M; Mofenson, LM; Moreira, RI; Morgado, MG; Moye, J; Mussi-Pinhata, MM; Nielsen-Saines, K; Pilotto, JH; Pinto, J; Santos, B; Siberry, G; Theron, G; Veloso, VG; Watts, DH; Xu, J | 1 |
Abrams, EJ; Barlow-Mosha, L; Bobat, R; Chi, BH; Cotton, MF; Eshleman, SH; Hughes, MD; Jean-Philippe, P; Kamthunzi, P; Khadse, S; Lindsey, JC; Millar, L; Mofenson, LM; Moultrie, H; Mujuru, HA; Palumbo, P; Petzold, E; Purdue, L; Schimana, W; Violari, A | 1 |
Herman, BD; Radzio, J; Sluis-Cremer, N; Tachedjian, G; Yap, SH | 1 |
Jaye, A; Oko, F; Okomo, U; Peterson, I; Peterson, K; Togun, T; Townend, J | 1 |
Capeau, J; Danner, SA; Domingo, P; Feeney, ER; Mallon, PW; Reiss, P; van Agtmael, MA; van Vonderen, MG; Villarroya, F; Wit, F | 1 |
Bajunirwe, F; Kiwanuka, J; Nyesigire Ruhinda, E | 1 |
Côté, HC; Hukezalie, KR; Thumati, NR; Wong, JM | 1 |
Capparelli, E; Essex, M; Leidner, J; Lockman, S; Makhema, J; Moffat, C; Moss, M; Moyo, S; Ogwu, A; Rossi, S; Shapiro, RL | 1 |
Agbaji, O; Ekong, E; Graham, C; Hawkins, C; Idoko, J; Kanki, P; Meloni, S; Muazu, M; Murphy, R; Nimzing, L; Sankalé, JL; Thio, CL | 1 |
Ananworanich, J; Chomchey, N; Gerschenson, M; Hongchookiat, P; Jadwattanakul, T; Kerr, SJ; Kim, JH; Mathajittiphun, P; Phanuphak, N; Phanuphak, P; Pinyakorn, S; Praihirunyakit, P; Rungrojrat, P; Shikuma, C; Teeratakulpisarn, N; Valcour, V | 1 |
Adams, O; Bolten, M; Borkhardt, A; Laws, HJ; Neubert, J; Niehues, T; Pfeffer, M; Reuter, S; Stannigel, H | 1 |
Aweeka, FT; Huang, L; Levy, JA; Liu, L; Siu, V; Teque, F; Wang, L | 1 |
Babu, KN; Kumar, BR; Kumar, VR; Reddy, BP; Sreekanth, K | 1 |
Frenkel, L; Ton, Q | 1 |
Darak, S; Darak, T; Hutter, I; Janssen, F; Kulkarni, S; Kulkarni, V; Parchure, R | 1 |
Barr, CD; Essex, M; Makhema, J; Maruapula, D; Mongwato, D; Moyo, S; Novitsky, V; Pain, D; Wang, R; Weng, J | 1 |
Arnett, DK; Bagchi, S; Chi, BH; Heimburger, DC; Kabagambe, EK; Kiage, JN; Koethe, JR; Nyirenda, CK; Wellons, MF | 1 |
Adeyeye, M; Edowhorhu, G; Esseku, F; Gbadero, D; Joshi, A; Oyegbile, Y | 1 |
Holmes, D | 1 |
Aguilar, A; De La Torre, J; Del Arco, A; García-Alegría, J; Olalla, J; Pombo, M; Prada, JL; Ruiz-Mateas, F; Urdiales, D | 1 |
Delaporte, E; Desclaux, A; Koita Fall, MB; Ndoye, I; Taverne, B | 1 |
Ao, Z; Chen, L; Jayappa, KD; Kobinger, G; Liu, S; Wainberg, MA; Wu, G; Yao, X | 1 |
Aghokeng, A; Belec, L; Bertagnolio, S; Bunupuradah, T; Burda, S; Cane, P; Cappelli, G; Charpentier, C; Dagnra, AY; de Wit, TF; Deshpande, AK; El-Katib, Z; Eshleman, SH; Fleury, HJ; Fokam, J; Ford, N; Gody, JC; Hamers, RL; Hawkins, CA; Holmes, S; Hosseinipour, MC; Jordan, MR; Kanki, PJ; Katzenstein, D; Koyalta, DD; Kumwenda, JJ; Lallemant, M; Lynen, L; Manosuthi, W; Marconi, VC; Margot, NA; Moussa, S; Ndung'u, T; Ngo-Giang-Huong, N; Nyambi, PN; Orrell, C; Peeters, M; Rhee, SY; Ruxrungtham, K; Schapiro, JM; Schuurman, R; Shafer, RW; Sigaloff, KC; Sirivichayakul, S; Smith, D; Stevens, W; Tang, MW; van Zyl, GU; Wallis, CL; Zolfo, M | 1 |
Chamnanchanunt, S; Chierakul, W; Desakorn, V; Kiertiburanakul, S; Kyaw, NL; Manosuthi, W; Pitisuttithum, P; Sungkanuparph, S; Thanachartwet, V | 1 |
Chasela, C; Ellington, SR; Hosseinipour, M; Hyde, L; Jamieson, DJ; Kayira, D; Kourtis, AP; van der Horst, C; Wiener, J | 1 |
Boonsuk, S; Butchon, R; Chokephaibulkit, K; Kullert, N; Kulpeng, W; Phanuphak, N; Pilasant, S; Tantivess, S; Teerawattananon, Y; Tosanguan, K; Voramongkol, N; Werayingyong, P | 1 |
Bosco, O; Cruciani, M; Malena, M; Mengoli, C; Parisi, SG; Serpelloni, G | 1 |
Amie, SM; Bambara, RA; Daly, MB; Kim, B; Noble, E; Schinazi, RF | 1 |
Massawe, A; Mghamba, FW; Minzi, OM; Sasi, P | 1 |
Ampofo, WK; Barnor, JS; Brandful, JA; Ibe, S; Ishikawa, K; Nii-Trebi, NI; Ofori, SB; Sugiura, W; Yamaoka, S | 1 |
Gedefaw, L; Sahlemariam, Z; Yemane, T; Yilma, D | 1 |
de Oliveira, T; Lessells, RJ; Manasa, J; McGrath, N; Naidu, KK; Newell, ML; Skingsley, A | 1 |
Blanco, J | 1 |
Allen, M; Donnell, D; Fowler, MG; Guay, LA; Jackson, JB; Mmiro, F; Musoke, P; Mwatha, A; Owor, M | 1 |
Bentaleb, H; Cisse, VM; Dia Badiane, NM; Dieng, AB; Diop, BM; Diop, SA; Diouf, A; Fortes Déguénonvo, L; Ka, D; Lakhe, NA; Leye, MM; Manga, MN; Ndour, CT; Seydi, M; Soumaré, M; Sow, PS | 1 |
Chersich, MF; Farley, TM; Luchters, S; Meda, N; Mwaura, M; Newell, ML; Sartorius, BK; Temmerman, M | 1 |
Lu, H; Qi, T; Shen, Y; Wang, J; Wang, Z | 1 |
Gilks, CF; Goodall, RL; Gupta, RK; Kaleebu, P; Kityo, C; Lyagoba, F; Mugarura, L; Munderi, P; Pillay, D; Ranopa, M | 1 |
Doumbo, OK; Guirou, EA; Hendrix, CW; Kayentao, K; Nyunt, MM; Parsons, TL; Plowe, CV; Venkatesan, M | 1 |
Adedeji, WA; Adewole, IF; Akinola, IT; Akinyinka, OO; Aweeka, FT; Darin, KM; Fehintola, FA; Lindegardh, N; Ma, Q; Morse, GD; Murphy, RL; Ojengbede, O; Parikh, S; Scarsi, KK; Taiwo, B; Tarning, J | 1 |
Anino, E; Choge, JK; Khayeka-Wandabwa, C; Kweka, EJ; Ngemu, EK; Oyoo-Okoth, E | 1 |
Bharti, A; Chakravarty, J; Goel, R; Meena, LP; Rai, M; Sundar, S; Tiwary, NK | 1 |
Choun, K; De Weggheleire, A; Lynen, L; Phirum, L; Thai, S; van Griensven, J | 1 |
Boppana, SB; Chowdhury, N; Hsiao, NY; Hutto, C; Kroon, SM; Manicklal, S; Novak, Z; Pati, SK; van Niekerk, AM | 1 |
Audu, RA; Ekama, SO; Ezechi, OC; Odeigah, PG; Onwuamah, CK; Poirier, MC | 1 |
Dunn, DT; Gibb, DM; Gilks, CF; Goodall, RL; Kaleebu, P; Kasirye, R; Kityo, C; Mambule, I; Mugyenyi, P; Pillay, D; Walker, AS | 1 |
Aghokeng, AF; Chia, JE; Delaporte, E; Einterz, E; Eymard-Duvernay, S; Molina, JM; Mpoudi-Ngole, E; Peeters, M; Taieb, F | 1 |
Abongomera, G; Arach, B; Asiimwe, AR; Cook, A; Gibb, DM; Kabamba, D; Kayiwa, J; Kekitiinwa, A; Kenny, J; Kityo, C; Klein, N; Komunyena, J; Mirembe, G; Mulenga, V; Musiime, V; Nansubuga, C; Walker, SA; Wavamunno, P; Zangata, D | 1 |
Crowe, SM; David, M; Gare, J; Hearps, AC; Imara, U; Kaima, P; Kelly-Hanku, A; Kombati, Z; Ryan, CE; Siba, PM; Timbi, D | 1 |
Abbas, SQ; Abro, AG; Baig-Ansari, N; Kazi, MA; Mir, F; Qamar, FN; Rizvi, A; Zaidi, AK | 1 |
Holla, P; Jameel, S; Munshi, SU; Panda, H; Rewari, BB | 1 |
Gui, T; Guo, W; Jia, L; Jiao, L; Li, H; Li, J; Li, L; Liu, S; Liu, Y; Zhuang, D | 1 |
Clumeck, N; Delforge, M; Ilunga, J; Kabeya, K; Kadiebwe, D; Kapend, L; Kasamba, E; Matanda, S; Milolo, C; Mwamba, C; Necsoi, C; Vaira, D | 1 |
Audu, RA; Ezechi, OC; Herbertson, EC; Odeigah, PG; Onwuamah, CK; Ujah, IA | 1 |
Aoko, A; Bii, M; Close, N; Khamadi, S; Kiptoo, I; Langat, RC; Langat, RK; Maswai, J; Obiero, E; Sawe, FK; Shaffer, DN; Shikuku, KP; Sinei, S; Tarus, J; Yegon, P | 1 |
Fan, P; Li, J; Li, N; Liang, Y; Ma, Y; Sun, D; Wang, Z; Yang, W; Zhu, Q | 1 |
Aris, E; Baernighausen, T; Chalamilla, G; Fawzi, W; Hertzmark, E; Jackson, E; Machumi, L; Muya, A; Mwanyika-Sando, M; Sando, D; Spiegelman, D | 1 |
Gordon, M; Moodley, P; Naidoo, A; Parboosing, R; Paredes, R; Samuel, R; Singh, L | 1 |
Barlow-Mosha, L; Cotton, M; Dominguez, K; Ford, N; Penazzato, M | 1 |
Barr, E; Davies, J; Forster, JE; Kinzie, K; Levin, MJ; McFarland, EJ; Pappas, J; Paul, S; Smith, C; Weinberg, A | 1 |
Abrams, EJ; Epie, F; Geffner, ME; Jao, J; Kirmse, B; Kurland, IJ; LeRoith, D; Nshom, E; Powis, K; Qiu, Y; Sperling, RS; Tih, PM; Yu, C | 1 |
Bhardwaj, S; Chopra, M; Dinh, TH; Doherty, T; Goga, A; Jackson, D; Lombard, C; Mogashoa, M; Pillay, Y; Puren, A; Ramokolo, V; Shaffer, N; Sherman, G; Woldesenbet, S | 1 |
Antony, J; Arumugam, K; D'Souza, G; De Costa, A; Kumar, DS; Kumarasamy, N; Poongulali, S; Rewari, BB; Shastri, S; Shet, A | 1 |
Bonnet, F; Calmy, A; Ciaffi, L; Delhumeau, C; Fampou, JC; Hill, A; Menga, G; Nchotu Ngang, P; Rougemont, M; Stoll, B | 1 |
Cressey, TR; Jourdain, G; Kanjanavikai, P; Klinbuayaem, V; Koetsawang, S; Lallemant, M; Le Coeur, S; Mcintosh, K; Ngo-Giang-Huong, N; Sabsanong, P; Sirirungsi, W; Traisathit, P | 1 |
Chirwa, M; Ishikawa, N; Jimba, M; Kapyata, H; Komada, K; Miyano, S; Msiska, CY; Okawa, S; Syakantu, G; Yasuoka, J | 1 |
Abongomera, G; Asiimwe, A; Burger, D; Chabala, C; Chintu, C; Cook, AD; Gibb, DM; Kekitiinwa, A; Kenny, J; Kityo, C; Klein, N; McIlleron, H; Mirembe, G; Mulenga, V; Musiime, V; Owen-Powell, E; Thomason, MJ; Walker, AS | 1 |
Catalan, IC; de Rozieres, CM; Dowling, CC; Hoefer, MM; Kaul, M; Maung, R; Sanchez, AB; Sejbuk, NE; Varano, GP | 1 |
Federico, M; Frezza, C; Grelli, S; Macchi, B; Marino-Merlo, F; Mastino, A | 1 |
Agbaji, OO; Darin, KM; Eisen, G; Gashau, W; Kanki, PJ; Meloni, ST; Murphy, RL; Nkado, R; Okonkwo, P; Onwujekwe, DI; Rawizza, HE; Scarsi, KK; Tchetgen Tchetgen, EJ | 1 |
Cotton, MF; Holgate, S; Mirochnick, M; Nelson, A; Rabie, H; Wedderburn, C | 1 |
Godet, J; Mély, Y; Przybilla, F; Restle, T; Sharma, KK | 1 |
Maharaj, N; Moodley, D; Moodley, T; Sartorius, B; Sebitloane, M | 1 |
Fan, P; Li, N; Liang, Y; Nie, Y; Sun, D; Wang, Z; Yang, W; Zhu, Q | 1 |
Birnbaum, JM; Cha, A; Elsamadisi, P; Phipps, E; Su, CP | 1 |
Dogra, S; Gupta, A; Kumar, A; Suri, D | 1 |
Gordon, M; Julian, MN; Moodley, P; Naidoo, A; Parboosing, R; Paredes, R; Samuel, R; Singh, L | 1 |
Bacha, T; Olana, T; Tadesse, BT; Worku, W | 1 |
Birbal, S; Dheda, M; Ojewole, E; Oosthuizen, F | 1 |
Abach, J; Abongomera, G; Chabala, C; Colebunders, R; Cook, A; Gibb, DM; Kekitiinwa, A; Kityo, C; Lamorde, M; Mulenga, V; Musiime, V; Thomason, M; Walker, AS | 1 |
Basar, M; Bhosale, R; Bobat, R; Browning, R; Chi, BH; Chipato, T; Coletti, AS; Currier, JS; Fenton, T; Fiscus, SA; Flynn, PM; Fowler, MG; Gnanashanmugam, D; Klingman, KL; Loftis, AJ; Martinson, FE; McIntyre, J; Mlay, P; Mofenson, LM; Moodley, D; Owor, M; Purdue, L; Qin, M; Shapiro, DE; Siberry, GK; Strehlau, R; Taha, TE; Theron, GB; Violari, A | 1 |
Adesanya, OJ; Adeyeye, MC; Esseku, F; Gbadero, D; Joshi, A | 1 |
Barlow-Mosha, L; Borkowsky, W; Chen, J; Chi, BH; Deygoo, N; Duffy, PE; Gabriel, EE; Hobbs, CV; Ilmet, T; Jean Philippe, P; Kamthunzi, P; Kirmse, B; Li, Y; Mofenson, L; Musoke, P; Neal, J; Palumbo, P; Parikh, S; Petzold, E; Prescott, W; Tauzie, J; Tegha, G | 1 |
Alteri, C; Bernardi, S; Bertoli, A; Liuzzi, G; Manno, EC; Palma, P; Perno, CF; Rossi, P; Tchidjou, HK; Zangari, P | 1 |
Harrison, M; Matjila, M; Riemer, L; Tooke, L | 1 |
Dunn, DT; Gilks, C; Goodall, RL; Gupta, RK; Kaleebu, P; Kityo, C; Mugarura, L; Munderi, P; Nkurunziza, P; Pattery, T; Pillay, D | 1 |
Aarons, L; Borkird, T; Capparelli, EV; Cressey, TR; Jittayanun, K; Jourdain, G; Lallemant, M; Le Coeur, S; Luvira, A; Phanomcheong, S; Puangsombat, A; Punyawudho, B; Saenjum, C; Sukrakanchana, PO; Urien, S | 1 |
Awoke, T; Birlie, B; Braekers, R; Kasim, A; Shkedy, Z | 1 |
Canals, F; Gutiérrez, F; Masiá, M | 1 |
Brambilla, D; Ceffa, S; De Luca, A; Liotta, G; Luhanga, R; Magid, NA; Mancinelli, S; Marazzi, MC; Palombi, L; Sidumo, ZJ; Zanelli, G | 1 |
Emanuel, K; Fox, HS; Lamberty, BG; Morsey, B; Stauch, KL | 1 |
Abrams, EJ; Côté, HCF; Epie, F; Geffner, ME; Jao, J; Kirmse, B; Kurland, IJ; Leroith, D; Nshom, E; Powis, KM; Sperling, RS; Yu, C | 1 |
Chen, X; Fairley, CK; He, J; Jing, J; Mao, L; Sasadeusz, J; Su, S; Wei, X; Zeng, H; Zhang, L | 1 |
Aroke, D; Bechem, NN; Dimala, CA; Kadia, BM | 1 |
Cuong, DD; Dung, NT; Dung, NTH; Haneuse, S; Kinh, NV; Matsumoto, S; Oka, S; Tanuma, J; Thuy, PTT; Trung, NV; Vu, TV | 1 |
Awodele, O; Oshikoya, KA; Popoola, TD | 1 |
Castelnuovo, B; Gonza, P; Kambugu, A; Kiragga, AN; Mbabazi, O; Mubiru, F; Musomba, R; Ratanshi, RP | 1 |
Antony, J; Ashoor, HM; Blondal, E; Finkelstein, Y; Ghassemi, M; Gough, K; Hemmelgarn, BR; Hutton, B; Ivory, JD; Khan, PA; Lillie, E; Straus, SE; Tricco, AC; Vafaei, A; Veroniki, AA | 1 |
Desai, M; Dinh, C; Gonzalez, R; Haaland, RE; Heneine, W; Katana, A; Martin, A; Menendez, C; Otieno, K; Slutsker, L; Williamson, J | 1 |
Adeyeye, CM; Ali, I; Aliu, R; Awodele, O; Oni, Y | 1 |
Agyingi, K; Domkam, I; Joyce, AN; Keou, CK; Mbu, RE; Moudourou, S; Nanfack, A; Njefi, K; Sosso, S; Takang, W; Takou, D; Torimiro, JN | 1 |
Chendi, BH; Eyoh, A; Ikomey, GM; Jacobs, GB; Lyonga, E; Mesembe, M; Okomo Assoumou, MC; Yekwa, EL | 1 |
Huang, JP; Huang, WH; Luo, SD; Luo, XL; Mo, LD; Ni, ZY; Su, GS; Su, HZ; Wu, JY | 1 |
Aling, E; Bbosa, N; Kaleebu, P; Kapaata, A; Kateete, DP; Lunkuse, S; Nabirye, SE; Nannyonjo, M; Nassolo, F; Nsubuga, RN; Omooja, J; Sanyu, G; Segujja, F; Ssebaggala, E; Ssemwanga, D | 1 |
Anugulruengkitt, S; Chokephaibulkit, K; Cressey, TR; Jantarabenjakul, W; Ounchanum, P; Pancharoen, C; Punnahitanon, S; Puthanakit, T; Sophonphan, J; Srirompotong, U; Suntarattiwong, P | 1 |
Chen, IT; Chen, JK; Chen, YS; Lee, SS; Sy, CL; Tsai, HC; Tseng, YT; Weng, YW; Wu, KS | 1 |
Barros Silva, LCPB; da Silva, RMF; de Lima, LG; de Medeiros, FPM; de Sousa, ALMD; Lavra, ZMM; Neto, PJR; Rolim, LA; Rosa, TA; Wanderley Sales, VA | 1 |
Chi, BH; Fairlie, L; Farhad, M; Fenton, T; Fowler, MG; Moodley, D; Naik, S; Nakabiito, C; Stringer, JSA; Venkatesh, KK | 1 |
Ajibola, G; Batlang, O; Bennett, K; Capparelli, EV; Hughes, MD; Jean-Philippe, P; Kuritzkes, DR; Lichterfeld, M; Lockman, S; Makhema, J; Maswabi, K; Mohammed, T; Moyo, S; Sakoi, M; Shapiro, RL | 1 |
Teshale, AB; Tsegaye, AT; Wolde, HF | 1 |
Amzal, B; Cressey, TR; Jarupanich, T; Jourdain, G; Kanjanavikai, P; Klinbuayaem, V; Koetsawang, S; Lallemant, M; Le Coeur, S; Ngo-Giang-Huong, N; Rawangban, B; Sabsanong, P; Siriwachirachai, T; Sripan, P; Urien, S; Wanasiri, P | 1 |
Bae, J; Cook, RL; Delcher, C; Francois, K; Joseph, N; Pessoa-Brandão, L; Puttkammer, N; Rich, SN; Robin, E; Yaghjyan, L | 1 |
da Silva, CH; da Silva, CLO; Friedrich, L; Magdaleno, AM; Menegotto, M | 1 |
Morales-Pérez, M | 1 |
Blanche, S; Brossard, M; Dollfus, C; Faye, A; Frange, P; Le Chenadec, J; Mandelbrot, L; Tubiana, R; Warszawski, J | 1 |
Bhatt, N; Couto, A; Cuco, RM; Degomme, O; Juga, A; Loquiha, O; Meggi, B; Osman, N; Sevene, E; Sidat, M; Temermam, M; Vubil, A | 1 |
Ahmed, FO; Aning, BD; Ansah, RO; Ayisi-Boateng, NK; Enimil, AK; Ojuang, DA; Okeke, CB; Opoku, S; Sakyi, SA; Sarfo, AD; Senu, E; Wekesa, DN | 1 |
Adebisi, SA; Adedeji, NO; Adedeji, TA; Ajeigbe, AK; Ajose, AO; Akande, AA; Fawale, MB; Jeje, OA; Okesina, BA; Smith, OS | 1 |
Ali, S; Bayserkin, B; Dzissyuk, N; Issanov, A; Mukhatayev, Z; Mukhatayeva, A; Mustafa, A; Vermund, SH | 1 |
Abrams, EJ; Bonner, LB; Geffner, ME; Gerschenson, M; Jao, J; Kgole, S; Kurland, IJ; Legbedze, J; Makhema, J; Masasa, G; Mmalane, M; Mmasa, KN; Mohammed, T; Moyo, S; Powis, KM; Sun, S | 1 |
Aghokeng, A; Ateba Ndongo, F; Bilong, S; Djeuda, ABD; Eboumbou Moukoko, CE; Eyoum Bille, B; Fokam, J; Grace, N; Koki Ndombo, P; Moukoko Mbonjo, M; Ndjolo, A; Penda, CI | 1 |
38 review(s) available for nevirapine and zidovudine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Resistance, drug failure, and disease progression.
Topics: Antiviral Agents; Disease Progression; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; Humans; Nevirapine; Pyridines; Randomized Controlled Trials as Topic; Zalcitabine; Zidovudine | 1994 |
Antiretroviral therapy: a guide to the most important trials.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Indinavir; Lamivudine; Nevirapine; Pyridines; Ritonavir; Saquinavir; Stavudine; Viral Load; Zalcitabine; Zidovudine | 1997 |
[Resistance to antiretroviral drugs].
Topics: Antiviral Agents; Drug Resistance; Drug Resistance, Multiple; HIV Seropositivity; HIV-1; Humans; Lamivudine; Nevirapine; Point Mutation; Retroviridae; Retroviridae Infections; Zidovudine | 1997 |
Antiretroviral chemotherapy.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Delavirdine; Didanosine; Dideoxynucleosides; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Nelfinavir; Nevirapine; Oxazines; Ritonavir; Saquinavir; Stavudine; Zalcitabine; Zidovudine | 1998 |
Antiretrovirals.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Carbamates; Cyclopropanes; Delavirdine; Didanosine; Dideoxynucleosides; Female; Furans; HIV Infections; Humans; Indinavir; Lamivudine; Nelfinavir; Nevirapine; Oxazines; Pregnancy; Pregnancy Complications, Infectious; Protease Inhibitors; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Stavudine; Sulfonamides; Zalcitabine; Zidovudine | 1999 |
Meta-analysis of two randomized controlled trials comparing combined zidovudine and didanosine therapy with combined zidovudine, didanosine, and nevirapine therapy in patients with HIV. INCAS study team.
Topics: Adult; Didanosine; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Middle Aged; Multivariate Analysis; Nevirapine; Proportional Hazards Models; Viral Load; Zidovudine | 1999 |
[New therapy reduces AIDS passed to fetuses and costs less].
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Developing Countries; Female; Health Care Costs; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Premedication; Reverse Transcriptase Inhibitors; Zidovudine | 2000 |
Update on preventing vertical transmission of HIV type 1.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Prenatal Care; Zidovudine | 2000 |
Management of the infant born to a mother infected with human immunodeficiency virus type 1 (HIV-1): current concepts.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Administration Schedule; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Zidovudine | 2000 |
Prevention of mother-to-child transmission of HIV: challenges for the current decade.
Topics: Anti-HIV Agents; Breast Feeding; Cesarean Section; Drug Resistance, Microbial; Female; Health Resources; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Premedication; Reverse Transcriptase Inhibitors; Risk Factors; United Nations; Zidovudine | 2001 |
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Zidovudine | 2002 |
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Zidovudine | 2002 |
Mother to child transmission of HIV.
Topics: Anti-HIV Agents; Breast Feeding; Cesarean Section; Combined Modality Therapy; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Risk; Treatment Outcome; Zidovudine | 2002 |
Mother to child transmission of HIV.
Topics: Anti-HIV Agents; Breast Feeding; Cesarean Section; Combined Modality Therapy; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2002 |
Antiretroviral therapy-induced psychosis: case report and brief review of the literature.
Topics: Adult; Antipsychotic Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Drug Combinations; Female; Hallucinations; HIV Seropositivity; Humans; Lamivudine; Nevirapine; Psychoses, Substance-Induced; Zidovudine | 2003 |
[Antiretrovirals].
Topics: Acidosis, Lactic; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Didanosine; Hemophilia A; Hemorrhage; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Indinavir; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2003 |
The continuing evolution of HIV therapy.
Topics: Adenine; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Benzoxazines; Carbamates; CD4 Lymphocyte Count; Cyclopropanes; Delayed-Action Preparations; Deoxycytidine; Didanosine; Dideoxynucleosides; Drug Monitoring; Emtricitabine; Furans; HIV Infections; Humans; Lamivudine; Nevirapine; Oligopeptides; Organophosphates; Organophosphonates; Organophosphorus Compounds; Oxazines; Pyridines; Randomized Controlled Trials as Topic; Stavudine; Sulfonamides; Tenofovir; Treatment Outcome; Viral Load; Zidovudine | 2003 |
Preventing neonatal HIV: a review.
Topics: Anti-HIV Agents; Breast Feeding; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 2003 |
HIV: mother to child transmission.
Topics: Administration, Intravaginal; Anti-HIV Agents; Breast Feeding; Cesarean Section; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2005 |
Do non-nucleoside reverse transcriptase inhibitors contribute to lipodystrophy?
Topics: Alkynes; Anti-Retroviral Agents; Benzoxazines; Cardiovascular Diseases; Cyclopropanes; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Metabolic Syndrome; Nevirapine; Oxazines; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Risk Factors; Stavudine; Zidovudine | 2005 |
[The treatment of HIV infection].
Topics: Adenine; Anti-Retroviral Agents; Carbamates; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Therapy, Combination; Furans; HIV Infections; Humans; Lamivudine; Nevirapine; Organophosphates; Organophosphonates; Risk Factors; Sulfonamides; Tenofovir; Zidovudine | 2005 |
Evidence behind the WHO guidelines: hospital care for children: what antiretroviral agents and regimens are effective in the prevention of mother-to-child transmission of HIV?
Topics: Anti-HIV Agents; Breast Feeding; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; World Health Organization; Zidovudine | 2006 |
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Zidovudine | 2007 |
Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.
Topics: Anti-HIV Agents; Antimetabolites; Antiretroviral Therapy, Highly Active; Child; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Risk Factors; Treatment Outcome; Zidovudine | 2007 |
Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine?
Topics: Adenine; Adult; Africa South of the Sahara; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bone Diseases; Child; Child, Preschool; Congenital Abnormalities; Disease Models, Animal; Drug Resistance, Viral; Female; Health Services Accessibility; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Macaca; Mitochondria; Nevirapine; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Zidovudine | 2009 |
Optimal versus suboptimal treatment for HIV-infected pregnant women and HIV-exposed infants in clinical research studies.
Topics: Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; Drug Resistance, Viral; Female; HIV; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2009 |
Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals.
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Child; Cyclopropanes; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; HIV Infections; Humans; Lamivudine; Nevirapine; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Zidovudine | 2010 |
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Zidovudine | 2011 |
HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review.
Topics: Adolescent; Africa; Alkynes; Anti-HIV Agents; Asia; Benzoxazines; Child; Child, Preschool; Cross-Sectional Studies; Cyclopropanes; Developing Countries; Drug Resistance, Viral; Female; Health Resources; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Latin America; Lopinavir; Male; Mutation; Nevirapine; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Treatment Failure; Viral Load; Zidovudine | 2011 |
Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the fetal compartment (placenta and amniotic fluid).
Topics: Adenine; Adult; Amniotic Fluid; Anti-HIV Agents; Cyclohexanes; Enfuvirtide; Female; Fetal Blood; Fetus; HIV Envelope Protein gp41; HIV Fusion Inhibitors; HIV Infections; HIV Integrase Inhibitors; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Maraviroc; Nevirapine; Organophosphonates; Peptide Fragments; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pyrrolidinones; Raltegravir Potassium; Reverse Transcriptase Inhibitors; Tenofovir; Triazoles; Viral Load; Zidovudine | 2011 |
HIV drug resistance in mothers and infants following use of antiretrovirals to prevent mother-to-child transmission.
Topics: Alkynes; Anti-HIV Agents; Aptamers, Nucleotide; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Developing Countries; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Mothers; Nevirapine; Point Mutation; Pregnancy; Pregnancy Complications, Infectious; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Sentinel Surveillance; Sequence Analysis, DNA; Viral Load; Zidovudine | 2013 |
A randomized pahse I bioequivalence clinincal trial of a paediatric fixed-dose combination antiretroviral reconstitutable suspension in healthy adult volunteers.
Topics: Adult; Anti-HIV Agents; Cross-Over Studies; Drug Combinations; Female; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Therapeutic Equivalency; Young Adult; Zidovudine | 2013 |
Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.
Topics: Adult; Aged; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Dideoxynucleosides; Drug Substitution; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Lipids; Maintenance Chemotherapy; Middle Aged; Nevirapine; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Treatment Failure; Viral Load; Young Adult; Zidovudine | 2013 |
Choice of antiretroviral drugs for postexposure prophylaxis for children: a systematic review.
Topics: Anti-HIV Agents; Child; Child, Preschool; Cohort Studies; Dideoxynucleosides; Drug Combinations; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Nevirapine; Post-Exposure Prophylaxis; Pregnancy; Prospective Studies; Randomized Controlled Trials as Topic; Ritonavir; Zidovudine | 2015 |
Developments in early diagnosis and therapy of HIV infection in newborns.
Topics: Anti-HIV Agents; Early Diagnosis; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Ritonavir; Zidovudine | 2018 |
Comparative safety and effectiveness of perinatal antiretroviral therapies for HIV-infected women and their children: Systematic review and network meta-analysis including different study designs.
Topics: Abnormalities, Drug-Induced; Alkynes; Anti-HIV Agents; Benzoxazines; Child; Congenital Abnormalities; Cyclopropanes; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Network Meta-Analysis; Nevirapine; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Stavudine; Stillbirth; Zidovudine | 2018 |
Factors associated with viral suppression and rebound among adult HIV patients on treatment: a retrospective study in Ghana.
Topics: Adult; Anti-HIV Agents; Ghana; HIV Infections; Humans; Lamivudine; Nevirapine; Retrospective Studies; Viral Load; Zidovudine | 2022 |
125 trial(s) available for nevirapine and zidovudine
Article | Year |
---|---|
Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Male; Middle Aged; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; United States; Zidovudine | 1995 |
Resistance, drug failure, and disease progression.
Topics: Antiviral Agents; Disease Progression; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; Humans; Nevirapine; Pyridines; Randomized Controlled Trials as Topic; Zalcitabine; Zidovudine | 1994 |
Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protoco
Topics: Adult; CD4 Lymphocyte Count; Didanosine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Erythema; Female; HIV Infections; HIV-1; Humans; Male; Nevirapine; Prospective Studies; Pyridines; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine | 1996 |
A controlled trial of nevirapine plus zidovudine versus zidovudine alone in p24 antigenaemic HIV-infected patients. The Dutch-Italian-Australian Nevirapine Study Group.
Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Male; Nevirapine; Pyridines; Zidovudine | 1996 |
Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection.
Topics: Administration, Oral; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Male; Nevirapine; Pyridines; RNA, Viral; Viral Load; Zidovudine | 1997 |
Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Drug Therapy, Combination; HIV-1; Humans; Monitoring, Physiologic; Nevirapine; Phenotype; Prospective Studies; Pyridines; RNA, Viral; Viral Load; Zidovudine | 1997 |
A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Nevirapine; RNA, Viral; Viral Load; Zidovudine | 1998 |
Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy.
Topics: Anti-HIV Agents; Australia; Canada; CD4 Lymphocyte Count; Didanosine; Double-Blind Method; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Italy; Netherlands; Nevirapine; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Zidovudine | 1998 |
A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A Study T
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Disease-Free Survival; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV; Humans; Male; Nevirapine; Placebos; Reverse Transcriptase Inhibitors; RNA, Viral; Survival Rate; Time Factors; Zalcitabine; Zidovudine | 1998 |
Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anti-HIV Agents; Didanosine; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Middle Aged; Models, Biological; Nevirapine; Zidovudine | 1999 |
A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients with advanced disease.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nevirapine; Zidovudine | 1999 |
Sequence clusters in human immunodeficiency virus type 1 reverse transcriptase are associated with subsequent virological response to antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Amino Acid Sequence; Anti-HIV Agents; Didanosine; Drug Therapy, Combination; Evolution, Molecular; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Sequence Data; Nevirapine; Sequence Alignment; Time Factors; Viral Load; Zidovudine | 1999 |
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.
Topics: Adult; Anti-HIV Agents; Double-Blind Method; Drug Administration Schedule; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Uganda; Zidovudine | 1999 |
Multiple sites in HIV-1 reverse transcriptase associated with virological response to combination therapy.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; DNA Mutational Analysis; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Reverse Transcriptase; HIV-1; Humans; Nevirapine; Placebos; Point Mutation; Regression Analysis; Reverse Transcriptase Inhibitors; Sequence Analysis, Protein; Viral Load; Zidovudine | 2000 |
Patterns of resistance mutations selected by treatment of human immunodeficiency virus type 1 infection with zidovudine, didanosine, and nevirapine.
Topics: Acquired Immunodeficiency Syndrome; Codon; Didanosine; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Nevirapine; Polymerase Chain Reaction; Zidovudine | 2000 |
Meta-analysis of two randomized controlled trials comparing combined zidovudine and didanosine therapy with combined zidovudine, didanosine, and nevirapine therapy in patients with HIV. INCAS study team.
Topics: Adult; Didanosine; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Middle Aged; Multivariate Analysis; Nevirapine; Proportional Hazards Models; Viral Load; Zidovudine | 1999 |
Nevirapine and perinatal transmission.
Topics: Anti-HIV Agents; Drug Administration Schedule; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; South Africa; Treatment Outcome; Zidovudine | 2000 |
A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4+ cell counts >/=350/mm3.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Didanosine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; Humans; Indinavir; Injections, Subcutaneous; Interleukin-2; Lamivudine; Lymphocyte Count; Male; Nelfinavir; Nevirapine; Ritonavir; RNA, Viral; Saquinavir; Stavudine; Zalcitabine; Zidovudine | 2000 |
Plasma HIV-1 copy number and in vitro infectivity of plasma prior to and during combination antiretroviral treatment.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Double-Blind Method; Drug Therapy, Combination; Giant Cells; HIV Infections; HIV-1; Humans; Nevirapine; RNA, Viral; Viral Load; Zidovudine | 2000 |
Quality of life outcomes of combination zidovudine- didanosine-nevirapine and zidovudine-didanosine for antiretroviral-naive advanced HIV-infected patients.
Topics: Adult; Anti-HIV Agents; Didanosine; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Nevirapine; Quality of Life; Reverse Transcriptase Inhibitors; Treatment Outcome; Zidovudine | 2000 |
Research study of combination AIDS therapies underway.
Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; Humans; Lamivudine; Nevirapine; Pyridines; Zidovudine | 1996 |
Viramune triple combo reduces viral load below limit of detection.
Topics: Adult; Anti-HIV Agents; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Male; Nevirapine; Randomized Controlled Trials as Topic; Viral Load; Zidovudine | 1997 |
New double vs. triple antiviral combination study, CD4 200-500, no prior treatment.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine | 1995 |
Maintaining a low viral load with Nevirapine?
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 1998 |
Virus sidesteps convergent therapy.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Pyridines; Zidovudine | 1995 |
High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals.
Topics: Anti-HIV Agents; Didanosine; Double-Blind Method; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Nevirapine; Retrospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Treatment Outcome; Zidovudine | 2001 |
Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapine.
Topics: Anti-HIV Agents; Didanosine; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Genotype; HIV Infections; HIV-1; Humans; Mutation; Nevirapine; Phenotype; Reverse Transcriptase Inhibitors; Zidovudine | 2001 |
Effect of HIV-1 antiretroviral prophylaxis on hepatic and hematological parameters of African infants.
Topics: Alanine Transaminase; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Liver Function Tests; Malawi; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 2002 |
A randomized clinical trial comparing nelfinavir or nevirapine associated to zidovudine/lamivudine in HIV-infected naive patients (the Combine Study).
Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Argentina; Cohort Studies; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nelfinavir; Nevirapine; Reverse Transcriptase Inhibitors; RNA, Viral; Spain; Treatment Outcome; Zidovudine | 2002 |
Time-dependent changes in HIV nucleoside analogue phosphorylation and the effect of hydroxyurea.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Drug Interactions; Drug Resistance, Viral; Female; HIV Infections; Humans; Hydroxyurea; Lamivudine; Leukocytes, Mononuclear; Male; Middle Aged; Nevirapine; Nucleosides; Phosphorylation; Reverse Transcriptase Inhibitors; Zidovudine | 2002 |
Compliance with antiretroviral regimens to prevent perinatal HIV-1 transmission in Kenya.
Topics: Adult; Anti-HIV Agents; Female; Focus Groups; Follow-Up Studies; Health Knowledge, Attitudes, Practice; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Nevirapine; Patient Compliance; Patient Selection; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Zidovudine | 2003 |
A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
Topics: Adult; Anti-HIV Agents; Delivery, Obstetric; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor, Obstetric; Lamivudine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Treatment Outcome; Zidovudine | 2003 |
Genotype and phenotype at baseline and at failure in human immunodeficiency virus-infected antiretroviral-naive patients in a randomized trial comparing zidovudine and lamivudine plus nelfinavir or nevirapine.
Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Argentina; Cohort Studies; Drug Therapy, Combination; Genotype; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Middle Aged; Mutation; Nelfinavir; Nevirapine; Phenotype; Reverse Transcriptase Inhibitors; Spain; Treatment Failure; Zidovudine | 2003 |
Feeding risk cut for HIV-infected women.
Topics: Anti-HIV Agents; Breast Feeding; Didanosine; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Rwanda; Uganda; Zidovudine | 2003 |
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.
Topics: Adult; Anti-HIV Agents; Disease Transmission, Infectious; Drug Administration Schedule; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor Onset; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Uganda; Zidovudine | 2003 |
Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial.
Topics: Anti-HIV Agents; Female; Follow-Up Studies; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 2003 |
Performance characteristics of HIV-1 culture and HIV-1 DNA and RNA amplification assays for early diagnosis of perinatal HIV-1 infection.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; DNA, Viral; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Lymphocytes; Nevirapine; Nucleic Acid Amplification Techniques; Predictive Value of Tests; RNA, Viral; Sensitivity and Specificity; Zidovudine | 2003 |
TMC125 exerts similar initial antiviral potency as a five-drug, triple class antiretroviral regimen.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Dideoxynucleosides; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Nevirapine; Nitriles; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Zidovudine | 2003 |
Immune restoration in HIV-positive, antiretroviral-naive patients after 1 year of zidovudine/lamivudine plus nelfinavir or nevirapine.
Topics: Adult; Aged; Anti-HIV Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Seropositivity; Humans; Lamivudine; Lymphocyte Activation; Male; Middle Aged; Nelfinavir; Nevirapine; Reverse Transcriptase Inhibitors; T-Lymphocyte Subsets; Zidovudine | 2004 |
Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.
Topics: Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Gestational Age; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor, Obstetric; Male; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnancy Trimester, Third; Risk Factors; RNA, Viral; Thailand; Viral Load; Zidovudine | 2004 |
Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy.
Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Double-Blind Method; Drug Resistance, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; HIV Infections; HIV-1; Humans; Labor, Obstetric; Logistic Models; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Risk Factors; RNA, Viral; Treatment Failure; Viral Load; Zidovudine | 2004 |
Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.
Topics: Adult; AIDS Serodiagnosis; Anti-HIV Agents; Delivery, Obstetric; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Malawi; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Survival Analysis; Viral Load; Zidovudine | 2004 |
Haematological changes in African children who received short-term prophylaxis with nevirapine and zidovudine at birth.
Topics: Agranulocytosis; Anemia; Anti-HIV Agents; Blood Cell Count; Drug Therapy, Combination; Female; Hematocrit; Hemoglobins; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Longitudinal Studies; Nevirapine; Risk Factors; RNA, Viral; Zidovudine | 2004 |
Persistence of nevirapine exposure during the postpartum period after intrapartum single-dose nevirapine in addition to zidovudine prophylaxis for the prevention of mother-to-child transmission of HIV-1.
Topics: Adolescent; Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Thailand; Zidovudine | 2005 |
Field assessment of generic antiretroviral drugs: a prospective cohort study in Cameroon.
Topics: Adult; Anti-HIV Agents; Cameroon; CD4 Lymphocyte Count; Cohort Studies; Drug Resistance, Viral; Drug Therapy, Combination; Drugs, Generic; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Nevirapine; Prospective Studies; Stavudine; Treatment Outcome; Viral Load; Zidovudine | 2005 |
Antiretroviral treatment simplification with 3 NRTIs or 2 NRTIs plus nevirapine in HIV-1-infected patients treated with successful first-line HAART.
Topics: Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Resistance, Viral; Female; Genotype; HIV Infections; HIV-1; Humans; Lamivudine; Male; Mutation; Nevirapine; Patient Compliance; Patient Satisfaction; Prospective Studies; Quality of Life; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine | 2005 |
A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers.
Topics: Anti-HIV Agents; Bottle Feeding; Breast Feeding; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Survival Analysis; Treatment Outcome; Zidovudine | 2005 |
Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment.
Topics: Adult; Anti-HIV Agents; Botswana; Breast Feeding; Female; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Lactation; Lamivudine; Milk, Human; Nevirapine; Reverse Transcriptase Inhibitors; Statistics, Nonparametric; Zidovudine | 2005 |
Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine.
Topics: Adult; Anti-HIV Agents; DNA, Viral; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Milk, Human; Nevirapine; Postnatal Care; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; RNA, Viral; Zidovudine | 2005 |
A randomized crossover study to determine bioequivalence of generic and brand name nevirapine, zidovudine, and lamivudine in HIV-negative women in India.
Topics: Administration, Oral; Adult; Anti-HIV Agents; Cohort Studies; Confidence Intervals; Cross-Over Studies; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Drugs, Generic; Female; HIV Infections; HIV Seronegativity; Humans; India; Lamivudine; Nevirapine; Tablets; Therapeutic Equivalency; Zidovudine | 2006 |
A prospective, 96-week study of the impact of Trizivir, Combivir/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Black or African American; CD4 Lymphocyte Count; Cholesterol; Dideoxynucleosides; Drug Combinations; Female; Hispanic or Latino; HIV Infections; HIV-1; Humans; Hyperlipidemias; Lactic Acid; Lamivudine; Male; Nelfinavir; Nevirapine; Prospective Studies; Sex Factors; Stavudine; Treatment Outcome; Triglycerides; Zidovudine | 2006 |
Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana.
Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Botswana; Drug Administration Schedule; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Logistic Models; Nevirapine; Postpartum Period; Treatment Outcome; Zidovudine | 2006 |
Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Botswana; Breast Feeding; Disease-Free Survival; Female; HIV Infections; HIV-1; Humans; Infant; Infant Formula; Infant Mortality; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 2006 |
A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe.
Topics: Adult; Anti-HIV Agents; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Reverse Transcriptase Inhibitors; Zidovudine; Zimbabwe | 2007 |
Triple antiretroviral prophylaxis administered during pregnancy and after delivery significantly reduces breast milk viral load: a study within the Drug Resource Enhancement Against AIDS and Malnutrition Program.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV; HIV Infections; Humans; Lamivudine; Milk, Human; Nevirapine; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; RNA, Viral; Stavudine; Zidovudine | 2007 |
Response to antiretroviral therapy after a single, peripartum dose of nevirapine.
Topics: Adult; Anti-Retroviral Agents; Double-Blind Method; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Kaplan-Meier Estimate; Labor, Obstetric; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Proportional Hazards Models; Prospective Studies; Risk Factors; RNA, Viral; Treatment Failure; Viral Load; Zidovudine | 2007 |
Two-year morbidity-mortality and alternatives to prolonged breast-feeding among children born to HIV-infected mothers in Côte d'Ivoire.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Breast Feeding; Cohort Studies; Cote d'Ivoire; Female; HIV Infections; Humans; Infant; Infant Formula; Infant Mortality; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Milk, Human; Morbidity; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Time Factors; Treatment Outcome; Zidovudine | 2007 |
Late postnatal transmission of HIV-1 and associated factors.
Topics: Breast Feeding; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Incidence; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Malawi; Milk, Human; Nevirapine; Risk Factors; RNA, Viral; Time Factors; Zidovudine | 2007 |
Pathology of placenta in HIV infection.
Topics: Anti-HIV Agents; Chorioamnionitis; Female; Fetal Death; HIV Infections; Humans; Hyperplasia; Infant, Low Birth Weight; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Reverse Transcriptase Inhibitors; Treatment Outcome; Trophoblasts; Zidovudine | 2007 |
Mother-to-child transmission of HIV among women who chose not to exclusively breastfeed their infants in Pune, India.
Topics: Adult; Anti-HIV Agents; Bottle Feeding; Breast Feeding; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; Humans; India; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2007 |
Pharmacokinetics of lamivudine, zidovudine, and nevirapine administered as a fixed-dose combination formulation versus coadministration of the individual products.
Topics: Adolescent; Adult; Cross-Sectional Studies; Drug Combinations; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; Zidovudine | 2007 |
Twenty-four-week safety and tolerability of nevirapine vs. abacavir in combination with zidovudine/lamivudine as first-line antiretroviral therapy: a randomized double-blind trial (NORA).
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Dideoxynucleosides; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; Treatment Outcome; Uganda; Zidovudine | 2008 |
Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon.
Topics: Adult; Anemia; Anti-HIV Agents; Cameroon; CD4 Lymphocyte Count; Cohort Studies; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Multivariate Analysis; Nevirapine; Patient Compliance; Peripheral Nervous System Diseases; Prospective Studies; Stavudine; Treatment Outcome; Viral Load; Zidovudine | 2008 |
Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
Topics: Anti-HIV Agents; Breast Feeding; Developing Countries; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infant Mortality; Infant, Newborn; Infectious Disease Transmission, Vertical; Kaplan-Meier Estimate; Malawi; Male; Milk, Human; Neutropenia; Nevirapine; Proportional Hazards Models; Risk Factors; Zidovudine | 2008 |
HIV-1 persists in breast milk cells despite antiretroviral treatment to prevent mother-to-child transmission.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cell-Free System; DNA, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Milk, Human; Nevirapine; Postpartum Period; RNA, Viral; Time Factors; Treatment Outcome; Viral Load; Zidovudine | 2008 |
Hematologic and hepatic toxicities associated with antenatal and postnatal exposure to maternal highly active antiretroviral therapy among infants.
Topics: Alanine Transaminase; Anti-HIV Agents; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Aspartate Aminotransferases; Biomarkers; Botswana; Breast Feeding; Cohort Studies; Female; Follow-Up Studies; Hemoglobins; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Neutropenia; Nevirapine; Platelet Count; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Zidovudine | 2008 |
Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Milk, Human; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral; Treatment Outcome; Zidovudine | 2008 |
Risk factors for early and late transmission of HIV via breast-feeding among infants born to HIV-infected women in a randomized clinical trial in Botswana.
Topics: Adult; Anti-HIV Agents; Botswana; Breast Feeding; Female; HIV Infections; HIV-1; Humans; Infant; Infant Formula; Infant, Newborn; Infectious Disease Transmission, Vertical; Milk, Human; Nevirapine; Risk Factors; RNA, Viral; Zidovudine | 2009 |
A randomized, open-label study of a nucleoside analogue reverse transcriptase inhibitor-sparing regimen in antiretroviral-naive HIV-infected patients.
Topics: Adult; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Lopinavir; Male; Nevirapine; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Viral Load; Zidovudine | 2009 |
Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Dideoxynucleosides; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Intra-Abdominal Fat; Lopinavir; Male; Middle Aged; Nevirapine; Pyrimidinones; Radiography, Abdominal; Stavudine; Thigh; Viral Load; Zidovudine | 2009 |
Resistance mutations in HIV-1 infected pregnant women and their infants receiving antiretrovirals to prevent HIV-1 vertical transmission in China.
Topics: Adult; CD4 Lymphocyte Count; China; Cohort Studies; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 2009 |
First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bone Density; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Nevirapine; Osteoporosis; Pyrimidinones; Ritonavir; Young Adult; Zidovudine | 2009 |
Lower risk of resistance after short-course HAART compared with zidovudine/single-dose nevirapine used for prevention of HIV-1 mother-to-child transmission.
Topics: Amino Acid Substitution; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Base Sequence; DNA Primers; DNA, Viral; Drug Resistance, Viral; Female; Genes, pol; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Kenya; Mutation, Missense; Nevirapine; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Time Factors; Zidovudine | 2009 |
Predictors of early and late mother-to-child transmission of HIV in a breastfeeding population: HIV Network for Prevention Trials 012 experience, Kampala, Uganda.
Topics: Anti-HIV Agents; Breast Feeding; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Multivariate Analysis; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Proportional Hazards Models; Uganda; Viral Load; Zidovudine | 2009 |
Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Breast Feeding; CD4 Lymphocyte Count; Chemoprevention; Drug Administration Schedule; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Malawi; Male; Nevirapine; Pregnancy; Young Adult; Zidovudine | 2009 |
Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Resistance, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome; Viral Load; Zidovudine | 2009 |
Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus Abacavir.
Topics: Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Mutation; Nevirapine; RNA, Viral; Uganda; Viral Load; Zidovudine | 2010 |
Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial.
Topics: Adenine; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Community Health Services; Female; HIV; HIV Infections; Home Care Services; Humans; Lamivudine; Male; Nevirapine; Organophosphonates; Stavudine; Tenofovir; Uganda; Zidovudine | 2009 |
Temporal reduction of HIV type 1 viral load in breast milk by single-dose nevirapine during prevention of MTCT.
Topics: Anti-HIV Agents; Breast Feeding; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Milk, Human; Nevirapine; Postpartum Period; Viral Load; Zidovudine | 2009 |
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.
Topics: Adenine; Adolescent; Adult; Africa; Aged; Anemia; Anti-Retroviral Agents; CD4 Lymphocyte Count; Creatinine; Dideoxynucleosides; Disease Progression; Drug Monitoring; Female; Glomerular Filtration Rate; Hemoglobins; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Male; Middle Aged; Neutropenia; Neutrophils; Nevirapine; Organophosphonates; RNA, Viral; Tenofovir; Urea; Viral Load; Zidovudine | 2010 |
Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.
Topics: Adult; Body Weight; CD4 Lymphocyte Count; Dideoxynucleosides; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Medication Adherence; Middle Aged; Nevirapine; Recurrence; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Uganda; Viral Load; Zidovudine | 2010 |
Eighteen-month follow-up of HIV-1-infected mothers and their children enrolled in the Kesho Bora study observational cohorts.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Breast Feeding; Burkina Faso; CD4 Lymphocyte Count; Chemoprevention; Cohort Studies; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Kenya; Male; Mothers; Nevirapine; Prospective Studies; South Africa; Viral Load; Zidovudine | 2010 |
Maternal or infant antiretroviral drugs to reduce HIV-1 transmission.
Topics: Adult; Anti-Retroviral Agents; Breast Feeding; CD4 Lymphocyte Count; Drug Hypersensitivity; Drug Therapy, Combination; Female; HIV Infections; HIV Seronegativity; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Kaplan-Meier Estimate; Lamivudine; Male; Neutropenia; Nevirapine; Pregnancy; Risk Factors; Stevens-Johnson Syndrome; Young Adult; Zidovudine | 2010 |
Antiretroviral regimens in pregnancy and breast-feeding in Botswana.
Topics: Adult; Antiretroviral Therapy, Highly Active; Breast Feeding; CD4 Lymphocyte Count; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Neutropenia; Nevirapine; Patient Compliance; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; RNA, Viral; Viral Load; Young Adult; Zidovudine | 2010 |
Safety and effectiveness of antiretroviral drugs during pregnancy, delivery and breastfeeding for prevention of mother-to-child transmission of HIV-1: the Kesho Bora Multicentre Collaborative Study rationale, design, and implementation challenges.
Topics: Africa, Eastern; Africa, Southern; Africa, Western; Anti-Retroviral Agents; Breast Feeding; Child, Preschool; Clinical Protocols; Cohort Studies; Delivery, Obstetric; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Mothers; Nevirapine; Pregnancy; Pyrimidinones; Research Design; Ritonavir; Zidovudine | 2011 |
Growth of infants born to HIV-infected women in South Africa according to maternal and infant characteristics.
Topics: Adult; Anti-HIV Agents; Body Height; Body Weight; CD4 Lymphocyte Count; Epidemiologic Methods; Female; Growth Disorders; HIV Infections; Humans; Infant Formula; Infant Nutritional Physiological Phenomena; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Maternal Age; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Viral Load; Young Adult; Zidovudine | 2010 |
Population pharmacokinetics of nevirapine in HIV-1-infected pregnant women and their neonates.
Topics: Adenine; Adult; Anti-HIV Agents; Deoxycytidine; Emtricitabine; Female; HIV Infections; Humans; Infant, Newborn; Nevirapine; Organophosphonates; Pregnancy; Tenofovir; Treatment Outcome; Young Adult; Zidovudine | 2011 |
Long-term effectiveness and safety of didanosine combined with lamivudine and efavirenz or nevirapine in antiretroviral-naive patients: a 9-year cohort study in Senegal.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Treatment Outcome; Viral Load; Zidovudine | 2011 |
Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
Topics: Adult; Africa South of the Sahara; Anti-HIV Agents; Breast Feeding; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Young Adult; Zidovudine | 2011 |
Postexposure prophylaxis of breastfeeding HIV-exposed infants with antiretroviral drugs to age 14 weeks: updated efficacy results of the PEPI-Malawi trial.
Topics: Anti-HIV Agents; Breast Feeding; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Malawi; Male; Nevirapine; Post-Exposure Prophylaxis; Zidovudine | 2011 |
Residual activity of two HIV antiretroviral regimens prescribed without virological monitoring.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Dideoxynucleosides; HIV Infections; HIV-1; Humans; Lamivudine; Nevirapine; RNA, Viral; Viral Load; Zidovudine | 2011 |
Glomerular dysfunction and associated risk factors over 4-5 years following antiretroviral therapy initiation in Africa.
Topics: Adenine; Adult; Africa; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Creatinine; Dideoxynucleosides; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Diseases; Kidney Glomerulus; Lamivudine; Male; Nevirapine; Organophosphonates; Risk Factors; Tenofovir; Time Factors; Zidovudine | 2011 |
A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine.
Topics: Adolescent; Adult; Anti-HIV Agents; Drug Administration Schedule; Drug Resistance, Viral; Female; HIV; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Middle Aged; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome; Viral Load; Zidovudine | 2012 |
Valacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels during pregnancy and postpartum: a randomized trial.
Topics: Acyclovir; Adolescent; Adult; Anti-HIV Agents; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Kenya; Milk, Human; Nevirapine; Placebos; Plasma; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral; Treatment Outcome; Valacyclovir; Valine; Viral Load; Young Adult; Zidovudine | 2012 |
Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children.
Topics: Anti-HIV Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Biological Availability; Body Weight; Child; Child, Preschool; Cytochrome P-450 CYP2B6; Drug Administration Schedule; Drug Combinations; Drug Dosage Calculations; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; HIV; HIV Infections; Humans; Infant; Lamivudine; Male; Nevirapine; Oxidoreductases, N-Demethylating; Reverse Transcriptase Inhibitors; Tablets; Zidovudine | 2011 |
Short-course Combivir after single-dose nevirapine reduces but does not eliminate the emergence of nevirapine resistance in women.
Topics: Anti-HIV Agents; Drug Combinations; Drug Resistance, Viral; Female; Genotype; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral; Viral Load; Zidovudine | 2012 |
Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial.
Topics: Adult; Anti-Retroviral Agents; Breast Feeding; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Young Adult; Zidovudine | 2012 |
Effects of valacyclovir on markers of disease progression in postpartum women co-infected with HIV-1 and herpes simplex virus-2.
Topics: Acyclovir; Antiviral Agents; Biomarkers; CD4 Antigens; Disease Progression; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Kenya; Linear Models; Nevirapine; Postpartum Period; Pregnancy; RNA, Viral; Valacyclovir; Valine; Zidovudine | 2012 |
Three postpartum antiretroviral regimens to prevent intrapartum HIV infection.
Topics: Anti-Retroviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant Formula; Infant, Newborn; Infectious Disease Transmission, Vertical; Kaplan-Meier Estimate; Lamivudine; Male; Nelfinavir; Nevirapine; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2012 |
Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children.
Topics: Anti-Retroviral Agents; CD4 Lymphocyte Count; Child, Preschool; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Kaplan-Meier Estimate; Lamivudine; Lopinavir; Male; Nevirapine; Ritonavir; RNA, Viral; Zidovudine | 2012 |
Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa.
Topics: Adolescent; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Child; Child, Preschool; Cohort Studies; Cyclopropanes; Drug Combinations; Female; Follow-Up Studies; Gambia; HIV Infections; HIV-1; HIV-2; Humans; Infant; Kaplan-Meier Estimate; Lamivudine; Lopinavir; Male; Nevirapine; Reverse Transcriptase Inhibitors; Ritonavir; Treatment Outcome; Viral Load; Zidovudine | 2012 |
Zidovudine/lamivudine but not nevirapine in combination with lopinavir/ritonavir decreases subcutaneous adipose tissue mitochondrial DNA.
Topics: Absorptiometry, Photon; Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Anti-HIV Agents; Atrophy; CD4 Lymphocyte Count; DNA, Mitochondrial; Drug Combinations; Drug Therapy, Combination; HIV Seropositivity; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Nevirapine; Prospective Studies; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Subcutaneous Fat; Treatment Outcome; Young Adult; Zidovudine | 2012 |
Anaemia in HIV-infected children: severity, types and effect on response to HAART.
Topics: Adolescent; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; Child, Preschool; Cross-Sectional Studies; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Lamivudine; Logistic Models; Male; Nevirapine; Prevalence; Prospective Studies; Severity of Illness Index; Treatment Outcome; Uganda; Zidovudine | 2012 |
Therapeutic levels of lopinavir in late pregnancy and abacavir passage into breast milk in the Mma Bana Study, Botswana.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Botswana; Breast Feeding; Dideoxynucleosides; Female; HIV Infections; HIV-1; Humans; Infant; Lactation; Lamivudine; Lopinavir; Middle Aged; Milk, Human; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Viral Load; Zidovudine | 2013 |
A 72-week randomized study of the safety and efficacy of a stavudine to zidovudine switch at 24 weeks compared to zidovudine or tenofovir disoproxil fumarate when given with lamivudine and nevirapine.
Topics: Adenine; Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Diet; Drug Administration Schedule; Drug Substitution; Female; Glomerular Filtration Rate; Hemoglobins; HIV Infections; Humans; Lamivudine; Male; Nevirapine; Organophosphonates; Peripheral Nervous System Diseases; Stavudine; Tenofovir; Treatment Outcome; Viral Load; Zidovudine | 2012 |
Short communication: effect of short-course antenatal zidovudine and single-dose nevirapine on the BED capture enzyme immunoassay levels in HIV type 1 subtype C infection.
Topics: Adult; Anti-HIV Agents; Drug Administration Schedule; Female; HIV Antibodies; HIV Infections; HIV-1; Humans; Immunoenzyme Techniques; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Young Adult; Zidovudine | 2013 |
A randomized pahse I bioequivalence clinincal trial of a paediatric fixed-dose combination antiretroviral reconstitutable suspension in healthy adult volunteers.
Topics: Adult; Anti-HIV Agents; Cross-Over Studies; Drug Combinations; Female; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Therapeutic Equivalency; Young Adult; Zidovudine | 2013 |
Health outcomes of HIV-exposed uninfected African infants.
Topics: Anti-Retroviral Agents; Antiviral Agents; Breast Feeding; Cause of Death; Drug Therapy, Combination; Female; HIV Seropositivity; HIV-1; Humans; Infant; Infant Mortality; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Malawi; Morbidity; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Proportional Hazards Models; Zidovudine | 2013 |
Long-term follow-up of children in the HIVNET 012 perinatal HIV prevention trial: five-year growth and survival.
Topics: Anthropometry; Anti-HIV Agents; Body Height; Body Weight; Chemoprevention; Child, Preschool; Female; Follow-Up Studies; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Nevirapine; Pregnancy; Survival Analysis; Zidovudine | 2013 |
Maternal anaemia and duration of zidovudine in antiretroviral regimens for preventing mother-to-child transmission: a randomized trial in three African countries.
Topics: Adult; Africa South of the Sahara; Anemia; Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Kaplan-Meier Estimate; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2013 |
High rate of HIV resuppression after viral failure on first-line antiretroviral therapy in the absence of switch to second-line therapy.
Topics: Anti-HIV Agents; Dideoxynucleosides; Drug Combinations; Humans; Lamivudine; Nevirapine; Viral Load; Viremia; Zidovudine | 2014 |
Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women.
Topics: Administration, Oral; Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Counseling; Drug Administration Schedule; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Infusions, Intravenous; Kenya; Lamivudine; Medication Adherence; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Socioeconomic Factors; Viral Load; Viremia; Young Adult; Zidovudine | 2014 |
High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cross-Sectional Studies; Dideoxynucleosides; Drug Combinations; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Probability; Retrospective Studies; RNA, Viral; Tenofovir; Uganda; Viral Load; Zidovudine | 2014 |
Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial.
Topics: Anthropometry; Anti-HIV Agents; Child; Child, Preschool; Cross-Sectional Studies; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Lipid Metabolism; Lipodystrophy; Lipoproteins, HDL; Lipoproteins, LDL; Male; Nevirapine; Stavudine; Triglycerides; Viral Load; Zidovudine | 2014 |
First-line antiretroviral therapy with nevirapine versus lopinavir-ritonavir based regimens in a resource-limited setting.
Topics: Adenine; Adult; CD4 Lymphocyte Count; Deoxycytidine; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Nevirapine; Organophosphonates; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Tenofovir; Treatment Outcome; Viral Load; Zidovudine | 2014 |
Kericho CLinic-based ART Diagnostic Evaluation (CLADE): design, accrual, and baseline characteristics of a randomized controlled trial conducted in predominately rural, district-level, HIV clinics of Kenya.
Topics: Adult; Anti-HIV Agents; Cost-Benefit Analysis; Female; HIV Infections; HIV-1; Humans; Kenya; Male; Middle Aged; Nevirapine; Prospective Studies; Research Design; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load; Zidovudine | 2015 |
Safety of zidovudine dose reduction in treatment-naïve HIV infected patients. A randomized controlled study (MiniZID).
Topics: Adult; Anemia; Anti-HIV Agents; Cameroon; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Nevirapine; Prospective Studies; Treatment Outcome; Zidovudine | 2016 |
Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in Thailand.
Topics: Adult; Anti-HIV Agents; Chemoprevention; DNA, Viral; Double-Blind Method; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Placebos; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Thailand; Treatment Outcome; Young Adult; Zidovudine | 2015 |
Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial.
Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Child; Child, Preschool; Cyclopropanes; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Lamivudine; Male; Nevirapine; Stavudine; Tablets; Uganda; Zambia; Zidovudine | 2016 |
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention.
Topics: Adult; Anti-Retroviral Agents; Black or African American; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; Gestational Age; HIV Infections; Humans; Infant; Infant Mortality; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infectious Disease Transmission, Vertical; Nevirapine; Perinatal Care; Pregnancy; Pregnancy Outcome; Tenofovir; Young Adult; Zidovudine | 2016 |
A randomized two-way crossover bioequivalence study in healthy adult volunteers of paediatric zidovudine/lamivudine/nevirapine fast-disintegrating fixed-dose combination tablet.
Topics: Adult; Cross-Over Studies; Drug Combinations; Female; Healthy Volunteers; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Solubility; Tablets; Therapeutic Equivalency; Young Adult; Zidovudine | 2017 |
Malaria in HIV-Infected Children Receiving HIV Protease-Inhibitor- Compared with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy, IMPAACT P1068s, Substudy to P1060.
Topics: Antimalarials; CD4 Lymphocyte Count; Child; Child, Preschool; Coinfection; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant; Lamivudine; Lopinavir; Malaria, Falciparum; Malawi; Male; Nevirapine; Plasmodium falciparum; Reverse Transcriptase Inhibitors; Ritonavir; Viral Load; Zidovudine | 2016 |
Assessment of Nevirapine Prophylactic and Therapeutic Dosing Regimens for Neonates.
Topics: Anti-HIV Agents; Breast Feeding; Chemoprevention; Clinical Protocols; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Nevirapine; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Thailand; World Health Organization; Zidovudine | 2017 |
Association between HIV antiretroviral therapy and preterm birth based on antenatal ultrasound gestational age determination: a comparative analysis.
Topics: Adult; Anti-HIV Agents; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Emtricitabine; Female; Gestational Age; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Logistic Models; Lopinavir; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Risk; Ritonavir; Tenofovir; Ultrasonography, Prenatal; Young Adult; Zidovudine | 2019 |
Lower Insulin Sensitivity in Newborns With In Utero HIV and Antiretroviral Exposure Who Are Uninfected in Botswana.
Topics: Anti-HIV Agents; Anti-Retroviral Agents; Botswana; Female; HIV Infections; Humans; Infant; Infant, Newborn; Insulin Resistance; Nevirapine; Pregnancy; Zidovudine | 2022 |
485 other study(ies) available for nevirapine and zidovudine
Article | Year |
---|---|
Synthesis and evaluation of 2-pyridinone derivatives as HIV-1-specific reverse transcriptase inhibitors. 2. Analogues of 3-aminopyridin-2(1H)-one.
Topics: Aminopyridines; Antiviral Agents; Benzoxazoles; Cells, Cultured; HIV Reverse Transcriptase; HIV-1; Pyridones; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 1992 |
Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 1. Tricyclic pyridobenzo- and dipyridodiazepinones.
Topics: Antiviral Agents; Azepines; Benzodiazepinones; Chemical Phenomena; Chemistry; HIV-1; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 1991 |
Synthesis and anti-HIV-1 activity of a series of imidazo[1,5-b]pyridazines.
Topics: Antiviral Agents; Cell Division; Cell Line; Crystallization; HIV Reverse Transcriptase; HIV-1; Imidazoles; Molecular Structure; Pyridazines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Virus Replication; Zidovudine | 1993 |
1,2,3-Triazole-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D- ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"-oxathiole 2",2"-dioxide) (TSAO) analogues: synthesis and anti-HIV-1 activity.
Topics: Antiviral Agents; Base Sequence; Cells, Cultured; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Sequence Data; Reverse Transcriptase Inhibitors; Spiro Compounds; Structure-Activity Relationship; Thymidine; Triazoles; Uridine | 1994 |
Thiadiazole derivatives: highly potent and specific HIV-1 reverse transcriptase inhibitors.
Topics: Antiviral Agents; Cell Line; HIV Reverse Transcriptase; HIV-1; Humans; Reverse Transcriptase Inhibitors; Thiadiazoles | 1995 |
Synthesis and anti-HIV-1 activity of thio analogues of dihydroalkoxybenzyloxopyrimidines.
Topics: Antiviral Agents; Cell Line; Cytopathogenic Effect, Viral; HIV-1; Humans; Magnetic Resonance Spectroscopy; Pyrimidines; Structure-Activity Relationship | 1995 |
5-chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase.
Topics: Animals; Antiviral Agents; Base Sequence; Biological Availability; HIV; HIV Reverse Transcriptase; HIV-1; Indoles; Macaca mulatta; Molecular Sequence Data; Molecular Structure; Reverse Transcriptase Inhibitors; Sulfoxides | 1993 |
Bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: structure-activity relationships of novel substituted indole analogues and the identification of 1-[(5-methanesulfonamido-1H-indol-2-yl)-carbonyl]-4-[3- [(1-methylethyl)amino]-pyridinyl]pi
Topics: Antiviral Agents; Delavirdine; Indoles; Piperazines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Virus Replication | 1993 |
Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogs.
Topics: Animals; Antiviral Agents; Cell Line; HIV-1; Humans; Isothiocyanates; Rats; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiazoles; Thiourea | 1995 |
2-Sulfonyl-4-chloroanilino moiety: a potent pharmacophore for the anti-human immunodeficiency virus type 1 activity of pyrrolyl aryl sulfones.
Topics: Antiviral Agents; Cell Line; Cytopathogenic Effect, Viral; HIV-1; HIV-2; Magnetic Resonance Spectroscopy; Sulfinic Acids; Sulfones | 1996 |
Pyrrolobenzothiazepinones and pyrrolobenzoxazepinones: novel and specific non-nucleoside HIV-1 reverse transcriptase inhibitors with antiviral activity.
Topics: Antiviral Agents; Cell Line; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Molecular Structure; Oxazepines; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Structure-Activity Relationship; Thiazepines | 1996 |
Dihydro(alkylthio)(naphthylmethyl)oxopyrimidines: novel non-nucleoside reverse transcriptase inhibitors of the S-DABO series.
Topics: Cell Line; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Magnetic Resonance Spectroscopy; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 1997 |
Novel 1,1,3-trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine derivatives as non-nucleoside reverse transcriptase inhibitors that inhibit human immunodeficiency virus type 1 replication.
Topics: Cell Line; HIV Reverse Transcriptase; HIV-1; Humans; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiadiazines; Virus Replication | 1998 |
Rational design of N-[2-(2,5-dimethoxyphenylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea (HI-236) as a potent non-nucleoside inhibitor of drug-resistant human immunodeficiency virus.
Topics: Anti-HIV Agents; Delavirdine; Drug Design; Humans; Inhibitory Concentration 50; Kinetics; Models, Molecular; Nevirapine; Pyridines; Thiourea | 1999 |
N-[2-(1-cyclohexenyl)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea and N'-[2-(1-cyclohexenyl)ethyl]-N'-[2-(5-chloropyridyl)]-thiourea as potent inhibitors of multidrug-resistant human immunodeficiency virus-1.
Topics: Aminopyridines; Anti-HIV Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Reverse Transcriptase Inhibitors; Thiourea | 1999 |
N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)] thiourea as a potent inhibitor of NNI-resistant and multidrug-resistant human immunodeficiency virus-1.
Topics: Anti-HIV Agents; Cells, Cultured; HIV-1; Humans; Microbial Sensitivity Tests; Models, Molecular; Pyridines; Reverse Transcriptase Inhibitors; Thiourea; Virus Replication | 1999 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Synthesis and antiviral activity of 4-benzyl pyridinone derivatives as potent and selective non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Cell Line; Cells, Cultured; Drug Resistance, Microbial; HIV-1; Humans; Pyridones; Recombinant Proteins; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Structure-Activity Relationship; Virion; Virus Replication | 2000 |
Quinoxalinylethylpyridylthioureas (QXPTs) as potent non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors. Further SAR studies and identification of a novel orally bioavailable hydrazine-based antiviral agent.
Topics: Animals; Anti-HIV Agents; Biological Availability; Cell Line; Didanosine; Drug Synergism; HIV Reverse Transcriptase; HIV-1; Humans; Mice; Models, Molecular; Pyridines; Quinoxalines; Reverse Transcriptase Inhibitors; Stereoisomerism; Structure-Activity Relationship; Thiourea; Zidovudine | 2001 |
The biological effects of structural variation at the meta position of the aromatic rings and at the end of the alkenyl chain in the alkenyldiarylmethane series of non-nucleoside reverse transcriptase inhibitors.
Topics: Alkenes; Benzene Derivatives; Cell Line; Cytopathogenic Effect, Viral; Drug Resistance, Multiple; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Humans; In Vitro Techniques; Leukocytes, Mononuclear; Models, Molecular; Monocytes; Mutagenesis, Site-Directed; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Virus Replication | 2001 |
Threshold interaction energy of NRTI's (2'-deoxy 3'-substituted nucleosidic analogs of reverse transcriptase inhibitors) to undergo competitive inhibition.
Topics: Anti-HIV Agents; Binding, Competitive; Inhibitory Concentration 50; Models, Molecular; Nucleosides; Protein Binding; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thermodynamics | 2004 |
Specific targeting highly conserved residues in the HIV-1 reverse transcriptase primer grip region. Design, synthesis, and biological evaluation of novel, potent, and broad spectrum NNRTIs with antiviral activity.
Topics: Amino Acid Sequence; Animals; Anti-HIV Agents; Binding Sites; Cells, Cultured; Conserved Sequence; Drug Design; Drug Resistance, Viral; Drug Synergism; HIV Reverse Transcriptase; HIV-1; Humans; Macrophages; Mice; Models, Molecular; Mutation; Oxazepines; Pyrroles; Reverse Transcriptase Inhibitors; Stereoisomerism; Structure-Activity Relationship; Virus Replication; Zidovudine | 2005 |
Parallel solution-phase and microwave-assisted synthesis of new S-DABO derivatives endowed with subnanomolar anti-HIV-1 activity.
Topics: Anti-HIV Agents; Cell Line; Drug Resistance, Multiple, Viral; HIV Reverse Transcriptase; HIV-1; Humans; Microwaves; Models, Molecular; Mutation; Pyrimidines; Pyrimidinones; Reverse Transcriptase Inhibitors; Solutions; Structure-Activity Relationship | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Synthesis and biological investigation of S-aryl-S-DABO derivatives as HIV-1 inhibitors.
Topics: Anti-HIV Agents; Binding Sites; Cell Death; Cell Line; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Pyrimidines; Reverse Transcriptase Inhibitors; Stereoisomerism; Structure-Activity Relationship | 2006 |
Selective inhibition of porcine endogenous retrovirus replication in human cells by acyclic nucleoside phosphonates.
Topics: Adenine; Amino Acid Sequence; Animals; Antiviral Agents; Catalysis; Cell Line; Dose-Response Relationship, Drug; Endogenous Retroviruses; HIV-1; Humans; Kidney; Molecular Sequence Data; Organophosphonates; Polymerase Chain Reaction; Protein Structure, Tertiary; Reverse Transcriptase Inhibitors; Stavudine; Swine; Swine, Miniature; Tenofovir; Virus Replication; Zidovudine | 2007 |
Intracellular metabolism and persistence of the anti-human immunodeficiency virus activity of 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine, a novel thymidine analog.
Topics: Anti-HIV Agents; Cell Line; Dideoxynucleotides; Dose-Response Relationship, Drug; HeLa Cells; HIV; Humans; Phosphorylation; Reverse Transcriptase Inhibitors; Stavudine; Thymine Nucleotides; Virus Replication; Zidovudine | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Synthesis and anti-HIV evaluation of novel 1,3-disubstituted thieno[3,2-c][1,2,6]thiadiazin-4(3H)-one 2,2-dioxides(TTDDs).
Topics: Cell Line; Heterocyclic Oxides; HIV-1; Humans; Inhibitory Concentration 50; Molecular Structure; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiadiazines | 2008 |
Dihydro-alkylthio-benzyl-oxopyrimidines as inhibitors of reverse transcriptase: synthesis and rationalization of the biological data on both wild-type enzyme and relevant clinical mutants.
Topics: Anti-HIV Agents; Cell Line; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Mutation; Pyrimidines; Quantitative Structure-Activity Relationship; Recombinant Proteins; Reverse Transcriptase Inhibitors; Sulfides | 2007 |
Mutations in human immunodeficiency virus type 1 integrase confer resistance to the naphthyridine L-870,810 and cross-resistance to the clinical trial drug GS-9137.
Topics: Cell Line; Drug Resistance, Viral; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Models, Molecular; Mutation; Naphthyridines; Quinolones; Virus Replication | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Biological Assay; Cell Line; Chemistry, Pharmaceutical; Drug Design; Drug Evaluation, Preclinical; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Models, Chemical; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiadiazoles; Virus Replication | 2008 |
Studies on anti-HIV quinolones: new insights on the C-6 position.
Topics: Anti-HIV Agents; HIV; Humans; Quinolones; Structure-Activity Relationship; Transcription, Genetic; Virus Replication | 2009 |
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship | 2009 |
Specific targeting of highly conserved residues in the HIV-1 reverse transcriptase primer grip region. 2. Stereoselective interaction to overcome the effects of drug resistant mutations.
Topics: Anti-HIV Agents; Conserved Sequence; Drug Resistance; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Mutation; Reverse Transcriptase Inhibitors; Stereoisomerism; Structure-Activity Relationship | 2009 |
Human immunodeficiency virus type 1 isolates with the reverse transcriptase (RT) mutation Q145M retain nucleoside and nonnucleoside RT inhibitor susceptibility.
Topics: Amino Acid Sequence; Anti-HIV Agents; Drug Resistance, Viral; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Nucleosides; Phenotype; Reverse Transcriptase Inhibitors | 2009 |
Genital tract, cord blood, and amniotic fluid exposures of seven antiretroviral drugs during and after pregnancy in human immunodeficiency virus type 1-infected women.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amniotic Fluid; Anti-HIV Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Female; Fetal Blood; Genitalia, Female; HIV-1; Humans; Hydrocortisone; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Synthesis and anti-HIV activity evaluation of 2-(4-(naphthalen-2-yl)-1,2,3-thiadiazol-5-ylthio)-N-acetamides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
Topics: Acetamides; Anti-HIV Agents; Cell Line; HIV Infections; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Models, Molecular; Protein Binding; Structure-Activity Relationship | 2009 |
Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
Topics: Acetanilides; Anti-HIV Agents; Binding Sites; Computer Simulation; HIV Reverse Transcriptase; Humans; Imidazoles; Structure-Activity Relationship | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Biomimetic synthesis and anti-HIV activity of dimeric phloroglucinols.
Topics: Anti-HIV Agents; Biomimetic Materials; Dimerization; HIV Infections; HIV Reverse Transcriptase; Humans; Phloroglucinol; Structure-Activity Relationship; Virus Replication | 2010 |
Combinations of mutations in the connection domain of human immunodeficiency virus type 1 reverse transcriptase: assessing the impact on nucleoside and nonnucleoside reverse transcriptase inhibitor resistance.
Topics: Amino Acid Substitution; Anti-HIV Agents; Drug Resistance, Viral; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Mutagenesis, Site-Directed; Mutation; Nucleosides; Phenotype; pol Gene Products, Human Immunodeficiency Virus; Protein Structure, Tertiary; Reverse Transcriptase Inhibitors; Virus Replication | 2010 |
"Viologen" dendrimers as antiviral agents: the effect of charge number and distance.
Topics: Anti-HIV Agents; Antiviral Agents; Cell Line; Dendrimers; HIV; Humans; Static Electricity; Structure-Activity Relationship; Viologens | 2010 |
Diarylaniline derivatives as a distinct class of HIV-1 non-nucleoside reverse transcriptase inhibitors.
Topics: Aniline Compounds; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Hydrogen Bonding; Magnetic Resonance Spectroscopy; Models, Molecular; Reverse Transcriptase Inhibitors; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship | 2010 |
Anti-HIV and antiplasmodial activity of original flavonoid derivatives.
Topics: Anti-HIV Agents; Antimalarials; Cell Line; Cell Survival; Flavonoids; HIV; HIV Infections; Humans; Malaria, Falciparum; Plasmodium falciparum | 2010 |
Lersivirine, a nonnucleoside reverse transcriptase inhibitor with activity against drug-resistant human immunodeficiency virus type 1.
Topics: Cell Line; Cell Line, Tumor; Crystallography, X-Ray; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Sequence Data; Mutagenesis, Site-Directed; Nitriles; Pyrazoles; Reverse Transcriptase Inhibitors | 2010 |
Identification and characterization of persistent intracellular human immunodeficiency virus type 1 integrase strand transfer inhibitor activity.
Topics: Adenine; Anti-HIV Agents; Cell Line; HeLa Cells; HIV-1; Humans; Integrase Inhibitors; Organophosphonates; Pyrrolidinones; Quinolones; Raltegravir Potassium; Tenofovir; Zidovudine | 2011 |
Synthesis and biological evaluation of novel dihydro-aryl/alkylsulfanyl-cyclohexylmethyl-oxopyrimidines (S-DACOs) as high active anti-HIV agents.
Topics: Anti-HIV Agents; Cell Line; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Nevirapine; Pyrimidines; Structure-Activity Relationship; Zidovudine | 2011 |
Synthesis of 9-substituted derivatives of berberine as anti-HIV agents.
Topics: Anti-HIV Agents; Berberine; Biological Products; Cell Line; HIV Reverse Transcriptase; HIV-1; Humans | 2011 |
Antiviral activity of seed extract from Citrus bergamia towards human retroviruses.
Topics: Benzoxepins; Citrus; HIV Reverse Transcriptase; HIV-1; Humans; Limonins; Reverse Transcriptase Inhibitors; Seeds | 2011 |
Asymmetric total synthesis of (+)- and (-)-clusianone and (+)- and (-)-clusianone methyl enol ether via ACC alkylation and evaluation of their anti-HIV activity.
Topics: Alkylation; Anti-HIV Agents; Benzophenones; Benzoquinones; Bridged Bicyclo Compounds; Cell Line; Ethers; HIV; Humans; Stereoisomerism | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Cell Line, Tumor; Crystallography, X-Ray; Dose-Response Relationship, Drug; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Pyrimidinones; Reverse Transcriptase Inhibitors; Stereoisomerism; Structure-Activity Relationship; Virus Replication | 2011 |
Synthesis and structure-activity relationship of novel diarylpyrimidines with hydromethyl linker (CH(OH)-DAPYs) as HIV-1 NNRTIs.
Topics: Aniline Compounds; Cell Line; Chlorine; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2011 |
Arylazolylthioacetanilide. Part 8: Design, synthesis and biological evaluation of novel 2-(2-(2,4-dichlorophenyl)-2H-1,2,4-triazol-3-ylthio)-N-arylacetamides as potent HIV-1 inhibitors.
Topics: Acetamides; Anti-HIV Agents; Cell Line; HIV Infections; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Triazoles; Virus Replication | 2011 |
Design, synthesis and biological evaluation of cycloalkyl arylpyrimidines (CAPYs) as HIV-1 NNRTIs.
Topics: Anti-HIV Agents; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2011 |
Synthesis and biological evaluation of piperidine-substituted triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Cell Line; Chemistry Techniques, Synthetic; HIV Reverse Transcriptase; HIV-1; Inhibitory Concentration 50; Piperidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Triazines | 2012 |
Chiral resolution, absolute configuration assignment and biological activity of racemic diarylpyrimidine CH(OH)-DAPY as potent nonnucleoside HIV-1 reverse transcriptase inhibitors.
Topics: HIV Reverse Transcriptase; HIV-1; HIV-2; Models, Molecular; Protein Conformation; Pyrimidines; Reverse Transcriptase Inhibitors; Stereoisomerism | 2012 |
Design, synthesis, anti-HIV evaluation and molecular modeling of piperidine-linked amino-triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors.
Topics: Amines; Anti-HIV Agents; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Design; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Piperidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Triazines | 2012 |
Diverse combinatorial design, synthesis and in vitro evaluation of new HEPT analogues as potential non-nucleoside HIV-1 reverse transcription inhibitors.
Topics: Cell Line; Chemistry Techniques, Synthetic; Combinatorial Chemistry Techniques; Drug Design; HIV Reverse Transcriptase; HIV-1; Reverse Transcriptase Inhibitors; Thymine | 2012 |
New nitrogen containing substituents at the indole-2-carboxamide yield high potent and broad spectrum indolylarylsulfone HIV-1 non-nucleoside reverse transcriptase inhibitors.
Topics: Cell Line; HIV Reverse Transcriptase; HIV-1; Indoles; Mutation; Nitrogen; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Sulfones | 2012 |
Arylazolyl(azinyl)thioacetanilides. Part 10: design, synthesis and biological evaluation of novel substituted imidazopyridinylthioacetanilides as potent HIV-1 inhibitors.
Topics: Acetanilides; Anti-HIV Agents; Cell Line; Dose-Response Relationship, Drug; Drug Design; HIV-1; Humans; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Virus Replication | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Structure-based bioisosterism design, synthesis and biological evaluation of novel 1,2,4-triazin-6-ylthioacetamides as potent HIV-1 NNRTIs.
Topics: Binding Sites; Cell Line; Drug Design; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Docking Simulation; Protein Structure, Tertiary; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thioglycolates; Triazines | 2012 |
Discovery of novel 2-(3-(2-chlorophenyl)pyrazin-2-ylthio)-N-arylacetamides as potent HIV-1 inhibitors using a structure-based bioisosterism approach.
Topics: Anti-HIV Agents; Drug Design; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Structure-Activity Relationship; Thioacetamide | 2012 |
Synthesis, biological evaluation and molecular modeling of 4,6-diarylpyrimidines and diarylbenzenes as novel non-nucleosides HIV-1 reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Antineoplastic Agents; Benzene Derivatives; Cell Survival; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Models, Molecular; Molecular Structure; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Tumor Cells, Cultured | 2012 |
Cytotoxic, antitopoisomerase IIα, and anti-HIV-1 activities of triterpenoids isolated from leaves and twigs of Gardenia carinata.
Topics: Anti-HIV Agents; Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; Gardenia; HIV-1; Microbial Sensitivity Tests; Molecular Structure; Plant Leaves; Plant Stems; Thailand; Topoisomerase II Inhibitors; Triterpenes | 2013 |
Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Benzophenones; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Design; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2013 |
Synthesis and evaluation of novel 3-(3,5-dimethylbenzyl)uracil analogs as potential anti-HIV-1 agents.
Topics: Binding Sites; Cell Line; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Dynamics Simulation; Picolinic Acids; Protein Structure, Tertiary; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Uracil; Virus Replication | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Towards new C6-rigid S-DABO HIV-1 reverse transcriptase inhibitors: synthesis, biological investigation and molecular modeling studies.
Topics: Binding Sites; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Docking Simulation; Protein Binding; Protein Structure, Tertiary; Pyrimidines; Pyrimidinones; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2013 |
Design, synthesis and preliminary SAR studies of novel N-arylmethyl substituted piperidine-linked aniline derivatives as potent HIV-1 NNRTIs.
Topics: Aniline Compounds; Anti-HIV Agents; Drug Design; HIV-1; Humans; Models, Molecular; Piperidines; Structure-Activity Relationship | 2014 |
Phenylspirodrimanes with anti-HIV activity from the sponge-derived fungus Stachybotrys chartarum MXH-X73.
Topics: Animals; Anti-HIV Agents; HIV-1; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Polycyclic Sesquiterpenes; Porifera; Reverse Transcriptase Inhibitors; Sesquiterpenes; Spiro Compounds; Stachybotrys; Structure-Activity Relationship | 2013 |
Discovery of nitropyridine derivatives as potent HIV-1 non-nucleoside reverse transcriptase inhibitors via a structure-based core refining approach.
Topics: Cell Line; Drug Discovery; HIV Reverse Transcriptase; HIV-1; Humans; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Pyridines; Reverse Transcriptase Inhibitors; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Virus Replication | 2014 |
Structural modifications of CH(OH)-DAPYs as new HIV-1 non-nucleoside reverse transcriptase inhibitors.
Topics: Binding Sites; Cell Line; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Docking Simulation; Protein Structure, Tertiary; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2014 |
New indolylarylsulfones as highly potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitors.
Topics: Cell Line; Drug Design; HIV Reverse Transcriptase; HIV-1; Humans; Indoles; Inhibitory Concentration 50; Models, Molecular; Protein Conformation; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Sulfones | 2014 |
Synthesis and biological evaluation of CHX-DAPYs as HIV-1 non-nucleoside reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Benzamides; Cell Survival; Cells, Cultured; Drug Design; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Molecular Docking Simulation; Molecular Structure; Nitriles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Tumor Cells, Cultured; Virus Replication | 2014 |
Synthesis of novel fluoro analogues of MKC442 as microbicides.
Topics: Anti-HIV Agents; Cell Line; Drug Resistance, Viral; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Pyrimidinones; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Uracil | 2014 |
Jatrophane diterpenes as inhibitors of chikungunya virus replication: structure-activity relationship and discovery of a potent lead.
Topics: Alphavirus Infections; Antiviral Agents; Chikungunya Fever; Chikungunya virus; Diterpenes; Euphorbia; France; HIV-1; HIV-2; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Semliki forest virus; Sindbis Virus; Structure-Activity Relationship; Virus Replication | 2014 |
Design and synthesis of a new series of modified CH-diarylpyrimidines as drug-resistant HIV non-nucleoside reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Dose-Response Relationship, Drug; Drug Design; HIV Reverse Transcriptase; HIV-1; HIV-2; Microbial Sensitivity Tests; Molecular Structure; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2014 |
2,4,5-Trisubstituted thiazole derivatives: a novel and potent class of non-nucleoside inhibitors of wild type and mutant HIV-1 reverse transcriptase.
Topics: Drug Design; Drug Resistance, Viral; HEK293 Cells; HIV Reverse Transcriptase; HIV-1; Humans; Inhibitory Concentration 50; Models, Molecular; Mutation; Protein Conformation; Quantitative Structure-Activity Relationship; Reverse Transcriptase Inhibitors; Thiazoles | 2014 |
Design, synthesis and anti-HIV evaluation of novel diarylnicotinamide derivatives (DANAs) targeting the entrance channel of the NNRTI binding pocket through structure-guided molecular hybridization.
Topics: Anti-HIV Agents; Catalytic Domain; Dose-Response Relationship, Drug; Drug Design; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Molecular Structure; Niacinamide; Protein Conformation; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Tumor Cells, Cultured | 2014 |
Synthesis and biological evaluation of DAPY-DPEs hybrids as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Topics: Anti-HIV Agents; Binding Sites; Cell Line; Drug Design; HIV Reverse Transcriptase; HIV-1; Humans; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2015 |
Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 3: optimization of [1,2,4]triazolo[1,5-a]pyrimidine core via structure-based and physicochemical property-driven approaches.
Topics: Anti-HIV Agents; Cell Line, Tumor; Dose-Response Relationship, Drug; Heterocyclic Compounds; Heterocyclic Compounds, 2-Ring; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Nitrogen; Reverse Transcriptase Inhibitors; Solubility; Structure-Activity Relationship; Sulfones | 2015 |
Design, synthesis of new β-carboline derivatives and their selective anti-HIV-2 activity.
Topics: Carbolines; Drug Design; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Piperazines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2015 |
Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 4: design, synthesis and biological evaluation of novel imidazo[1,2-a]pyrazines.
Topics: Anti-HIV Agents; Chemistry Techniques, Synthetic; Computational Biology; Drug Design; HIV Reverse Transcriptase; HIV-1; Imidazoles; Molecular Docking Simulation; Protein Conformation; Pyrazines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2015 |
Anti-HIV diarylpyrimidine-quinolone hybrids and their mode of action.
Topics: Anti-HIV Agents; Binding Sites; Cell Line; Drug Design; Granulocyte Precursor Cells; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Molecular Docking Simulation; Pyrimidines; Quinolones; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Tetradecanoylphorbol Acetate; Virus Latency | 2015 |
Antiviral Activity of Flexibilane and Tigliane Diterpenoids from Stillingia lineata.
Topics: Antiviral Agents; Chikungunya virus; Diterpenes; Euphorbiaceae; France; HCT116 Cells; HIV-1; HIV-2; Humans; Macrocyclic Compounds; MCF-7 Cells; Molecular Structure; Semliki forest virus; Sindbis Virus; Virus Replication | 2015 |
Design and Synthesis of DiselenoBisBenzamides (DISeBAs) as Nucleocapsid Protein 7 (NCp7) Inhibitors with anti-HIV Activity.
Topics: Anti-HIV Agents; Benzamides; Cell Line, Tumor; Drug Resistance, Viral; gag Gene Products, Human Immunodeficiency Virus; Glutamic Acid; Glycine; HIV-1; Humans; Isoleucine; Molecular Docking Simulation; Molecular Dynamics Simulation; Organoselenium Compounds; Simian Immunodeficiency Virus; Structure-Activity Relationship | 2015 |
Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives targeting the entrance channel of NNRTI binding pocket.
Topics: Anti-HIV Agents; Binding Sites; Drug Design; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Docking Simulation; Point Mutation; Pyridines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2016 |
Design, synthesis and evaluation of novel HIV-1 NNRTIs with dual structural conformations targeting the entrance channel of the NNRTI binding pocket.
Topics: Anti-HIV Agents; Binding Sites; Dose-Response Relationship, Drug; Drug Design; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Structure; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Virus Replication | 2016 |
Design, synthesis and anti-HIV activity of novel quinoxaline derivatives.
Topics: Animals; Anti-HIV Agents; Chlorocebus aethiops; Computer Simulation; Drug Design; HIV Integrase; Molecular Docking Simulation; Quantitative Structure-Activity Relationship; Quinoxalines; Vero Cells | 2016 |
1,6-Bis[(benzyloxy)methyl]uracil derivatives-Novel antivirals with activity against HIV-1 and influenza H1N1 virus.
Topics: Animals; Antiviral Agents; Cells, Cultured; Dogs; Dose-Response Relationship, Drug; HIV-1; Influenza A Virus, H1N1 Subtype; Madin Darby Canine Kidney Cells; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Uracil | 2016 |
Synthesis and antiproliferative evaluation of novel 2-(4H-1,2,4-triazole-3-ylthio)acetamide derivatives as inducers of apoptosis in cancer cells.
Topics: Acetamides; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Humans; Membrane Potential, Mitochondrial; Structure-Activity Relationship; Triazoles | 2016 |
Systematic evaluation of methyl ester bioisosteres in the context of developing alkenyldiarylmethanes (ADAMs) as non-nucleoside reverse transcriptase inhibitors (NNRTIs) for anti-HIV-1 chemotherapy.
Topics: Anti-HIV Agents; Drug Stability; Esters; HIV-1; Humans; Inhibitory Concentration 50; Methane; Models, Molecular; Reverse Transcriptase Inhibitors | 2016 |
Structural optimization of pyridine-type DAPY derivatives to exploit the tolerant regions of the NNRTI binding pocket.
Topics: Binding Sites; Dose-Response Relationship, Drug; Drug Design; HIV Reverse Transcriptase; Molecular Docking Simulation; Protein Conformation; Pyridines; Pyrimidines; Reverse Transcriptase Inhibitors; Solubility; Structure-Activity Relationship; Water | 2016 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance Profiles.
Topics: Animals; Anti-HIV Agents; Cell Line, Tumor; Drug Resistance, Viral; Heterocyclic Compounds, 2-Ring; HIV Reverse Transcriptase; HIV-1; Humans; Male; Mice; Molecular Docking Simulation; Mutation; Pyrimidines; Rats, Sprague-Dawley; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Sulfonamides; Thiophenes | 2016 |
Synthesis of arylated coumarins by Suzuki-Miyaura cross-coupling. Reactions and anti-HIV activity.
Topics: Anti-HIV Agents; Cell Line, Tumor; Coumarins; Crystallography, X-Ray; Dose-Response Relationship, Drug; HIV-1; HIV-2; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Structure-Activity Relationship | 2016 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Discovery of uracil-bearing DAPYs derivatives as novel HIV-1 NNRTIs via crystallographic overlay-based molecular hybridization.
Topics: Animals; Anti-HIV Agents; Cell Line; Drug Discovery; HIV Reverse Transcriptase; HIV-1; Mice; Models, Molecular; Reverse Transcriptase Inhibitors; Solubility; Structure-Activity Relationship; Uracil | 2017 |
Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120.
Topics: Anti-HIV Agents; Biomimetic Materials; CD4 Antigens; Cell Line; Crystallography, X-Ray; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Molecular Docking Simulation; Molecular Targeted Therapy; Pyrroles; Structure-Activity Relationship; Thiazoles; Virus Internalization | 2017 |
Structural modifications of diarylpyrimidines (DAPYs) as HIV-1 NNRTIs: Synthesis, anti-HIV activities and SAR.
Topics: Anti-HIV Agents; Carbon-13 Magnetic Resonance Spectroscopy; HIV-1; Molecular Docking Simulation; Proton Magnetic Resonance Spectroscopy; Pyrimidines; Reverse Transcriptase Inhibitors; Spectrometry, Mass, Electrospray Ionization | 2017 |
Design and synthesis of hybrids of diarylpyrimidines and diketo acids as HIV-1 inhibitors.
Topics: Anti-HIV Agents; Cell Line; Drug Design; HIV Infections; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Keto Acids; Molecular Docking Simulation; Pyrimidines; Reverse Transcriptase Inhibitors | 2017 |
An integrated chemical biology approach reveals the mechanism of action of HIV replication inhibitors.
Topics: Binding Sites; Cells, Cultured; Genotype; Half-Life; HIV Reverse Transcriptase; HIV-1; Humans; Inhibitory Concentration 50; Microfluidics; Microsomes; Molecular Conformation; Molecular Docking Simulation; Pyrimidinones; Reverse Transcriptase Inhibitors; Stereoisomerism; Virus Replication | 2017 |
Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants.
Topics: Animals; Anti-HIV Agents; Drug Resistance, Viral; HEK293 Cells; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Pyrimidines; Rats, Sprague-Dawley; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiophenes | 2017 |
Potent Inhibitor of Drug-Resistant HIV-1 Strains Identified from the Medicinal Plant Justicia gendarussa.
Topics: Anti-HIV Agents; Glycosides; HIV-1; Humans; Justicia; Lignans; Molecular Structure; Plant Roots; Plant Stems; Plants, Medicinal; Reverse Transcriptase Inhibitors; Vietnam; Zidovudine | 2017 |
Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 Agents.
Topics: Animals; Anti-HIV Agents; Cells, Cultured; Glutamic Acid; HIV-1; Humans; Indoles; Lipopolysaccharides; Mice, Inbred C57BL; Microglia; Molecular Docking Simulation; Mutation; Neurons; Neuroprotective Agents; Reverse Transcriptase Inhibitors; Stereoisomerism; Structure-Activity Relationship; Sulfones | 2017 |
Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives as potent HIV-1 NNRTIs.
Topics: Anti-HIV Agents; Carbon-13 Magnetic Resonance Spectroscopy; Cell Line; Drug Design; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Proton Magnetic Resonance Spectroscopy; Reverse Transcriptase Inhibitors; Spectrometry, Mass, Electrospray Ionization | 2017 |
Discovery of Thiophene[3,2-
Topics: | 2017 |
Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1.
Topics: Anti-HIV Agents; Biphenyl Compounds; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mutation; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Tumor Cells, Cultured | 2018 |
The discovery of novel diarylpyri(mi)dine derivatives with high level activity against a wide variety of HIV-1 strains as well as against HIV-2.
Topics: Allosteric Regulation; Binding Sites; Drug Design; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Molecular Docking Simulation; Protein Structure, Tertiary; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2018 |
Targeting the entrance channel of NNIBP: Discovery of diarylnicotinamide 1,4-disubstituted 1,2,3-triazoles as novel HIV-1 NNRTIs with high potency against wild-type and E138K mutant virus.
Topics: Anti-HIV Agents; Drug Design; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Docking Simulation; Niacinamide; Point Mutation; Structure-Activity Relationship; Triazoles | 2018 |
Discovery of Novel Diarylpyrimidine Derivatives as Potent HIV-1 NNRTIs Targeting the "NNRTI Adjacent" Binding Site.
Topics: | 2018 |
Further Exploring Solvent-Exposed Tolerant Regions of Allosteric Binding Pocket for Novel HIV-1 NNRTIs Discovery.
Topics: | 2018 |
The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic.
Topics: Animals; Anti-HIV Agents; Clinical Trials as Topic; Drug Discovery; HIV Infections; HIV-1; Humans; Reverse Transcriptase Inhibitors | 2019 |
Synthesis and in-vitro anti-HIV-1 evaluation of novel pyrazolo[4,3-c]pyridin-4-one derivatives.
Topics: Anti-HIV Agents; Blood-Brain Barrier; Cell Survival; Drug Design; HeLa Cells; HIV Reverse Transcriptase; Humans; Molecular Docking Simulation; Molecular Structure; Protein Binding; Pyrazoles; Pyridines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2019 |
Discovery of 2-isoxazol-3-yl-acetamide analogues as heat shock protein 90 (HSP90) inhibitors with significant anti-HIV activity.
Topics: Acetamides; Androstenols; Anti-HIV Agents; Dose-Response Relationship, Drug; Drug Discovery; HIV-1; HSP90 Heat-Shock Proteins; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Virus Replication | 2019 |
Indazolyl-substituted piperidin-4-yl-aminopyrimidines as HIV-1 NNRTIs: Design, synthesis and biological activities.
Topics: Anti-HIV Agents; Dose-Response Relationship, Drug; Drug Design; HIV; HIV Reverse Transcriptase; Humans; Indazoles; Microbial Sensitivity Tests; Molecular Structure; Piperidines; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2020 |
New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains.
Topics: Anti-HIV Agents; Cell Line, Tumor; Drug Design; Drug Synergism; HIV Reverse Transcriptase; HIV-1; Humans; Indoles; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Mutation; Protein Binding; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Sulfones; Zidovudine | 2020 |
Targeting dual tolerant regions of binding pocket: Discovery of novel morpholine-substituted diarylpyrimidines as potent HIV-1 NNRTIs with significantly improved water solubility.
Topics: Binding Sites; HIV Reverse Transcriptase; HIV-1; Morpholines; Mutation; Pyrimidines; Reverse Transcriptase Inhibitors; Solubility; Structure-Activity Relationship; Water | 2020 |
Exploiting the tolerant region I of the non-nucleoside reverse transcriptase inhibitor (NNRTI) binding pocket. Part 2: Discovery of diarylpyrimidine derivatives as potent HIV-1 NNRTIs with high Fsp
Topics: Anti-HIV Agents; Binding Sites; Drug Design; HIV-1; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Protein Binding; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2021 |
Design, synthesis, and evaluation of "dual-site"-binding diarylpyrimidines targeting both NNIBP and the NNRTI adjacent site of the HIV-1 reverse transcriptase.
Topics: Anti-HIV Agents; Drug Design; HIV Reverse Transcriptase; Humans; Molecular Dynamics Simulation; Molecular Structure; Pyrimidines; Structure-Activity Relationship | 2021 |
Design, synthesis and anti-HIV evaluation of novel 5-substituted diarylpyrimidine derivatives as potent HIV-1 NNRTIs.
Topics: Anti-HIV Agents; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Design; HIV; HIV Reverse Transcriptase; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2021 |
Exploiting the hydrophobic channel of the NNIBP: Discovery of novel diarylpyrimidines as HIV-1 NNRTIs against wild-type and K103N mutant viruses.
Topics: Anti-HIV Agents; Dose-Response Relationship, Drug; Drug Discovery; HIV Reverse Transcriptase; HIV-1; Humans; Hydrophobic and Hydrophilic Interactions; Microbial Sensitivity Tests; Molecular Structure; Mutation; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2021 |
Design of the naphthyl-diarylpyrimidines as potent non-nucleoside reverse transcriptase inhibitors (NNRTIs) via structure-based extension into the entrance channel.
Topics: Anti-HIV Agents; Dose-Response Relationship, Drug; Drug Design; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Structure; Naphthalenes; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2021 |
Chemical space exploration around indolylarylsulfone scaffold led to a novel class of highly active HIV-1 NNRTIs with spiro structural features.
Topics: Anti-HIV Agents; Drug Design; HIV Reverse Transcriptase; HIV-1; Molecular Structure; Reverse Transcriptase Inhibitors; Space Flight; Structure-Activity Relationship | 2022 |
Expansion of the S-CN-DABO scaffold to exploit the impact on inhibitory activities against the non-nucleoside HIV-1 reverse transcriptase.
Topics: Animals; Anti-HIV Agents; HIV Reverse Transcriptase; HIV-1; Mice; Molecular Docking Simulation; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2022 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
3'-Azido-3'-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitors.
Topics: Antiviral Agents; Base Sequence; Benzodiazepines; Cloning, Molecular; Drug Resistance, Microbial; HIV Reverse Transcriptase; HIV-1; Humans; Imidazoles; Molecular Sequence Data; Mutagenesis, Site-Directed; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; Zidovudine | 1992 |
In vitro selection and molecular characterization of human immunodeficiency virus-1 resistant to non-nucleoside inhibitors of reverse transcriptase.
Topics: Antiviral Agents; Base Sequence; Benzodiazepines; CD4-Positive T-Lymphocytes; Cloning, Molecular; Drug Resistance, Microbial; Foscarnet; Gene Expression; HeLa Cells; HIV-1; Humans; Imidazoles; Molecular Sequence Data; Nevirapine; Phosphonoacetic Acid; Polymerase Chain Reaction; Pyridines; Recombinant Proteins; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Zidovudine | 1992 |
HIV-1 reverse transcriptase inhibition by a dipyridodiazepinone derivative: BI-RG-587.
Topics: Antiviral Agents; Foscarnet; HIV-1; Kinetics; Nevirapine; Phosphonoacetic Acid; Pyridines; Reverse Transcriptase Inhibitors; Templates, Genetic; Zidovudine | 1992 |
BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine.
Topics: Antigens, Viral; Antiviral Agents; Cytopathogenic Effect, Viral; Drug Resistance, Microbial; Drug Synergism; HeLa Cells; HIV-1; HIV-2; Humans; Macrophages; Nevirapine; Picornaviridae; Pyridines; Reverse Transcriptase Inhibitors; T-Lymphocytes; Viral Plaque Assay; Zidovudine | 1991 |
Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy.
Topics: Antiviral Agents; Base Sequence; CD4-Positive T-Lymphocytes; Drug Resistance, Microbial; Drug Therapy, Combination; Genotype; HIV Core Protein p24; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Leukocyte Count; Molecular Sequence Data; Mutagenesis; Nevirapine; Phenotype; Pyridines; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; RNA, Viral; Selection, Genetic; Time Factors; Zidovudine | 1994 |
Combinative interactions of a human immunodeficiency virus (HIV) Tat antagonist with HIV reverse transcriptase inhibitors and an HIV protease inhibitor.
Topics: Antiviral Agents; Benzodiazepines; Didanosine; Drug Synergism; Gene Products, tat; HeLa Cells; HIV; HIV Protease Inhibitors; Humans; Isoquinolines; Nevirapine; Pyridines; Pyrroles; Quinolines; Reverse Transcriptase Inhibitors; Saquinavir; tat Gene Products, Human Immunodeficiency Virus; Zalcitabine; Zidovudine | 1994 |
Development of a human immunodeficiency virus-1 in vitro DNA synthesis system to study reverse transcriptase inhibitors.
Topics: Dideoxynucleotides; DNA, Viral; HIV Reverse Transcriptase; HIV-1; Hydrogen-Ion Concentration; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Thymine Nucleotides; Time Factors; Zidovudine | 1994 |
Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors.
Topics: Amino Acid Sequence; Base Sequence; Binding Sites; Catalysis; Deoxyguanine Nucleotides; Dideoxynucleotides; DNA, Viral; Drug Resistance, Microbial; HIV Reverse Transcriptase; HIV-1; Hot Temperature; Humans; Kinetics; Molecular Sequence Data; Mutation; Nevirapine; Phenanthrolines; Pyridines; Reverse Transcriptase Inhibitors; Ribonuclease H; RNA-Directed DNA Polymerase; Templates, Genetic; Thymine Nucleotides; Tyrosine; Zidovudine | 1994 |
Natural occurrence of drug resistance mutations in the reverse transcriptase of human immunodeficiency virus type 1 isolates.
Topics: Amino Acid Sequence; Antiviral Agents; Base Sequence; Cloning, Molecular; DNA, Viral; Drug Resistance, Microbial; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Sequence Data; Mutation; Nevirapine; Point Mutation; Polymerase Chain Reaction; Pyridines; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Stavudine; Virus Cultivation; Zalcitabine; Zidovudine | 1994 |
Fluorometric measurement of reverse transcriptase activity with 4',6-diamidino-2-phenylindole.
Topics: Antiviral Agents; Dideoxynucleotides; Fluorescent Dyes; HIV Reverse Transcriptase; HIV-1; Indicators and Reagents; Indoles; Kinetics; Nevirapine; Phosphorus Radioisotopes; Pyrazines; Pyridines; Radioisotope Dilution Technique; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Spectrometry, Fluorescence; Thiones; Thiophenes; Thymine Nucleotides; Zidovudine | 1995 |
Resistance to 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives is generated by mutations at multiple sites in the HIV-1 reverse transcriptase.
Topics: Antiviral Agents; Cell Line; Dose-Response Relationship, Drug; Drug Resistance, Microbial; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Mutagenesis, Site-Directed; Nevirapine; Pyridines; Recombinant Proteins; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Structure-Activity Relationship; Thymine; Uracil; Zidovudine | 1995 |
The inhibition of human immunodeficiency virus type 1 in vitro by a non-nucleoside reverse transcriptase inhibitor MKC-442, alone and in combination with other anti-HIV compounds.
Topics: Antiviral Agents; Cells, Cultured; Cytotoxicity Tests, Immunologic; Didanosine; Drug Interactions; HIV Reverse Transcriptase; HIV-1; Humans; Indolizines; Isoquinolines; Leukocytes, Mononuclear; Molecular Structure; Nevirapine; Pyridines; Quinolines; Reverse Transcriptase Inhibitors; Saquinavir; Uracil; Zalcitabine; Zidovudine | 1995 |
In vitro comparison of selected triple-drug combinations for suppression of HIV-1 replication: the Inter-Company Collaboration Protocol.
Topics: Antiviral Agents; Cell Line, Transformed; Cytopathogenic Effect, Viral; Didanosine; Drug Synergism; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Isoquinolines; Lamivudine; Nevirapine; Pyridines; Quinolines; Reverse Transcriptase Inhibitors; Saquinavir; Virus Replication; Zalcitabine; Zidovudine | 1995 |
Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy.
Topics: Acquired Immunodeficiency Syndrome; Biological Evolution; Didanosine; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Nevirapine; Polymerase Chain Reaction; Pyridines; Pyridones; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Selection, Genetic; Virus Replication; Zidovudine | 1993 |
Triple whammy. Will an AIDS therapy live up to its advance billing?
Topics: Acquired Immunodeficiency Syndrome; Cells, Cultured; Didanosine; Drug Therapy, Combination; HIV; Humans; Nevirapine; Pyridines; Pyridones; Reverse Transcriptase Inhibitors; Virus Replication; Zidovudine | 1993 |
AIDS drugs. Harvard group makes a splash--twice.
Topics: Antiviral Agents; Didanosine; HIV; Mutation; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; Virus Replication; Zidovudine | 1993 |
Resisting the temptation.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Didanosine; Drug Combinations; HIV; Humans; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Virus Replication; Zidovudine | 1993 |
Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro.
Topics: Base Sequence; Didanosine; DNA, Viral; Drug Resistance, Microbial; HeLa Cells; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Sequence Data; Mutagenesis, Site-Directed; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Zidovudine | 1993 |
Nevirapine synergistically inhibits HIV-1 replication in combination with zidovudine, interferon or CD4 immunoadhesin.
Topics: Antiviral Agents; CD4 Immunoadhesins; Drug Synergism; Feasibility Studies; HIV Reverse Transcriptase; HIV-1; Humans; In Vitro Techniques; Interferon Type I; Nevirapine; Pyridines; Recombinant Proteins; Reverse Transcriptase Inhibitors; Virus Replication; Zidovudine | 1993 |
Alternating nevirapine and zidovudine treatment of human immunodeficiency virus type 1-infected persons does not prolong nevirapine activity.
Topics: Adolescent; Adult; Antiviral Agents; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Nevirapine; Pyridines; Regression Analysis; Time Factors; Zidovudine | 1994 |
[AIDS: therapeutic changes in the second decade. Triple combination--HIV vaccination].
Topics: Acquired Immunodeficiency Syndrome; AIDS Vaccines; Antiviral Agents; Cross-Sectional Studies; Didanosine; Drug Therapy, Combination; Germany; Humans; Incidence; Nevirapine; Pyridines; Zidovudine | 1993 |
Effects of non-nucleoside inhibitors of human immunodeficiency virus type 1 in cell-free recombinant reverse transcriptase assays.
Topics: Cell-Free System; Delavirdine; Deoxycytosine Nucleotides; Dideoxynucleotides; Drug Antagonism; Drug Synergism; HIV Reverse Transcriptase; HIV-1; Indoles; Nevirapine; Piperazines; Pyridines; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Thymine Nucleotides; Zidovudine | 1995 |
Studies of neutralizing monoclonal antibody to human immunodeficiency virus type 1 reverse transcriptase: antagonistic and synergistic effects in reactions performed in the presence of nucleoside and nonnucleoside inhibitors, respectively.
Topics: Animals; Antibodies, Monoclonal; Antiviral Agents; Delavirdine; Deoxycytosine Nucleotides; Dideoxynucleotides; DNA; HIV Antibodies; HIV Reverse Transcriptase; Humans; Indoles; Mice; Neutralization Tests; Nevirapine; Peptide Chain Elongation, Translational; Piperazines; Pyridines; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Thymine Nucleotides; Zidovudine | 1996 |
Drug combinations and effect parameters of zidovudine, stavudine, and nevirapine in standardized drug-sensitive and resistant HIV type 1 strains.
Topics: Antiviral Agents; Cell Line, Transformed; Cytotoxicity, Immunologic; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV-1; Microbial Sensitivity Tests; Nevirapine; Pyridines; Stavudine; T-Lymphocytes; Zidovudine | 1996 |
Complete inhibition of viral breakthrough by combination of MKC-442 with AZT during a long-term culture of HIV-1 infected cells.
Topics: Acetamides; Acetophenones; Cell Line, Transformed; HIV; HIV Core Protein p24; HIV-1; Humans; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; Uracil; Zidovudine | 1996 |
Comparison of virus burden in blood and sequential lymph node biopsy specimens from children infected with human immunodeficiency virus.
Topics: Antiviral Agents; Biopsy; CD4 Lymphocyte Count; Child; Child, Preschool; Didanosine; DNA, Viral; Drug Therapy, Combination; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; In Situ Hybridization; Infant; Lymph Nodes; Male; Nevirapine; Pyridines; Viremia; Zidovudine | 1996 |
Quantitative analysis of the endogenous reverse transcriptase reactions of HIV type 1 variants with decreased susceptibility to azidothymidine and nevirapine.
Topics: Acquired Immunodeficiency Syndrome; Animals; COS Cells; DNA, Viral; Drug Resistance, Microbial; HIV-1; Nevirapine; Polymerase Chain Reaction; Pyridines; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Virus Replication; Zidovudine | 1996 |
Use of standardized SCID-hu Thy/Liv mouse model for preclinical efficacy testing of anti-human immunodeficiency virus type 1 compounds.
Topics: Animals; Antiviral Agents; Didanosine; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Fetal Tissue Transplantation; Flow Cytometry; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Liver Transplantation; Lymphocyte Count; Mice; Mice, SCID; Neutrophils; Nevirapine; Polymerase Chain Reaction; Pyridines; Rats; T-Lymphocytes; Thymus Gland; Transplantation, Heterologous; Zidovudine | 1996 |
[Nevirapine: a new principle of action against HIV].
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Child; Clinical Trials as Topic; Didanosine; Double-Blind Method; Drug Therapy, Combination; Female; HIV; HIV Infections; Humans; Infant, Newborn; Male; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pyridines; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Time Factors; Zidovudine | 1996 |
Stavudine selectively induces apoptosis in HIV type 1-infected cells.
Topics: Anti-HIV Agents; Apoptosis; Cell Line; Didanosine; DNA Fragmentation; Down-Regulation; HIV Reverse Transcriptase; HIV-1; Humans; Nevirapine; Proto-Oncogene Proteins c-bcl-2; Pyridines; Reverse Transcriptase Inhibitors; Stavudine; T-Lymphocytes; Thymidine; Zalcitabine; Zidovudine | 1997 |
A new reporter cell line to monitor HIV infection and drug susceptibility in vitro.
Topics: Anti-HIV Agents; Cell Line; Genes, Reporter; Green Fluorescent Proteins; HIV Envelope Protein gp120; HIV Long Terminal Repeat; HIV Protease Inhibitors; HIV-1; Luminescent Proteins; Microbial Sensitivity Tests; Nevirapine; Pyridines; Recombinant Proteins; Reverse Transcriptase Inhibitors; Saquinavir; T-Lymphocytes; Zidovudine | 1997 |
Genotypic and phenotypic changes during culture of a multinucleoside-resistant human immunodeficiency virus type 1 strain in the presence and absence of additional reverse transcriptase inhibitors.
Topics: Antiviral Agents; Cell Line; Cells, Cultured; Didanosine; Drug Interactions; Drug Resistance, Microbial; Drug Resistance, Multiple; Genotype; HIV-1; Humans; Lamivudine; Mutation; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; Virus Replication; Zidovudine | 1996 |
Transmission of human immunodeficiency virus type 1 resistant to nevirapine and zidovudine. Sydney Primary HIV Infection Study Group.
Topics: Adolescent; Adult; Anti-HIV Agents; Base Sequence; Codon; DNA Mutational Analysis; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homosexuality, Male; Humans; Male; Molecular Sequence Data; Nevirapine; Pyridines; RNA, Viral; Sexual Partners; Zidovudine | 1997 |
Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe.
Topics: Adult; Amino Acid Sequence; Base Sequence; Didanosine; DNA, Viral; Female; Genes, env; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Nevirapine; Nucleic Acid Heteroduplexes; Phylogeny; Pyridines; Reverse Transcriptase Inhibitors; Sequence Homology, Amino Acid; Zidovudine; Zimbabwe | 1997 |
Cure or control of HIV/AIDS?
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; Humans; Indinavir; Lamivudine; Models, Biological; Nevirapine; Pyridines; Ritonavir; Saquinavir; Stavudine; Zalcitabine; Zidovudine | 1997 |
Overshoot of HIV-1 viraemia after early discontinuation of antiretroviral treatment.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Indinavir; Models, Biological; Nevirapine; Pyridines; Risk Factors; RNA, Viral; Substance Withdrawal Syndrome; Viral Load; Viremia; Zidovudine | 1997 |
Drugs for HIV infection.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Delavirdine; Diarrhea; Didanosine; Drug Interactions; Drug Therapy, Combination; HIV Infections; Humans; Indinavir; Lamivudine; Nelfinavir; Nevirapine; Protease Inhibitors; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Virus Replication; Zalcitabine; Zidovudine | 1997 |
Patterns of T-cell repopulation, virus load reduction, and restoration of T-cell function in HIV-infected persons during therapy with different antiretroviral agents.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; HIV-1; Humans; Nevirapine; Ritonavir; RNA, Viral; T-Lymphocytes; Zidovudine | 1997 |
Drug susceptibility of subtypes A,B,C,D, and E human immunodeficiency virus type 1 primary isolates.
Topics: Anti-HIV Agents; Cell Line, Transformed; Cells, Cultured; Didanosine; Foscarnet; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Leukocytes, Mononuclear; Nevirapine; Reverse Transcriptase Inhibitors; Ritonavir; Zidovudine | 1998 |
Retention of marked sensitivity to (S)-4-isopropoxycarbonyl-6-methoxy-3-(methylthiomethyl)-3,4-di hydroquin oxaline-2(1H)-thione (HBY 097) by an azidothymidine (AZT)-resistant human immunodeficiency virus type 1 (HIV-1) strain subcultured in the combined
Topics: Anti-HIV Agents; Antiviral Agents; Benzodiazepines; Cell Line; Delavirdine; Drug Resistance, Microbial; Furans; HIV Reverse Transcriptase; HIV-1; Humans; Imidazoles; Lamivudine; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Mutation; Nevirapine; Quinoxalines; Recombinant Proteins; Reverse Transcriptase Inhibitors; Zidovudine | 1998 |
1,1,3-Trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine (TTD) derivatives: a new class of nonnucleoside human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitors with anti-HIV-1 activity.
Topics: Anti-HIV Agents; Cells, Cultured; Didanosine; Drug Resistance, Microbial; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Nevirapine; Structure-Activity Relationship; Zidovudine | 1998 |
Chimeric HIV-1 and feline immunodeficiency virus reverse transcriptases: critical role of the p51 subunit in the structural integrity of heterodimeric lentiviral DNA polymerases.
Topics: Antiviral Agents; Dideoxynucleotides; Dimerization; DNA, Viral; Drug Resistance, Microbial; HIV Reverse Transcriptase; HIV-1; Immunodeficiency Virus, Feline; Nevirapine; Protein Conformation; Recombinant Fusion Proteins; Reverse Transcriptase Inhibitors; Ribonuclease H; RNA-Directed DNA Polymerase; Thymine Nucleotides; Zidovudine | 1998 |
Induction-maintenance antiretroviral therapy: proof of concept.
Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; Follow-Up Studies; HIV Infections; Humans; Nevirapine; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 1998 |
Researchers report sustained suppression of HIV with nevirapine--didanosine--zidovudine.
Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Reverse Transcriptase Inhibitors; Zidovudine | 1998 |
Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents.
Topics: Anti-HIV Agents; G2 Phase; Gene Products, vpr; Genes, Reporter; Genes, vpr; HeLa Cells; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Leukocytes; Nevirapine; Reverse Transcriptase Inhibitors; Thy-1 Antigens; Virion; vpr Gene Products, Human Immunodeficiency Virus; Zidovudine | 1998 |
Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy.
Topics: Adult; Anti-HIV Agents; Data Interpretation, Statistical; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Nevirapine; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Virus Replication; Zidovudine | 1998 |
Rebound of plasma HIV viral load following prolonged suppression with combination therapy.
Topics: Adult; Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Male; Nevirapine; Reverse Transcriptase Inhibitors; Time Factors; Viral Load; Zidovudine | 1998 |
High incidence of nevirapine-associated rash in HIV-infected Chinese.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; China; Didanosine; Drug Eruptions; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 1998 |
Estimates of the virological benefit of antiretroviral therapy are both assay- and analysis-dependent.
Topics: Analysis of Variance; Anti-HIV Agents; Data Interpretation, Statistical; Didanosine; HIV Infections; HIV-1; Humans; Nevirapine; RNA, Viral; Statistics, Nonparametric; Time Factors; Viral Load; Zidovudine | 1998 |
HIV-1 peripheral neuropathy and combination antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Nelfinavir; Nevirapine; Peripheral Nervous System Diseases; Saquinavir; Zidovudine | 1998 |
Nevirapine, didanosine, and zidovudine for patients with HIV: the INCAS trial. Italy, Netherlands, Canada, and Australia.
Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Randomized Controlled Trials as Topic; Zidovudine | 1999 |
Nevirapine, didanosine, and zidovudine for patients with HIV: the INCAS trial. Italy, Netherlands, Canada, and Australia.
Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Randomized Controlled Trials as Topic; Viral Load; Zidovudine | 1999 |
Molecular basis for the enantioselectivity of HIV-1 reverse transcriptase: role of the 3'-hydroxyl group of the L-(beta)-ribose in chiral discrimination between D- and L-enantiomers of deoxy- and dideoxy-nucleoside triphosphate analogs.
Topics: Anti-HIV Agents; Carbohydrates; Catalysis; Deoxycytosine Nucleotides; Deoxyribonucleosides; Dideoxynucleosides; Dideoxynucleotides; DNA; Drug Resistance, Microbial; HIV Reverse Transcriptase; Humans; Hydroxyl Radical; Isoleucine; Kinetics; Nevirapine; Recombinant Fusion Proteins; Reverse Transcriptase Inhibitors; Ribose; Templates, Genetic; Thymine Nucleotides; Tyrosine; Zidovudine | 1999 |
Intramolecular chimeras of the p51 subunit between HIV-1 and FIV reverse transcriptases suggest a stabilizing function for the p66 subunit in the heterodimeric enzyme.
Topics: Amino Acid Sequence; Animals; Cats; Dideoxynucleotides; Dimerization; DNA, Viral; Enzyme Activation; Enzyme Stability; Genetic Vectors; HIV Reverse Transcriptase; Humans; Immunodeficiency Virus, Feline; Molecular Sequence Data; Nevirapine; Peptide Fragments; Protein Processing, Post-Translational; Recombinant Fusion Proteins; Reverse Transcriptase Inhibitors; Ribonuclease H; RNA-Directed DNA Polymerase; Structure-Activity Relationship; Thymine Nucleotides; Zidovudine | 1999 |
Biochemical characterization of HIV-1 reverse transcriptases encoding mutations at amino acid residues 161 and 208 involved in resistance to phosphonoformate.
Topics: Amino Acids; Diphosphates; Dose-Response Relationship, Drug; Drug Resistance; Enzyme Stability; Foscarnet; HIV Reverse Transcriptase; Kinetics; Mutagenesis, Site-Directed; Nevirapine; Recombinant Proteins; Reverse Transcriptase Inhibitors; Zidovudine | 1998 |
Inhibition of human immunodeficiency virus type 1 replication by combination of transcription inhibitor K-12 and other antiretroviral agents in acutely and chronically infected cells.
Topics: Alkaloids; Anti-HIV Agents; Anti-Infective Agents; Benzylisoquinolines; Cell Line; Drug Synergism; Fluoroquinolones; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Nelfinavir; Nevirapine; NF-kappa B; Piperazines; Reverse Transcriptase Inhibitors; Tumor Necrosis Factor-alpha; Virus Replication; Zidovudine | 1999 |
Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. INCAS Study Group.
Topics: Adult; Aging; Anti-HIV Agents; Didanosine; Follow-Up Studies; HIV Infections; HIV-1; Humans; Immunologic Memory; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; Time Factors; Zidovudine | 1999 |
Reverse transcriptase inhibitors can selectively block the synthesis of differently sized viral DNA transcripts in cells acutely infected with human immunodeficiency virus type 1.
Topics: Anti-HIV Agents; DNA, Single-Stranded; DNA, Viral; HIV-1; Humans; Nevirapine; Reverse Transcriptase Inhibitors; Time Factors; Transcription, Genetic; Tumor Cells, Cultured; Zidovudine | 1999 |
Changing cost of English HIV service provision 1996-1997. NPMS Steering Group. National Prospective Monitoring System.
Topics: Adult; Anti-HIV Agents; Didanosine; Drug Costs; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Hospital Costs; Humans; Nevirapine; RNA-Directed DNA Polymerase; United Kingdom; Zalcitabine; Zidovudine | 1999 |
Drug could slash rate of perinatal HIV.
Topics: Anti-HIV Agents; Drug Costs; Drug Therapy, Combination; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Reverse Transcriptase Inhibitors; Uganda; United States; Zidovudine | 1999 |
AIDS drug trials in Thailand and Uganda.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Thailand; Uganda; Zidovudine | 1999 |
HIVNET nevirapine trials.
Topics: Anti-HIV Agents; Drug Administration Schedule; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1999 |
Concern at cheap AIDS drug fears.
Topics: Acquired Immunodeficiency Syndrome; Africa, Southern; Anti-HIV Agents; Costs and Cost Analysis; Female; Foundations; Health Policy; Humans; Infant, Newborn; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
South Africa's health minister downplays AIDS drug concerns.
Topics: Anti-HIV Agents; Drug Resistance, Microbial; Humans; Nevirapine; Reverse Transcriptase Inhibitors; South Africa; Zidovudine | 1999 |
AZT--the saga continues.
Topics: Adolescent; Adult; Child; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Zidovudine | 1999 |
Rapid phenotypic drug susceptibility assay for HIV-1 with a CCR5 expressing indicator cell line.
Topics: Anti-HIV Agents; beta-Galactosidase; Cell Line; Drug Resistance, Microbial; Genes, Reporter; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Nevirapine; Phenotype; Receptors, CCR5; Reverse Transcriptase Inhibitors; Ritonavir; Zidovudine | 2000 |
Focus on AIDS.
Topics: Acquired Immunodeficiency Syndrome; Awareness; Commerce; Humans; Internet; Nevirapine; Politics; Prevalence; Public Health; South Africa; Zidovudine | 2000 |
The efficacy and tolerability of combination antiretroviral therapy in pregnancy: infant and maternal outcome.
Topics: Adolescent; Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Infant; Lamivudine; Male; Nelfinavir; Nevirapine; Pregnancy; Pregnancy Outcome; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Treatment Outcome; Zidovudine | 2000 |
Flirting with strange ideas. Mbeki reaches out to a controversial AIDS researcher.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Biochemistry; Clinical Trials as Topic; Famous Persons; Female; History, 20th Century; HIV Seropositivity; Humans; Insecticides; Male; Nevirapine; Organic Chemicals; Pregnancy; Research; Reverse Transcriptase Inhibitors; San Francisco; South Africa; United States; Zidovudine | 2000 |
Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir.
Topics: Adult; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Disease Reservoirs; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Semen; Stavudine; Viral Load; Zidovudine | 2000 |
The mother of all HIV challenges.
Topics: Africa South of the Sahara; AIDS Serodiagnosis; Anti-HIV Agents; Breast Feeding; Clinical Trials as Topic; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Social Conditions; Zidovudine | 2000 |
Mbeki gives AIDS scientists the cold shoulder.
Topics: Acquired Immunodeficiency Syndrome; Adult; Breast Feeding; Enzyme-Linked Immunosorbent Assay; Female; Government; HIV; Humans; Infectious Disease Transmission, Vertical; Male; Middle Aged; Nevirapine; Poverty; Predictive Value of Tests; Pregnancy; Pregnancy Complications, Infectious; South Africa; Zidovudine | 2000 |
Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC].
Topics: Anti-HIV Agents; Cells, Cultured; Deoxycytidine; Didanosine; Drug Combinations; Drug Resistance, Microbial; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Molecular Structure; Mutation; Nevirapine; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Stavudine; T-Lymphocytes; Thionucleosides; Zidovudine | 2000 |
AZT blues.
Topics: Anti-HIV Agents; Counseling; Female; Foster Home Care; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Reverse Transcriptase Inhibitors; South Africa; Zidovudine | 2000 |
[Cost effectiveness analysis of highly active antiretroviral therapy in HIV asymptomatic patients].
Topics: Adult; Anti-HIV Agents; Cost-Benefit Analysis; Didanosine; Drug Therapy, Combination; Female; HIV Seropositivity; Humans; Indinavir; Lamivudine; Male; Middle Aged; Nevirapine; Sickness Impact Profile; Spain; Stavudine; Viral Load; Zidovudine | 2000 |
Prevention of mother-child HIV transmission: progress and problems.
Topics: Africa; Antiviral Agents; Breast Feeding; Cesarean Section; Clinical Trials as Topic; Cohort Studies; Developing Countries; Drug Therapy, Combination; Europe; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Mitochondrial Myopathies; Nervous System Diseases; Nevirapine; Pregnancy; Pregnancy Trimester, Third; Reverse Transcriptase Inhibitors; Thailand; United States; Zidovudine | 2000 |
Absence of association between individual thymidine analogues or nonnucleoside analogues and lipid abnormalities in HIV-1-infected persons on initial therapy.
Topics: Adult; Alkynes; Anti-HIV Agents; Arteriosclerosis; Benzoxazines; Cholesterol; Cyclopropanes; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lipids; Male; Nevirapine; Oxazines; Risk Factors; Stavudine; Thymidine; Triglycerides; Zidovudine | 2000 |
[Genotypic resistance to antiretroviral drugs in patients with therapeutic failure to highly active antiretroviral therapy].
Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Resistance, Microbial; Endopeptidases; Female; Genotype; HIV; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Male; Middle Aged; Mutation; Nevirapine; Protease Inhibitors; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Treatment Failure; Zidovudine | 2000 |
Antiretroviral pharmacology in pregnant women and their newborns.
Topics: Administration, Oral; Anti-HIV Agents; Delivery, Obstetric; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor, Obstetric; Maternal-Fetal Exchange; Nevirapine; Placenta; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Protease Inhibitors; Reverse Transcriptase Inhibitors; Zidovudine | 2000 |
Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures--worldwide, 1997-2000.
Topics: Adult; Anti-HIV Agents; Chemical and Drug Induced Liver Injury; Drug Eruptions; Female; HIV Infections; Humans; Lamivudine; Liver Failure; Male; Nevirapine; Occupational Exposure; Reverse Transcriptase Inhibitors; Rhabdomyolysis; Zidovudine | 2001 |
Leukocytopenia due to zidovudine- and nevirapine-containing regimens in elderly patients with HIV infection.
Topics: Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Didanosine; Drug Therapy, Combination; Fatal Outcome; Granulocyte Colony-Stimulating Factor; HIV Infections; HIV-1; Humans; Leukopenia; Male; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; Zidovudine | 2000 |
Further views by the Erice working group on mother-to-child transmission of HIV type 1.
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2001 |
Potentiation of inhibition of wild-type and mutant human immunodeficiency virus type 1 reverse transcriptases by combinations of nonnucleoside inhibitors and d- and L-(beta)-dideoxynucleoside triphosphate analogs.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Dideoxynucleotides; DNA Replication; DNA, Viral; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Synergism; HIV Reverse Transcriptase; Humans; Inhibitory Concentration 50; Mutation; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors; Stereoisomerism; Thymine Nucleotides; Zidovudine | 2001 |
Triple therapy in previously untreated patients reduces viral load below limit of detection.
Topics: Adult; Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Pyridines; Viral Load; Zidovudine | 1996 |
Two studies suggest nevirapine benefit for children.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pyridines; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine | 1997 |
Viramune triple therapy shows suppression of HIV after 1 year, 7 months.
Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Zidovudine | 1997 |
Nevirapine triple combo results released.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; Erythema; HIV Infections; HIV-1; Humans; Nevirapine; Pyridines; Virus Replication; Zidovudine | 1995 |
New combo trial/same old style.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Protocols; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine | 1995 |
Nevirapine: ethical dilemmas and care for HIV-infected mothers.
Topics: Adolescent; Adult; Child; Child, Preschool; Clinical Trials as Topic; Counseling; Ethics, Medical; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pyridines; RNA-Directed DNA Polymerase; United States; Zidovudine | 1995 |
Nevirapine: new drug, new class, new questions.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Child; Didanosine; Drug Approval; Drug Therapy, Combination; HIV; HIV Infections; Humans; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; United States; United States Food and Drug Administration; Zidovudine | 1996 |
Nevirapine approved by FDA. Food and Drug Administration.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; Drug Approval; Drug Therapy, Combination; Female; HIV Infections; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pyridines; Reverse Transcriptase Inhibitors; United States; United States Food and Drug Administration; Viral Load; Zidovudine | 1996 |
NIAID researchers present new findings at retrovirus meeting. National Institute of Allergy and Infectious Diseases.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Chemokines; Clinical Trials as Topic; Clone Cells; Dendritic Cells; Didanosine; Disease Progression; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Interleukin-10; Killer Cells, Natural; Lamivudine; Male; Nevirapine; Pyridines; Receptors, Cytokine; Reverse Transcriptase Inhibitors; Ritonavir; Virus Replication; Zalcitabine; Zidovudine | 1997 |
Scientific basis for PEP rests in animal trials.
Topics: Adenine; Animals; Anti-HIV Agents; Centers for Disease Control and Prevention, U.S.; Health Personnel; HIV; HIV Infections; Humans; Macaca; Nevirapine; Occupational Diseases; Organophosphonates; Organophosphorus Compounds; Pan troglodytes; Pyridines; Reverse Transcriptase Inhibitors; Simian Immunodeficiency Virus; Tenofovir; United States; Zidovudine | 1997 |
Update on nevirapine: quest for a niche.
Topics: Adult; Anti-HIV Agents; Child; Clinical Trials as Topic; Didanosine; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant; Infant, Newborn; Nevirapine; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine | 1997 |
Preventing HIV infection in infants in developing countries: NIAID's role. National Institute of Allergy and Infectious Diseases.
Topics: Anti-HIV Agents; Child; Child, Preschool; Clinical Trials as Topic; Developing Countries; Ethiopia; Female; Health Planning; HIV Infections; Humans; Immunization, Passive; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; International Cooperation; Male; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Uganda; Zidovudine | 1997 |
Pediatric HIV clinical trials in the United States.
Topics: Adolescent; Anti-HIV Agents; Child; Child, Preschool; Clinical Trials as Topic; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Nevirapine; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; United States; Zidovudine | 1997 |
HIV in the brain: an interview with Dr. Michael Wool, UCLA researcher.
Topics: AIDS Dementia Complex; Anti-HIV Agents; Blood-Brain Barrier; Brain; Drug Therapy, Combination; Drugs, Investigational; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Nevirapine; Reverse Transcriptase Inhibitors; Stavudine; Viral Load; Zidovudine | 1998 |
Thai study success affects ongoing placebo trials.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor, Obstetric; Nevirapine; Placebos; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Thailand; Zidovudine | 1998 |
Viral load--how low is best?
Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 1998 |
Unequal care sustains vertical transmission rate.
Topics: Anti-HIV Agents; Cesarean Section; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
Single-dose Nevirapine during pregnancy.
Topics: Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor, Obstetric; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
Prevention of perinatal HIV infection: cause for optimism.
Topics: AIDS Serodiagnosis; Anti-HIV Agents; Cesarean Section; Clinical Trials as Topic; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Risk Factors; Time Factors; Viral Load; Zidovudine | 1999 |
Global strategies for the prevention of HIV transmission from mothers to infants: the second conference.
Topics: Anti-HIV Agents; Breast Feeding; Cesarean Section; Clinical Trials as Topic; Congresses as Topic; Developing Countries; Drug Therapy, Combination; Female; Global Health; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
Simpler regimens for preventing mother-to-child HIV transmission.
Topics: Delivery, Obstetric; Developing Countries; Drug Administration Schedule; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
Taking HIV to court.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Jurisprudence; Male; Nevirapine; Politics; Pregnancy; Pregnant Women; South Africa; Zidovudine | 2001 |
Drugs for HIV infection.
Topics: Alkynes; Benzoxazines; Cyclopropanes; Delavirdine; Didanosine; Dose-Response Relationship, Drug; HIV Infections; HIV Protease Inhibitors; Humans; Nelfinavir; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors; Saquinavir; Stavudine; Zidovudine | 2001 |
Effect of nevirapine toxicity on choice of perinatal HIV prevention strategies.
Topics: Anti-HIV Agents; Cohort Studies; Decision Support Techniques; Female; Fetal Death; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Perinatal Care; Pregnancy; Quality-Adjusted Life Years; Reproducibility of Results; Zidovudine | 2002 |
Stage of the epidemic and viral phenotype should influence recommendations regarding mother-to-child transmission of HIV-1.
Topics: Anti-HIV Agents; Breast Feeding; Disease Outbreaks; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Phenotype; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Virulence; Zidovudine | 2002 |
Feasibility of antenatal and late HIV testing in pregnant women in Phnom Penh Cambodia: the PERIKAM/ANRS1205 study.
Topics: AIDS Serodiagnosis; Cambodia; Counseling; Feasibility Studies; Female; HIV Infections; HIV Seroprevalence; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 2002 |
Improved long-term suppression of HIV-1 replication with a triple-class multidrug regimen compared with standard of care antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Follow-Up Studies; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Viral Load; Virus Replication; Zidovudine | 2002 |
Paying to waste lives: the affordability of reducing mother-to-child transmission of HIV in South Africa.
Topics: Adult; Anti-HIV Agents; Child Welfare; Child, Preschool; Cost of Illness; Cost-Benefit Analysis; Female; Health Care Costs; Health Policy; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Quality-Adjusted Life Years; South Africa; Zidovudine | 2002 |
Determination of zidovudine/lamivudine/nevirapine in human plasma using ion-pair HPLC.
Topics: Anti-HIV Agents; Calibration; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; Lamivudine; Nevirapine; Reference Standards; Reproducibility of Results; Spectrophotometry, Ultraviolet; Zidovudine | 2002 |
Genetic divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RT.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Resistance, Viral; Genetic Variation; Genotype; HIV Reverse Transcriptase; HIV-1; Nevirapine; Oxazines; Phylogeny; Reverse Transcriptase Inhibitors; Zidovudine | 2002 |
Simultaneous determination of zidovudine and nevirapine in human plasma by RP-LC.
Topics: Anti-HIV Agents; Chromatography, High Pressure Liquid; Humans; Nevirapine; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Zidovudine | 2002 |
Nevirapine reduces perinatal HIV transmission.
Topics: Disease Transmission, Infectious; HIV Infections; Humans; Nevirapine; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
When will once (-a day) be enough?
Topics: Acquired Immunodeficiency Syndrome; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Deoxycytidine; Didanosine; Emtricitabine; Humans; Hydroxyurea; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors; Zidovudine | 2000 |
Antiretroviral therapy.
Topics: Antiretroviral Therapy, Highly Active; Drug Administration Schedule; HIV Protease Inhibitors; Humans; Lopinavir; Nevirapine; Pyrimidinones; Ritonavir; Viral Load; Zidovudine | 2000 |
Antiretroviral treatment in developing countries.
Topics: AIDS Serodiagnosis; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Developing Countries; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Patient Compliance; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; Public Sector; Zidovudine | 2002 |
WHO takes major steps to make HIV treatment accessible.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Developing Countries; Drug Therapy, Combination; Health Services Accessibility; HIV Infections; Humans; Nevirapine; Practice Guidelines as Topic; World Health Organization; Zidovudine | 2002 |
Regression of HIV parotid swellings after antiviral therapy: case reports with computed tomographic scan evidence.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; CD8-Positive T-Lymphocytes; HIV Infections; Humans; Lymphocytosis; Lymphoproliferative Disorders; Male; Nevirapine; Parotid Diseases; Parotid Gland; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome; Viral Load; Zidovudine | 2002 |
Determinations of zidovudine/didanosine/nevirapine and zidovudine/didanosine/ritonavir in human serum by micellar electrokinetic chromatography.
Topics: Anti-HIV Agents; Chromatography, Micellar Electrokinetic Capillary; Didanosine; Humans; Nevirapine; Ritonavir; Zidovudine | 2002 |
Two drugs reduce transmission.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Thailand; Zidovudine | 2002 |
Survival of Ugandan infants with subtype A and D HIV-1 infection (HIVNET 012).
Topics: Cohort Studies; Female; Genotype; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Molecular Sequence Data; Nevirapine; Phylogeny; Pregnancy; Pregnancy Complications, Infectious; Survival Rate; Uganda; Zidovudine | 2002 |
Hope emerges for controlling perinatal HIV transmission.
Topics: Developing Countries; Drug Costs; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
Multiple relapses of human cytomegalovirus retinitis during HAART in an AIDS patient with reconstitution of CD4+ T cell count in the absence of HCMV-specific CD4+ T cell response.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cytomegalovirus Retinitis; Didanosine; Follow-Up Studies; Ganciclovir; HIV Protease Inhibitors; Humans; Lamivudine; Lymphocyte Activation; Male; Nevirapine; Recurrence; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2003 |
Nevirapine resistance mutation at codon 181 of the HIV-1 reverse transcriptase confers stavudine resistance by increasing nucleotide substrate discrimination and phosphorolytic activity.
Topics: Codon; Drug Resistance, Viral; HIV Reverse Transcriptase; Mutation; Nevirapine; Nucleotides; Phosphorylation; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2003 |
Preventing HIV transmission.
Topics: Anti-HIV Agents; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Zidovudine | 2003 |
Negligence. Liver transplant patient too late to sue Viramune maker.
Topics: Drug Combinations; Drug Industry; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Liver Failure; Liver Transplantation; Malpractice; Nevirapine; Reverse Transcriptase Inhibitors; Zidovudine | 2003 |
A saga in international HIV policy modeling: preventing mother-to-child HIV transmission.
Topics: Africa; Antiretroviral Therapy, Highly Active; Female; Fetus; Health Policy; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mothers; Nevirapine; Policy Making; Pregnancy; United Nations; Zidovudine | 2002 |
Nevirapine-based fixed-dose combination ARVs.
Topics: Dose-Response Relationship, Drug; Drug Eruptions; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Patient Compliance; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2003 |
Cost-effectiveness of strategies to reduce mother-to-child HIV transmission in Mexico, a low-prevalence setting.
Topics: AIDS Serodiagnosis; Anti-HIV Agents; Breast Feeding; Cesarean Section; Cost of Illness; Cost-Benefit Analysis; Counseling; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mexico; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Value of Life; Zidovudine | 2003 |
Non-nucleoside inhibitors of HIV-1 reverse transcriptase inhibit phosphorolysis and resensitize the 3'-azido-3'-deoxythymidine (AZT)-resistant polymerase to AZT-5'-triphosphate.
Topics: Adenosine Triphosphate; Anti-HIV Agents; Dideoxynucleotides; Diphosphates; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; HIV Reverse Transcriptase; Humans; Mutation, Missense; Nevirapine; Phosphorylation; Protein Subunits; Reverse Transcriptase Inhibitors; Thymine Nucleotides; Zidovudine | 2003 |
[Antiviral agents for reduction of mother-to-child transmission of HIV infection].
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Evidence-Based Medicine; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Zidovudine | 2003 |
Decision analysis to guide choice of interventions to reduce mother-to-child transmission of HIV.
Topics: Anti-Retroviral Agents; Breast Feeding; Child, Preschool; Decision Support Techniques; Decision Trees; Female; HIV Infections; Humans; Infant; Infant, Newborn; Maternal-Fetal Exchange; Mathematics; Models, Theoretical; Nevirapine; Pregnancy; Weaning; Zidovudine | 2003 |
Nevirapine reduced mother-to-child transmission better than AZT--at 70 times less the cost.
Topics: Drug Costs; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 2003 |
HIVNET 012 and Petra.
Topics: Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Treatment Outcome; Zidovudine | 2004 |
Preventing mother-to-child transmission: landmark decision by South African court.
Topics: Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; South Africa; Zidovudine | 2002 |
Mother-to-child transmission. How will AZT and nevirapine use for MTCT affect future treatment? Two studies provide clues.
Topics: CD4 Lymphocyte Count; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 2004 |
Immune status and uptake of antiretroviral interventions to prevent mother-to-child transmission of HIV-1 in Africa.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cote d'Ivoire; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2004 |
[Antiretroviral therapy of acute HIV-infection].
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Combinations; Female; HIV Infections; HIV Seropositivity; Humans; Lamivudine; Lymphocyte Count; Male; Nevirapine; Viral Load; Zidovudine | 2004 |
Antiretroviral agents--how best to protect infants from HIV and save their mothers from AIDS.
Topics: Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Developing Countries; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2004 |
Assessing the risk of birth defects associated with antiretroviral exposure during pregnancy.
Topics: Abnormalities, Drug-Induced; Anti-Retroviral Agents; Female; Gestational Age; Humans; Lamivudine; Maternal-Fetal Exchange; Nelfinavir; Nevirapine; Pregnancy; Pregnancy Outcome; Prospective Studies; Risk Factors; Stavudine; Zidovudine | 2004 |
Perinatal HIV research unit clarifies nevirapine resistance and transmission issues.
Topics: Anti-HIV Agents; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Zidovudine | 2004 |
Nevirapine plus zidovudine to prevent mother-to-child transmission of HIV.
Topics: Anti-Retroviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2004 |
Meeting report from the XV International AIDS Conference. Perinatal transmission.
Topics: Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 2004 |
Antiretroviral drug pharmacokinetics in hepatitis with hepatic dysfunction.
Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Drug Therapy, Combination; Hepatitis; HIV Infections; Humans; Indinavir; Liver Function Tests; Lopinavir; Nelfinavir; Nevirapine; Oxazines; Protease Inhibitors; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Zidovudine | 2005 |
Emergence of antiretroviral resistance in HIV-positive women receiving combination antiretroviral therapy in pregnancy.
Topics: Adolescent; Adult; Anti-HIV Agents; Base Sequence; Cohort Studies; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; HIV Infections; HIV-1; Humans; Lamivudine; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine | 2005 |
Inhibitory drug levels found in breast milk.
Topics: Anti-Retroviral Agents; Female; HIV Infections; Humans; Infant; Lamivudine; Milk, Human; Nevirapine; Zidovudine | 2004 |
HIV seroprevalence, uptake of interventions to reduce mother-to-child transmission and birth outcomes in greater Kingston, Jamaica.
Topics: Adolescent; Adult; Female; HIV Infections; HIV Seropositivity; HIV Seroprevalence; Humans; Infectious Disease Transmission, Vertical; Jamaica; Nevirapine; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Care; Program Evaluation; Zidovudine | 2004 |
Uptake of interventions, outcomes and challenges in caring for HIV-exposed infants in Kingston, Jamaica.
Topics: Antibiotic Prophylaxis; Female; HIV Infections; Humans; Infant; Infant Care; Infant, Newborn; Infectious Disease Transmission, Vertical; Jamaica; Nevirapine; Patient Acceptance of Health Care; Pregnancy; Prenatal Care; Prospective Studies; Retrospective Studies; Treatment Outcome; Zidovudine | 2004 |
Zidovudine monotherapy and the prevention of mother-to-child HIV-1 transmission.
Topics: Anti-HIV Agents; Child; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2005 |
Recent advances in prevention of mother to child (PMTCT) of HIV.
Topics: Africa; Anti-HIV Agents; Breast Feeding; Disease Outbreaks; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Prenatal Care; Treatment Outcome; Zidovudine | 2004 |
Effectiveness of nevirapine and zidovudine in a pilot program for the prevention of mother-to-child transmission of HIV-1 in Uganda.
Topics: Anti-HIV Agents; Breast Feeding; Cross-Sectional Studies; Disease Outbreaks; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Logistic Models; Nevirapine; Pilot Projects; Pregnancy; Risk Factors; Socioeconomic Factors; Treatment Outcome; Uganda; Zidovudine | 2004 |
AIDS treatment. A step toward cheaper anti-HIV therapy.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Developing Countries; Drug Approval; Drug Combinations; Drug Therapy, Combination; Drugs, Generic; Humans; Lamivudine; Nevirapine; United States; United States Food and Drug Administration; World Health Organization; Zidovudine | 2005 |
Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.
Topics: Adult; Anti-HIV Agents; Cote d'Ivoire; Developing Countries; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Viral Load; Zidovudine | 2005 |
Inhibition of phosphorolysis catalyzed by HIV-1 reverse transcriptase is responsible for the synergy found in combinations of 3'-azido-3'-deoxythymidine with nonnucleoside inhibitors.
Topics: Alkynes; Benzoxazines; Binding Sites; Catalysis; Cyclopropanes; Dideoxynucleotides; DNA Primers; Drug Combinations; Drug Synergism; Enzyme Stability; HIV Reverse Transcriptase; Nevirapine; Oxazines; Phosphoric Acids; Pyridones; Reverse Transcriptase Inhibitors; Templates, Genetic; Thymine Nucleotides; Zidovudine | 2005 |
Averting drug resistance while preventing MTCT.
Topics: Anti-HIV Agents; Drug Administration Schedule; Drug Resistance, Viral; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2005 |
A drug is effective if better than a harmless control.
Topics: Controlled Clinical Trials as Topic; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor, Obstetric; Nevirapine; Placebos; Pregnancy; Zidovudine | 2005 |
In vitro anti-HIV potency of stampidine alone and in combination with standard anti-HIV drugs.
Topics: Anti-HIV Agents; Dideoxynucleotides; Drug Combinations; Drug Interactions; HIV-1; Humans; Lamivudine; Least-Squares Analysis; Models, Theoretical; Nelfinavir; Nevirapine; Phenotype; Stavudine; Thymidine Monophosphate; Virus Replication; Zidovudine | 2005 |
Simple adjustments for randomized trials with nonrandomly missing or censored outcomes arising from informative covariates.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Humans; Likelihood Functions; Longitudinal Studies; Models, Statistical; Nevirapine; Proportional Hazards Models; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Zalcitabine; Zidovudine | 2006 |
Addressing the paediatric HIV epidemic: a perspective from the Western Cape Region of South Africa.
Topics: Adolescent; Adult; Anti-HIV Agents; Child; Disease Outbreaks; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Middle Aged; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; South Africa; Zidovudine | 2006 |
Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South Africa.
Topics: Adult; Anti-HIV Agents; Breast Feeding; Cross-Sectional Studies; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Program Development; Program Evaluation; South Africa; Treatment Outcome; Zidovudine | 2005 |
HIV antiretroviral agents inhibit protein synthesis and decrease ribosomal protein S6 and 4EBP1 phosphorylation in C2C12 myocytes.
Topics: Animals; Anti-HIV Agents; Cell Line; Mice; Muscle Cells; Nelfinavir; Nevirapine; Phosphorylation; Protein Synthesis Inhibitors; Ribosomal Protein S6; Zidovudine | 2005 |
Triple nucleoside reverse transcriptase inhibitor- vs. nonnucleoside reverse transcriptase inhibitor-containing regimens as first-line therapy: efficacy and durability in a prospective cohort of French HIV-infected patients.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cohort Studies; Cyclopropanes; Dideoxynucleosides; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Oxazines; Prospective Studies; Reverse Transcriptase Inhibitors; Treatment Failure; Treatment Outcome; Viral Load; Zidovudine | 2005 |
[Detection of HIV infection in pregnant women by rapid testing: a successful strategy to reduce its vertical transmission].
Topics: Adolescent; Adult; Anti-HIV Agents; Blotting, Western; Enzyme-Linked Immunosorbent Assay; Female; HIV Antibodies; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Middle Aged; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prevalence; Uruguay; Zidovudine | 2005 |
Development of nevirapine resistance in infants is reduced by use of infant-only single-dose nevirapine plus zidovudine postexposure prophylaxis for the prevention of mother-to-child transmission of HIV-1.
Topics: Anti-Retroviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Risk Factors; Zidovudine | 2006 |
Low risk of nevirapine resistance mutations in the prevention of mother-to-child transmission of HIV-1: Agence Nationale de Recherches sur le SIDA Ditrame Plus, Abidjan, Cote d'Ivoire.
Topics: Cote d'Ivoire; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Mothers; Mutation; Nevirapine; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 2006 |
Concerns regarding a randomized trial of two postexposure prophylaxis regimens.
Topics: Anti-HIV Agents; Bottle Feeding; Breast Feeding; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Nevirapine; Randomized Controlled Trials as Topic; Zidovudine | 2006 |
The contribution of HIV fitness to the evolution pattern of reverse transcriptase inhibitor resistance.
Topics: Anti-HIV Agents; Cell Line; Drug Resistance, Viral; Evolution, Molecular; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Nevirapine; Reverse Transcriptase Inhibitors; Thymidine; Zidovudine | 2006 |
Unrecognized near-fatal hyperlactatemia in an HIV-infected infant exposed to nucleoside reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Lactates; Lamivudine; Male; Mitochondria; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2007 |
Exposure to HIV and antiretroviral medication as a potential cause of necrotizing enterocolitis in term neonates.
Topics: Anti-HIV Agents; Enterocolitis, Necrotizing; HIV Seropositivity; Humans; Infant, Newborn; Lamivudine; Male; Nevirapine; Risk Factors; Zidovudine | 2006 |
Cost-effectiveness of HIV rescreening during late pregnancy to prevent mother-to-child HIV transmission in South Africa and other resource-limited settings.
Topics: Cost-Benefit Analysis; Decision Support Techniques; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mass Screening; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Quality-Adjusted Life Years; South Africa; Zidovudine | 2006 |
A simple and rapid liquid chromatography method for simultaneous determination of zidovudine and nevirapine in plasma.
Topics: Adult; Chromatography, High Pressure Liquid; Female; Humans; Male; Nevirapine; Reproducibility of Results; Sensitivity and Specificity; Zidovudine | 2006 |
Inhibition of endogenous reverse transcription of human and nonhuman primate lentiviruses: potential for development of lentivirucides.
Topics: Antiviral Agents; Cells, Cultured; Dideoxynucleotides; Disease Transmission, Infectious; HIV-1; Humans; Lentivirus Infections; Nevirapine; Reverse Transcriptase Inhibitors; Simian Immunodeficiency Virus; T-Lymphocytes; Thymine Nucleotides; Transcription, Genetic; Zidovudine | 2006 |
Potent nonnucleoside reverse transcriptase inhibitors target HIV-1 Gag-Pol.
Topics: Alkynes; Anti-HIV Agents; Antiviral Agents; Base Sequence; Benzoxazines; Cyclopropanes; Fusion Proteins, gag-pol; HeLa Cells; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Sequence Data; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors; Two-Hybrid System Techniques; Virus Replication; Zidovudine | 2006 |
The ethics of placebo-controlled studies on perinatal HIV transmission and its treatment in the developing world.
Topics: Anti-HIV Agents; Breast Feeding; Control Groups; Controlled Clinical Trials as Topic; Developing Countries; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mothers; Nevirapine; Placebos; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Zidovudine | 2006 |
Weight and body shape changes in a treatment-naive population after 6 months of nevirapine-based generic highly active antiretroviral therapy in South India.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Composition; Body Weight; CD4 Lymphocyte Count; Cohort Studies; Female; HIV Infections; Humans; India; Lamivudine; Male; Nevirapine; Stavudine; Zidovudine | 2007 |
[Vitiligo in a black patient associated with HIV infection and repigmentation under antiretroviral therapy].
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Lamivudine; Nevirapine; Treatment Outcome; Vitiligo; Zidovudine | 2007 |
Nevirapine clearance from plasma in African adults stopping therapy: a pharmacokinetic substudy.
Topics: Adult; Cohort Studies; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; Stavudine; Uganda; Zidovudine; Zimbabwe | 2007 |
Expanded services for the prevention of mother-to-child HIV transmission: field acceptability of a pilot program in Lusaka, Zambia.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Cities; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mothers; Nevirapine; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Zambia; Zidovudine | 2007 |
Safety of HIV-1 Perinatal Transmission Prophylaxis With Zidovudine and Nevirapine in Rural South India.
Topics: Anti-HIV Agents; Cohort Studies; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Zidovudine | 2007 |
Nodular regenerative hyperplasia: a new serious antiretroviral drugs side effect?
Topics: Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Chemical and Drug Induced Liver Injury; Didanosine; Female; HIV Infections; HIV-1; Humans; Hyperplasia; Liver; Liver Diseases; Liver Regeneration; Middle Aged; Nevirapine; Zidovudine | 2007 |
NNRTI-selected mutations at codon 190 of human immunodeficiency virus type 1 reverse transcriptase decrease susceptibility to stavudine and zidovudine.
Topics: Amino Acid Substitution; Anti-HIV Agents; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Inhibitory Concentration 50; Microbial Sensitivity Tests; Mutation; Nevirapine; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2007 |
Development of a highly efficient extraction technique and specific multiplex assay for measuring antiretroviral drug concentrations in breast milk.
Topics: Chromatography, High Pressure Liquid; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Milk, Human; Nevirapine; Postpartum Period; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Stavudine; Zidovudine | 2007 |
Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Breast Feeding; CD4 Lymphocyte Count; Cohort Studies; Cote d'Ivoire; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Program Evaluation; Puerperal Disorders; Viral Load; Zidovudine | 2007 |
Human immunodeficiency virus infection in a child presenting as herpes zoster ophthalmicus.
Topics: Acyclovir; Child; Eye Diseases; Herpes Zoster Ophthalmicus; HIV Infections; Humans; Lamivudine; Male; Nevirapine; Zidovudine | 2007 |
Efficacy of highly active antiretroviral therapy in HIV-1 infected children in Kenya.
Topics: Adolescent; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Weight; CD4 Lymphocyte Count; Child; Child, Preschool; Drugs, Generic; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Kenya; Lamivudine; Male; Nevirapine; Prospective Studies; RNA, Viral; Viral Load; Zidovudine | 2007 |
N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance.
Topics: Cell Line; Drug Resistance, Multiple, Viral; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Mutation; Nevirapine; Phenotype; Protein Conformation; Protein Structure, Tertiary; Retrospective Studies; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome; Viral Load; Zidovudine | 2007 |
Should we include connection domain mutations of HIV-1 reverse transcriptase in HIV resistance testing.
Topics: Drug Resistance, Multiple, Viral; Genetic Testing; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Nevirapine; Patient Selection; Phenotype; Protein Structure, Tertiary; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome; Viral Load; Zidovudine | 2007 |
Reverse transcriptase mutations in Cambodian CRF01_AE isolates after antiretroviral prophylaxis against HIV Type 1 perinatal transmission.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cambodia; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Infectious Disease Transmission, Vertical; Molecular Sequence Data; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 2007 |
Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cote d'Ivoire; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Microbial Sensitivity Tests; Nevirapine; Pregnancy; RNA, Viral; Treatment Outcome; Treatment Refusal; Viral Load; Zidovudine | 2008 |
A radiolabeled oligonucleotide ligation assay demonstrates the high frequency of nevirapine resistance mutations in HIV type 1 quasispecies of NVP-treated and untreated mother-infant pairs from Uganda.
Topics: Amino Acid Substitution; Anti-HIV Agents; Cluster Analysis; DNA, Viral; Drug Resistance, Viral; Genetic Techniques; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Infant; Infant, Newborn; Leukocytes, Mononuclear; Mothers; Mutation, Missense; Nevirapine; Phylogeny; Polymerase Chain Reaction; Recombination, Genetic; Sequence Analysis, DNA; Uganda; Zidovudine | 2008 |
18-month effectiveness of short-course antiretroviral regimens combined with alternatives to breastfeeding to prevent HIV mother-to-child transmission.
Topics: Africa; Anti-HIV Agents; Breast Feeding; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Proportional Hazards Models; Survival Rate; Treatment Outcome; Zidovudine | 2008 |
Adaptation of antiretroviral therapy in human immunodeficiency virus infection with central nervous system involvement.
Topics: Adenine; Adult; AIDS Dementia Complex; Alkynes; Anti-HIV Agents; Anticonvulsants; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Benzoxazines; Cerebrospinal Fluid; Cyclopropanes; Didanosine; HIV-1; Humans; Indinavir; Lamivudine; Male; Nelfinavir; Nevirapine; Oligopeptides; Organophosphonates; Pyridines; Ritonavir; Seizures; Stavudine; Tenofovir; Viral Load; Virus Replication; Zidovudine | 2008 |
Characteristics of pregnancy with human immuno-deficiency virus (HIV) and perinatal transmission in Nakornping Hospital.
Topics: Adolescent; Adult; Anti-Retroviral Agents; Female; HIV Infections; Humans; Incidence; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies; Risk Factors; Thailand; Zidovudine | 2008 |
[HIV-1 genotypic resistance profiles in children failing highly active antiretroviral therapy].
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Child; Child, Preschool; China; Cyclopropanes; Delavirdine; Drug Resistance, Viral; Genotype; HIV-1; Humans; Mutation; Nevirapine; Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Viral Load; Zidovudine | 2007 |
Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants.
Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cote d'Ivoire; Drug Administration Schedule; Female; Follow-Up Studies; HIV; HIV Infections; HIV-1; HIV-2; Humans; Lamivudine; Male; Nevirapine; Survival Analysis; Treatment Outcome; Zidovudine | 2008 |
Zidovudine with nevirapine for the prevention of HIV mother-to-child transmission reduces nevirapine resistance in mothers from the Western Cape, South Africa.
Topics: Anti-HIV Agents; Drug Resistance, Viral; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Mutation; Nevirapine; Pregnancy; South Africa; Zidovudine | 2008 |
Breast-feeding, antiretroviral prophylaxis, and HIV.
Topics: Anti-HIV Agents; Breast Feeding; Female; HIV; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Nevirapine; Weaning; Zidovudine | 2008 |
[Evaluation of antiretroviral therapy in HIV-infected adults in the Department of Haematology, University Hospital of Brazzavllle, Congo].
Topics: Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Congo; Cyclopropanes; Didanosine; Drug Evaluation; Drug Therapy, Combination; Female; Hematology; HIV Infections; Hospital Departments; Hospitals, University; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Retrospective Studies; Stavudine; Treatment Outcome; Viral Load; Zidovudine | 2008 |
HIV and obstetric complications and fetal outcomes in Vellore, India.
Topics: Adolescent; Adult; Anti-HIV Agents; Female; HIV Infections; HIV Seronegativity; Humans; India; Infant; Infectious Disease Transmission, Vertical; Medical Audit; Nevirapine; Obstetric Labor Complications; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Care; Zidovudine | 2008 |
A review of the prevention of mother-to-child transmission programme of the Western Cape provincial government, 2003 - 2004.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Program Evaluation; Retrospective Studies; Rural Population; South Africa; Urban Population; Zidovudine | 2008 |
Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cote d'Ivoire; Drug Administration Schedule; Female; HIV Infections; HIV-1; Humans; Infant, Low Birth Weight; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Logistic Models; Nevirapine; Perinatal Mortality; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Zidovudine | 2008 |
Antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
Topics: Anti-Retroviral Agents; Breast Feeding; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Zidovudine | 2008 |
Antiretroviral concentrations in breast-feeding infants of mothers receiving highly active antiretroviral therapy.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Blood; Breast Feeding; Clinical Trials, Phase II as Topic; Desiccation; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Lactation; Lamivudine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Young Adult; Zidovudine | 2009 |
A prospective study evaluating clinical outcomes and costs of three NNRTI-based HAART regimens in Kerala, India.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Female; HIV Infections; HIV-1; Hospitals, Teaching; Humans; India; Lamivudine; Male; Medication Adherence; Nevirapine; Prospective Studies; Stavudine; Treatment Outcome; Zidovudine | 2009 |
Prevention of mother-to-child HIV transmission using 3-drug combination antiretroviral treatment: observational cohort in clinical practice setting in India.
Topics: Adolescent; Adult; Anti-HIV Agents; Clinical Trials as Topic; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; India; Infant; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Treatment Outcome; Young Adult; Zidovudine | 2009 |
Higher placental anti-inflammatory IL-10 cytokine expression in HIV-1 infected women receiving longer zidovudine prophylaxis associated with nevirapine.
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Interleukin-10; Nevirapine; Placenta; Pregnancy; Pregnancy Complications, Infectious; Time Factors; Young Adult; Zidovudine | 2009 |
The obstetric face and challenge of HIV/AIDS.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Anti-Infective Agents; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Breast Feeding; Developing Countries; Disease Progression; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Maternal Mortality; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Trimethoprim, Sulfamethoxazole Drug Combination; World Health Organization; Zidovudine | 2009 |
Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.
Topics: Adolescent; Adult; Anti-HIV Agents; Blood; Chemoprevention; Drug Resistance, Viral; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Middle Aged; Mothers; Nevirapine; Thailand; Young Adult; Zidovudine | 2009 |
Prevention of human immunodeficiency virus mother-to-child transmission in Israel.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Emigrants and Immigrants; Ethiopia; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Israel; Middle Aged; National Health Programs; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Program Evaluation; Reverse Transcriptase Inhibitors; Viral Load; Young Adult; Zidovudine | 2009 |
[Establishment of pharmacological evaluation system for non-nucleoside reverse-transcriptase inhibitors resistant HIV-1].
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cell Line; Cyclopropanes; Delavirdine; Drug Evaluation, Preclinical; Drug Resistance, Viral; Genetic Vectors; HIV Reverse Transcriptase; HIV-1; Humans; Membrane Glycoproteins; Nevirapine; Plasmids; Point Mutation; Reverse Transcriptase Inhibitors; Stavudine; Transfection; Viral Envelope Proteins; Virion; Virus Replication; Zidovudine | 2009 |
Adherence to antiretroviral drug therapy in children with HIV/AIDS in Jamaica.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Anti-HIV Agents; Anti-Retroviral Agents; Biomarkers; CD4 Lymphocyte Count; Child; Child, Preschool; Cross-Sectional Studies; Female; HIV Infections; Humans; Infant; Jamaica; Lamivudine; Male; Medication Adherence; Nevirapine; Surveys and Questionnaires; Young Adult; Zidovudine | 2008 |
Confluent molluscum contagiosum covering the eyelids of an HIV-positive child.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Child, Preschool; Drug Therapy, Combination; Eye Infections, Viral; Eyelid Diseases; HIV Seropositivity; Humans; Lamivudine; Male; Molluscum Contagiosum; Nevirapine; Trimethoprim, Sulfamethoxazole Drug Combination; Viral Load; Zidovudine | 2009 |
Mother-to-child HIV and HHV-8 transmission in neonates at Saint Camille Medical Centre in Burkina Faso.
Topics: Adult; Anti-HIV Agents; Burkina Faso; CD4 Lymphocyte Count; DNA, Viral; Female; Herpesviridae Infections; Herpesvirus 8, Human; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Young Adult; Zidovudine | 2009 |
Frequency of gastroenteritis and gastroenteritis-associated mortality with early weaning in HIV-1-uninfected children born to HIV-infected women in Malawi.
Topics: Adult; Anti-HIV Agents; Breast Feeding; Developing Countries; Female; Gastroenteritis; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Kaplan-Meier Estimate; Malawi; Nevirapine; Randomized Controlled Trials as Topic; Risk Factors; Weaning; Zidovudine | 2010 |
Antiretroviral strategies to prevent mother-to-child transmission of HIV: striking a balance between efficacy, feasibility, and resistance.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2009 |
Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Mutation; Nelfinavir; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2010 |
Development of an allele-specific PCR for detection of the K65R resistance mutation in patients infected with subtype C human immunodeficiency virus type 1.
Topics: Alkynes; Alleles; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Mutation; Nevirapine; Polymerase Chain Reaction; Zidovudine | 2010 |
Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero.
Topics: Anti-HIV Agents; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Malawi; Male; Nevirapine; Post-Exposure Prophylaxis; Pregnancy; Viral Load; Zidovudine | 2010 |
Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008.
Topics: Adenine; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Deoxycytidine; Dideoxynucleosides; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Nevirapine; Oligopeptides; Organophosphonates; Proportional Hazards Models; Prospective Studies; Pyridines; Pyrimidinones; Risk Factors; Switzerland; Tenofovir; Zidovudine | 2010 |
Detecting and understanding combinatorial mutation patterns responsible for HIV drug resistance.
Topics: Anti-HIV Agents; Drug Resistance, Viral; HIV Infections; HIV Protease; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Models, Molecular; Mutation; Nevirapine; Protein Binding; Protein Structure, Tertiary; Zidovudine | 2010 |
Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Ligase Chain Reaction; Mutation, Missense; Nevirapine; Postpartum Period; Pregnancy; RNA, Viral; Sequence Analysis, DNA; Viral Load; Young Adult; Zidovudine | 2010 |
Another milestone in minimizing risks to mothers exposed to single-dose nevirapine for prevention of vertical transmission of HIV-1 to infants: what next?
Topics: Anti-HIV Agents; Didanosine; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Mutation, Missense; Nevirapine; Pregnancy; Zidovudine | 2010 |
Analysis of RT sequences of subtype C HIV-type 1 isolates from indian patients at failure of a first-line treatment according to clinical and/or immunological WHO guidelines.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; India; Lamivudine; Molecular Sequence Data; Nevirapine; Polymorphism, Single Nucleotide; Stavudine; Treatment Failure; Zidovudine | 2010 |
Positive and negative drug selection pressures on the N348I connection domain mutation: new insights from in vivo data.
Topics: Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; Case-Control Studies; Cyclopropanes; Databases, Genetic; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; HIV Reverse Transcriptase; HIV-1; Humans; Logistic Models; Mutation; Nevirapine; Organophosphonates; Reverse Transcriptase Inhibitors; Stavudine; Tenofovir; Zidovudine | 2010 |
[Durability and tolerability of long-term nevirapine-based HAART].
Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Comorbidity; Dideoxynucleosides; Female; Hepatitis, Viral, Human; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Lipids; Liver Function Tests; Male; Middle Aged; Nevirapine; Retrospective Studies; Stavudine; Viral Load; Young Adult; Zidovudine | 2010 |
Identification, isolation, and characterization of potential degradation products in a triple combination lamivudine, zidovudine, and nevirapine tablet for oral suspension.
Topics: Anti-HIV Agents; Chromatography, High Pressure Liquid; Drug Contamination; Indicators and Reagents; Lamivudine; Magnetic Resonance Spectroscopy; Nevirapine; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Suspensions; Tablets; Zidovudine | 2010 |
Reducing pediatric HIV infection: estimating mother-to-child transmission rates in a program setting in Zambia.
Topics: Antiretroviral Therapy, Highly Active; Breast Feeding; Child; DNA, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infant Formula; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Mother-Child Relations; Nevirapine; Odds Ratio; Polymerase Chain Reaction; Regression Analysis; Zambia; Zidovudine | 2010 |
Impact of maternal HAART on the prevention of mother-to-child transmission of HIV: results of an 18-month follow-up study in Ouagadougou, Burkina Faso.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Burkina Faso; Cohort Studies; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Peripartum Period; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Young Adult; Zidovudine | 2010 |
Addition of 7 days of zidovudine plus lamivudine to peripartum single-dose nevirapine effectively reduces nevirapine resistance postpartum in HIV-infected mothers in Malawi.
Topics: Adolescent; Adult; Anti-HIV Agents; Drug Resistance, Viral; Female; Genotype; HIV Infections; HIV-1; Humans; Lamivudine; Longitudinal Studies; Malawi; Nevirapine; Plasma; Polymerase Chain Reaction; Postpartum Period; Pregnancy; RNA, Viral; Sequence Analysis, DNA; Young Adult; Zidovudine | 2010 |
Immunological response to highly active antiretroviral therapy following treatment for prevention of mother to child transmission of HIV-1: a study in Côte d'Ivoire.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cote d'Ivoire; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Treatment Outcome; Zidovudine | 2010 |
Recent FDA approvals and changes.
Topics: Anti-HIV Agents; Child; Child, Preschool; Drug Approval; Drug Combinations; Drugs, Generic; HIV Antibodies; HIV Core Protein p24; HIV Infections; HIV-1; HIV-2; Humans; Lamivudine; Nevirapine; Reagent Kits, Diagnostic; Reverse Transcriptase Inhibitors; Tablets; United States; United States Food and Drug Administration; Zidovudine | 2010 |
Outcomes and challenges of scaling up comprehensive PMTCT services in rural Swaziland, Southern Africa.
Topics: Adult; AIDS Serodiagnosis; Anti-HIV Agents; Eswatini; Female; HIV Infections; Humans; Infant; Infant Care; Infant, Newborn; Infectious Disease Transmission, Vertical; Maternal Health Services; Neonatal Screening; Nevirapine; Outcome Assessment, Health Care; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Prevalence; Program Development; Program Evaluation; Rural Health; Zidovudine | 2010 |
Stavudine toxicity in women is the main reason for treatment change in a 3-year prospective cohort of adult patients started on first-line antiretroviral treatment in Uganda.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Female; HIV Infections; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Multivariate Analysis; Nevirapine; Prospective Studies; Risk Factors; Sex Factors; Stavudine; Uganda; Zidovudine | 2011 |
Evaluating patients for second-line antiretroviral therapy in India: the role of targeted viral load testing.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Female; HIV; HIV Infections; Humans; India; Lamivudine; Male; Middle Aged; Nevirapine; RNA, Viral; Stavudine; Treatment Failure; Viral Load; Zidovudine | 2010 |
Reduced dose of stavudine and lipoatrophy in HIV-infected patients in Cameroon.
Topics: Adult; Anti-HIV Agents; Cameroon; CD4 Lymphocyte Count; Cross-Sectional Studies; Female; HIV; HIV Infections; Humans; Lamivudine; Lipodystrophy; Male; Middle Aged; Nevirapine; Stavudine; Zidovudine | 2010 |
The impact of maternal highly active antiretroviral therapy and short-course combination antiretrovirals for prevention of mother-to-child transmission on early infant infection rates at the Mulago national referral hospital in Kampala, Uganda, January 20
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Confidence Intervals; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Multivariate Analysis; Nevirapine; Odds Ratio; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Uganda; Young Adult; Zidovudine | 2011 |
Perinatal tuberculosis: two unusual cases.
Topics: Anti-HIV Agents; Anti-Inflammatory Agents; Antimalarials; Drug Therapy, Combination; Endometritis; Female; HIV Infections; Humans; Immunocompromised Host; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Nevirapine; Prednisolone; Pregnancy; Pregnancy Complications, Infectious; Radiography; Tuberculosis, Meningeal; Tuberculosis, Pulmonary; Zidovudine | 2011 |
Effectiveness of a PMTCT programme in rural Western Kenya.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Epidemiologic Methods; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Kenya; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Program Evaluation; Rural Health; Treatment Outcome; Young Adult; Zidovudine | 2011 |
Phenotypic characterization of drug resistance-associated mutations in HIV-1 RT connection and RNase H domains and their correlation with thymidine analogue mutations.
Topics: Amino Acid Substitution; Anti-HIV Agents; Brazil; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Mutant Proteins; Mutation, Missense; Nevirapine; Protein Structure, Tertiary; Thymidine; Zidovudine | 2011 |
Short communication: high prevalence of drug resistance in HIV type 1-infected children born in Honduras and Belize 2001 to 2004.
Topics: Anti-HIV Agents; Base Sequence; Belize; Cohort Studies; Drug Resistance, Multiple, Viral; Female; HIV Infections; HIV-1; Honduras; Humans; Infant; Infant, Newborn; Male; Molecular Sequence Data; Mutation; Nevirapine; Phylogeny; pol Gene Products, Human Immunodeficiency Virus; Pregnancy; Prevalence; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine | 2011 |
Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis.
Topics: Anti-HIV Agents; Drug Resistance, Viral; Female; Genotype; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Malawi; Male; Nevirapine; Post-Exposure Prophylaxis; Viral Load; Zidovudine | 2011 |
Improving retention in the early infant diagnosis of HIV program in rural Mozambique by better service integration.
Topics: Adult; Anti-HIV Agents; Delivery of Health Care; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Mozambique; Nevirapine; Pregnancy; Retrospective Studies; Rural Population; Young Adult; Zidovudine | 2011 |
WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers.
Topics: Anti-HIV Agents; Breast Feeding; Child; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; National Health Programs; Nevirapine; Outcome Assessment, Health Care; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Survival Analysis; World Health Organization; Young Adult; Zidovudine; Zimbabwe | 2011 |
Evaluation of saliva as an alternative matrix for monitoring plasma Zidovudine, Lamivudine and nevirapine concentrations in Rwanda.
Topics: Adult; Anti-HIV Agents; Cross-Sectional Studies; Drug Monitoring; Feasibility Studies; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Medication Adherence; Middle Aged; Nevirapine; Rwanda; Saliva; Zidovudine | 2011 |
[Comparative study of two anti-antiretroviral protocols used for treatment of a cohort of HIV 1-positive patients followed at the Institute of Public Health and Hygiene in Dakar, Senegal].
Topics: Academies and Institutes; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; HIV Seropositivity; HIV-1; Humans; Hygiene; Lamivudine; Nevirapine; Public Health; Quality of Life; Retrospective Studies; Senegal; Survival Analysis; Treatment Outcome; Zidovudine | 2011 |
Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach.
Topics: Adult; Anti-HIV Agents; Breast Feeding; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Therapy, Combination; Female; Goals; Healthy People Programs; HIV Infections; HIV Seropositivity; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Malawi; Male; Nevirapine; Peripartum Period; Pregnancy; Pregnancy Complications, Infectious; Public Health; United Nations; Zidovudine | 2011 |
Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi.
Topics: Adult; Anti-HIV Agents; Breast Feeding; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Kaplan-Meier Estimate; Malawi; Morbidity; Nevirapine; Poisson Distribution; Post-Exposure Prophylaxis; Proportional Hazards Models; Randomized Controlled Trials as Topic; Weaning; Zidovudine | 2011 |
Antiretroviral resistance patterns and factors associated with resistance in adult patients failing NNRTI-based regimens in the Western Cape, South Africa.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cross-Sectional Studies; Cyclopropanes; Drug Resistance, Viral; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Nevirapine; Nitriles; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; RNA, Viral; South Africa; Treatment Failure; Viral Load; Zidovudine | 2011 |
The effects of RNase H inhibitors and nevirapine on the susceptibility of HIV-1 to AZT and 3TC.
Topics: Anti-HIV Agents; Cell Line, Tumor; Drug Resistance, Viral; HEK293 Cells; HIV Reverse Transcriptase; HIV-1; Humans; Inhibitory Concentration 50; Lamivudine; Mutation; Nevirapine; Reverse Transcriptase Inhibitors; Ribonuclease H; Ribonuclease H, Human Immunodeficiency Virus; Zidovudine | 2011 |
Should sponsors and DSMBs share interim results across trials?
Topics: Anti-HIV Agents; Clinical Trials as Topic; Clinical Trials Data Monitoring Committees; Confidentiality; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Interinstitutional Relations; Nevirapine; Pregnancy; Zidovudine | 2011 |
An autoimmune disease prevented by anti-retroviral drugs.
Topics: Animals; Autoimmune Diseases; Autoimmune Diseases of the Nervous System; Deoxycytidine; Drug Combinations; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Exodeoxyribonucleases; Green Fluorescent Proteins; Lupus Erythematosus, Systemic; Mice; Mice, Knockout; Myocarditis; Nervous System Malformations; Nevirapine; Organophosphorus Compounds; Phosphoproteins; Retroelements; Reverse Transcriptase Inhibitors; Zidovudine | 2011 |
Costs and benefits of multidrug, multidose antiretroviral therapy for prevention of mother-to-child transmission of HIV in the Dominican Republic.
Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cost-Benefit Analysis; Cyclopropanes; Dominican Republic; Drug Administration Schedule; Drug Costs; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Zidovudine | 2012 |
Exploiting the anti-HIV-1 activity of acyclovir: suppression of primary and drug-resistant HIV isolates and potentiation of the activity by ribavirin.
Topics: Acyclovir; Anti-HIV Agents; Cell Line; Drug Resistance, Viral; Drug Synergism; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Lamivudine; Nevirapine; Palatine Tonsil; Protease Inhibitors; Ribavirin; T-Lymphocytes; Tissue Culture Techniques; Zidovudine | 2012 |
Recombination between variants from genital tract and plasma: evolution of multidrug-resistant HIV type 1.
Topics: Adult; Anti-HIV Agents; Female; Genitalia, Female; HIV Infections; HIV-1; Humans; Lamivudine; Molecular Sequence Data; Nevirapine; Plasma; Recombination, Genetic; RNA, Viral; Sequence Analysis, DNA; Zidovudine | 2012 |
Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria.
Topics: Adenine; Adolescent; Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cohort Studies; Cyclopropanes; Drug-Related Side Effects and Adverse Reactions; Exanthema; Female; HIV Infections; Humans; Incidence; Lamivudine; Male; Middle Aged; Nevirapine; Nigeria; Organophosphonates; Pain; Retrospective Studies; Risk Factors; Stavudine; Tenofovir; Zidovudine | 2012 |
Development and validation of an HPLC-UV method for simultaneous determination of zidovudine, lamivudine, and nevirapine in human plasma and its application to pharmacokinetic study in human volunteers.
Topics: Anti-HIV Agents; Chromatography, High Pressure Liquid; Humans; Lamivudine; Limit of Detection; Liquid-Liquid Extraction; Nevirapine; Zidovudine | 2013 |
Emergence of minor drug-resistant HIV-1 variants after triple antiretroviral prophylaxis for prevention of vertical HIV-1 transmission.
Topics: Adult; Alleles; Anti-Retroviral Agents; Drug Resistance, Viral; Female; Genetic Variation; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Mutation; Nevirapine; Oligonucleotides; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Tanzania; Zidovudine | 2012 |
Effects of short-course zidovudine on the selection of nevirapine-resistant HIV-1 in women taking single-dose nevirapine.
Topics: Adult; Anti-HIV Agents; Cohort Studies; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Mutation, Missense; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Viral Proteins; Young Adult; Zidovudine | 2012 |
Lignosulfonic acid exhibits broadly anti-HIV-1 activity--potential as a microbicide candidate for the prevention of HIV-1 sexual transmission.
Topics: Anti-HIV Agents; Anti-Infective Agents; Antibodies, Monoclonal; Antibodies, Viral; Antibody Specificity; Binding Sites; CD4 Antigens; Cell Death; Cell Line; Drug Synergism; Epithelium; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Interleukin-8; Lignin; Models, Molecular; Nevirapine; NF-kappa B; Protein Structure, Secondary; Receptors, CCR5; Receptors, CXCR4; Virus Internalization; Zidovudine | 2012 |
N348I in HIV-1 reverse transcriptase counteracts the synergy between zidovudine and nevirapine.
Topics: Anti-HIV Agents; Drug Resistance, Viral; Drug Synergism; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Mutant Proteins; Mutation, Missense; Nevirapine; Selection, Genetic; Zidovudine | 2012 |
In vitro and ex vivo inhibition of human telomerase by anti-HIV nucleoside reverse transcriptase inhibitors (NRTIs) but not by non-NRTIs.
Topics: Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; Cell Line; Cyclopropanes; Didanosine; Dideoxynucleosides; DNA Primers; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Nevirapine; Organophosphonates; Reverse Transcriptase Inhibitors; Stavudine; Telomerase; Tenofovir; Zidovudine | 2012 |
Impact of hepatitis C virus on HIV response to antiretroviral therapy in Nigeria.
Topics: Adult; Alanine Transaminase; Alkynes; Anti-Retroviral Agents; Benzoxazines; Chemical and Drug Induced Liver Injury; Coinfection; Cyclopropanes; Deoxycytidine; Drug Combinations; Drug Therapy, Combination; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Lamivudine; Logistic Models; Male; Nevirapine; Nigeria; Organophosphorus Compounds; RNA, Viral; Stavudine; Zidovudine | 2013 |
Risk adapted transmission prophylaxis to prevent vertical HIV-1 transmission: effectiveness and safety of an abbreviated regimen of postnatal oral zidovudine.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Risk Factors; Treatment Outcome; Zidovudine | 2013 |
Toxicology and carcinogenesis studies of mixtures of 3'-azido-3'-deoxythymidine (AZT), lamivudine (3TC), nevirapine (NVP), and nelfinavir mesylate (NFV) (Cas Nos. 30516-87-1, 134678-17-4, 129618-40-2, 159989-65-8) in B6C3F1 Mice (transplacental exposure s
Topics: Administration, Oral; Animals; Anti-Retroviral Agents; DNA; Drug Therapy, Combination; Escherichia coli; Female; Lamivudine; Longevity; Male; Maternal Exposure; Mice; Mice, Inbred Strains; Nelfinavir; Nevirapine; Pregnancy; Prenatal Exposure Delayed Effects; Salmonella typhimurium; Skin Neoplasms; Zidovudine | 2013 |
Nevirapine inhibits the anti-HIV activity of CD8+ cells.
Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Coculture Techniques; HIV Infections; HIV Seropositivity; HIV-1; Humans; Nevirapine; RNA, Viral; Zidovudine | 2013 |
High throughput LC-MS/MS method for simultaneous determination of zidovudine, lamivudine and nevirapine in human plasma.
Topics: Anti-HIV Agents; Chromatography, Liquid; Humans; Lamivudine; Male; Nevirapine; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry; Zidovudine | 2013 |
Effect of highly active antiretroviral treatment (HAART) during pregnancy on pregnancy outcomes: experiences from a PMTCT program in western India.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; Gestational Age; HIV Infections; Humans; India; Infant, Low Birth Weight; Infant, Newborn; Infectious Disease Transmission, Vertical; Logistic Models; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Program Evaluation; Prospective Studies; Socioeconomic Factors; Viral Load; Young Adult; Zidovudine | 2013 |
Cardiometabolic risk factors among HIV patients on antiretroviral therapy.
Topics: Adenine; Adolescent; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cyclopropanes; Female; HIV; HIV Infections; Humans; Insulin Resistance; Lamivudine; Male; Middle Aged; Nevirapine; Organophosphonates; Risk Factors; Stavudine; Tenofovir; Triglycerides; Zambia; Zidovudine | 2013 |
Talk of HIV cure goes viral.
Topics: Adult; Anti-HIV Agents; CD4-Positive T-Lymphocytes; Child, Preschool; DNA, Viral; Drug Administration Schedule; Drug Therapy, Combination; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Male; Nevirapine; Primary Prevention; Ritonavir; Secondary Prevention; Time Factors; Zidovudine | 2013 |
Left ventricular hypertrophy detected by echocardiography in HIV-infected patients.
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Carbamates; Comorbidity; Cross-Sectional Studies; Cyclopropanes; Diabetes Mellitus; Drug Combinations; Dyslipidemias; Echocardiography; Female; Furans; HIV Infections; Humans; Hypertension; Hypertrophy, Left Ventricular; Lamivudine; Lopinavir; Male; Middle Aged; Nevirapine; Organophosphates; Organophosphonates; Risk Factors; Ritonavir; Smoking; Spain; Sulfonamides; Tenofovir; Zidovudine | 2013 |
Antiretroviral drugs in Africa: a public health versus a market approach.
Topics: Africa; Anti-HIV Agents; Drug Packaging; Health Resources; Health Services Accessibility; HIV Infections; Humans; Lamivudine; Nevirapine; Public Health; Zidovudine | 2013 |
Characterization of antiviral activity of benzamide derivative AH0109 against HIV-1 infection.
Topics: Active Transport, Cell Nucleus; CD4-Positive T-Lymphocytes; DNA, Viral; Drug Evaluation, Preclinical; HEK293 Cells; HIV Integrase Inhibitors; HIV-1; Humans; Lamivudine; Microbial Sensitivity Tests; Morphinans; Nevirapine; Reverse Transcriptase Inhibitors; Reverse Transcription; Virus Replication; Zidovudine | 2013 |
Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine.
Topics: Adenine; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cyclopropanes; Databases, Factual; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; HIV Infections; HIV-1; Humans; Mutation, Missense; Nevirapine; Organophosphonates; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Tenofovir; Zidovudine | 2013 |
Baseline CD4 cell counts and outcomes among adult treatment naive HIV patients after taking fixed dose combination GPO-VIR-S and GPO-VIR-Z in Thailand.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Female; Hematologic Tests; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Kaplan-Meier Estimate; Lamivudine; Male; Middle Aged; Nevirapine; Retrospective Studies; Stavudine; Thailand; Treatment Outcome; Viral Load; Zidovudine | 2013 |
Economic evaluation of 3-drug antiretroviral regimens for the prevention of mother-to-child HIV transmission in Thailand.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cost-Benefit Analysis; Cyclopropanes; Drug Therapy, Combination; Female; Health Services; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Models, Econometric; Mothers; Nevirapine; Pregnancy; Thailand; Zidovudine | 2015 |
Anti-HIV host factor SAMHD1 regulates viral sensitivity to nucleoside reverse transcriptase inhibitors via modulation of cellular deoxyribonucleoside triphosphate (dNTP) levels.
Topics: Blotting, Western; CD4-Positive T-Lymphocytes; Cell Line; Cells, Cultured; Deoxyribonucleosides; Dose-Response Relationship, Drug; HIV-1; Host-Pathogen Interactions; Humans; Macrophages; Monomeric GTP-Binding Proteins; Nevirapine; Reverse Transcriptase Inhibitors; RNA Interference; SAM Domain and HD Domain-Containing Protein 1; Viral Regulatory and Accessory Proteins; Virion; Virus Replication; Zidovudine | 2013 |
Adherence to antiretroviral therapy among HIV infected children measured by caretaker report, medication return, and drug level in Dar Es Salaam, Tanzania.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Caregivers; CD4 Lymphocyte Count; Child; Child, Preschool; Cross-Sectional Studies; Drug Administration Schedule; Drug Combinations; Female; HIV Infections; Humans; Lamivudine; Logistic Models; Male; Medication Adherence; Middle Aged; Nevirapine; Odds Ratio; Stavudine; Surveys and Questionnaires; Tanzania; Young Adult; Zidovudine | 2013 |
HIV-1 drug-resistance surveillance among treatment-experienced and -naïve patients after the implementation of antiretroviral therapy in Ghana.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Child; Child, Preschool; Cyclopropanes; Drug Resistance, Viral; Epidemiological Monitoring; Female; Ghana; HIV Infections; HIV Protease; HIV-1; Humans; Infant; Lamivudine; Male; Middle Aged; Molecular Epidemiology; Molecular Typing; Mutation, Missense; Nevirapine; Prevalence; Sequence Analysis, DNA; Stavudine; Zidovudine | 2013 |
Anemia and risk factors in HAART naïve and HAART experienced HIV positive persons in south west Ethiopia: a comparative study.
Topics: Adolescent; Adult; Anemia; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Child; Child, Preschool; Cross-Sectional Studies; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Lamivudine; Longitudinal Studies; Male; Middle Aged; Nevirapine; Risk Factors; Social Class; Surveys and Questionnaires; Zidovudine | 2013 |
High-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South Africa.
Topics: Adolescent; Adult; Alkynes; Analysis of Variance; Anti-HIV Agents; Benzoxazines; Cross-Sectional Studies; Cyclopropanes; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Mutation; Nevirapine; Outcome Assessment, Health Care; Prevalence; South Africa; Stavudine; Young Adult; Zidovudine | 2013 |
Child cured of HIV: can this be repeated?
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; Humans; Infant, Newborn; Lamivudine; Nevirapine; Reverse Transcriptase Inhibitors; Zidovudine | 2013 |
[Evaluation of tolerance of zidovudine-lamivudine-nevirapine combination in HIV 1 patients in Fann Teaching Hospital in Dakar].
Topics: Adult; Anti-HIV Agents; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; HIV-1; Hospitals, Teaching; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Retrospective Studies; Senegal; Zidovudine | 2013 |
Trends in clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Shanghai from 2006 to 2011.
Topics: Adolescent; Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; China; Cross-Sectional Studies; Female; HIV Infections; Humans; Immune Tolerance; Lamivudine; Male; Middle Aged; Nevirapine; Retrospective Studies; Stavudine; Viral Load; Zidovudine | 2014 |
Preliminary study of quinine pharmacokinetics in pregnant women with malaria-HIV co-infection.
Topics: Adult; Anti-HIV Agents; Antimalarials; Antiretroviral Therapy, Highly Active; Coinfection; Drug Interactions; Female; HIV Infections; Humans; Lamivudine; Malaria, Falciparum; Nevirapine; Parasite Load; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Quinidine; Quinine; Stavudine; Treatment Outcome; Young Adult; Zidovudine | 2014 |
Disposition of amodiaquine and desethylamodiaquine in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapy.
Topics: Adolescent; Adult; Amodiaquine; Anti-Retroviral Agents; Antimalarials; Antiretroviral Therapy, Highly Active; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Drug Interactions; Female; HIV Infections; Humans; Lamivudine; Malaria; Male; Middle Aged; Nevirapine; Nigeria; Plasma; Young Adult; Zidovudine | 2014 |
Clinical profile and response to first-line ARV in HIV patients from Eastern UP and Bihar: a retrospective study.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Infections; Humans; India; Lamivudine; Male; Middle Aged; Nevirapine; Retrospective Studies; Reverse Transcriptase Inhibitors; Stavudine; Treatment Outcome; Young Adult; Zidovudine | 2013 |
Toxicology and Carcinogenesis Studies of Mixtures of 3'-Azido-3'-Deoxythymidine (AZT), Lamivudine (3TC), and Nevirapine (NVP) (CAS Nos. 30516-87-1, 134678-17-4, 129618-40-2) in Genetically Modified C3B6.129F1-Trp53(tm1Brd) N12 Haploinsufficient Mice (in u
Topics: Animals; Animals, Genetically Modified; Animals, Newborn; Anti-HIV Agents; Body Weight; Chemistry, Pharmaceutical; Drug Combinations; Female; Haploinsufficiency; Intubation, Gastrointestinal; Lamivudine; Litter Size; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mutagens; Nevirapine; Organ Size; Pregnancy; Prenatal Exposure Delayed Effects; Reproduction; Reverse Transcriptase Inhibitors; Survival; Zidovudine | 2013 |
Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia.
Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cambodia; CD4 Lymphocyte Count; Coinfection; Cyclopropanes; Female; Hepatitis B; Hepatitis C; HIV Infections; Humans; Kaplan-Meier Estimate; Lamivudine; Liver; Logistic Models; Male; Middle Aged; Nevirapine; Proportional Hazards Models; Retrospective Studies; Stavudine; Treatment Outcome; Zidovudine | 2014 |
Birth prevalence of congenital cytomegalovirus among infants of HIV-infected women on prenatal antiretroviral prophylaxis in South Africa.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cytomegalovirus; Cytomegalovirus Infections; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Prevalence; South Africa; Viral Load; Zidovudine | 2014 |
Exposure of Allium cepa root cells to zidovudine or nevirapine induces cytogenotoxic changes.
Topics: Anti-HIV Agents; DNA Damage; Drug Evaluation, Preclinical; Inhibitory Concentration 50; Mitosis; Mitotic Index; Mutagens; Nevirapine; Onions; Plant Roots; Zidovudine | 2014 |
Challenges of antiretroviral treatment monitoring in rural and remote-access regions in Africa.
Topics: Acquired Immunodeficiency Syndrome; Adult; Africa; Alkynes; Anti-HIV Agents; Benzoxazines; Cross-Sectional Studies; Cyclopropanes; Drug Monitoring; Drug Resistance, Viral; Female; HIV-1; Hospitals, Rural; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Rural Health Services; Rural Population; Stavudine; Treatment Outcome; Zidovudine | 2014 |
Presence of HIV drug resistance in antiretroviral therapy-naive and -experienced patients from Papua New Guinea.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Dried Blood Spot Testing; Drug Resistance, Viral; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Papua New Guinea; Reverse Transcriptase Inhibitors; Stavudine; Treatment Failure; Viral Load; Young Adult; Zidovudine | 2014 |
Clinical manifestations and treatment outcomes in HIV-1-infected children receiving antiretroviral therapy in Karachi, Pakistan.
Topics: Anti-HIV Agents; Body Height; Body Weight; CD4 Lymphocyte Count; Child, Preschool; Drug Resistance, Viral; Female; Genotype; HIV; HIV Infections; Humans; Infant; Lamivudine; Male; Nevirapine; Pakistan; Retrospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load; Zidovudine | 2014 |
MicroRNA-150 is a potential biomarker of HIV/AIDS disease progression and therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Biomarkers; CD4 Lymphocyte Count; Cyclopropanes; Disease Progression; Drug Resistance, Viral; Female; Gene Expression Regulation; HIV; Humans; Lamivudine; Leukocytes, Mononuclear; Male; MicroRNAs; Nevirapine; Stavudine; Treatment Outcome; Viral Load; Zidovudine | 2014 |
Impact of Y181C and/or H221Y mutation patterns of HIV-1 reverse transcriptase on phenotypic resistance to available non-nucleoside and nucleoside inhibitors in China.
Topics: Alkynes; Benzoxazines; China; Cyclopropanes; Drug Resistance, Multiple, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Mutation; Nevirapine; Phenotype; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2014 |
Foetal loss and enhanced fertility observed in mice treated with Zidovudine or Nevirapine.
Topics: Animals; Anti-HIV Agents; Female; Fertility; Fetal Death; Male; Mice; Nevirapine; Pregnancy; Sex Ratio; Zidovudine | 2014 |
[Analysis on HIV suppression effect after initiating antiretroviral treatment and related factors among AIDS patients in Henan province during 2008 and 2013].
Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Female; Health Facilities; HIV Infections; Humans; Lamivudine; Male; Nevirapine; Stavudine; Time-to-Treatment; Treatment Outcome; Zidovudine | 2015 |
Time trends of baseline demographics and clinical characteristics of HIV infected children enrolled in care and treatment service in Dar es Salaam, Tanzania.
Topics: Adolescent; Age Distribution; Alkynes; Ambulatory Care Facilities; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Child; Child, Preschool; Comorbidity; Cyclopropanes; Female; HIV Infections; Humans; Infant; Lamivudine; Linear Models; Male; Nevirapine; Severity of Illness Index; Tanzania; Tuberculosis; Zidovudine | 2015 |
A post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; Deoxycytidine; Drug Administration Schedule; Drug Resistance, Viral; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Mothers; Mutation; Nevirapine; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Sequence Analysis, DNA; South Africa; Tenofovir; Viral Load; Zidovudine | 2015 |
Serious adverse events are uncommon with combination neonatal antiretroviral prophylaxis: a retrospective case review.
Topics: Anemia; Anti-HIV Agents; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Neutropenia; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Thrombocytopenia; Zidovudine | 2015 |
Lower Preprandial Insulin and Altered Fuel Use in HIV/Antiretroviral-Exposed Infants in Cameroon.
Topics: Amino Acids, Branched-Chain; Anti-Retroviral Agents; Cameroon; Energy Metabolism; Female; HIV Infections; Humans; Infant; Insulin; Male; Nevirapine; Pregnancy; Prospective Studies; Zidovudine | 2015 |
Missed Opportunities along the Prevention of Mother-to-Child Transmission Services Cascade in South Africa: Uptake, Determinants, and Attributable Risk (the SAPMTCTE).
Topics: Adolescent; Adult; AIDS Serodiagnosis; Anti-HIV Agents; CD4 Lymphocyte Count; Cross-Sectional Studies; Developing Countries; Female; HIV Infections; Home Childbirth; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Maternal Age; Maternal Health Services; Nevirapine; Parity; Patient Dropouts; Pregnancy; Pregnancy Complications, Infectious; Pregnancy in Adolescence; Prenatal Care; Risk Factors; Socioeconomic Factors; South Africa; Zidovudine | 2015 |
Longitudinal Analysis of Adherence to First-Line Antiretroviral Therapy: Evidence of Treatment Sustainability from an Indian HIV Cohort.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Administration Schedule; Female; HIV Infections; Humans; India; Lamivudine; Longitudinal Studies; Male; Medication Adherence; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2016 |
Longitudinal adherence to antiretroviral drugs for preventing mother-to-child transmission of HIV in Zambia.
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Medication Adherence; Nevirapine; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Probability; Prospective Studies; Referral and Consultation; Risk Factors; Rural Health Services; Self Report; Time Factors; Young Adult; Zambia; Zidovudine | 2015 |
Antiretrovirals, Methamphetamine, and HIV-1 Envelope Protein gp120 Compromise Neuronal Energy Homeostasis in Association with Various Degrees of Synaptic and Neuritic Damage.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Autophagy; Cell Culture Techniques; Cerebral Cortex; Drug Combinations; Embryo, Mammalian; HIV Envelope Protein gp120; HIV Integrase Inhibitors; Homeostasis; Methamphetamine; Neuroglia; Neurons; Nevirapine; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Saquinavir; Sirolimus; Zidovudine | 2016 |
Testing anti-HIV activity of antiretroviral agents in vitro using flow cytometry analysis of CEM-GFP cells infected with transfection-derived HIV-1 NL4-3.
Topics: Anti-HIV Agents; Cell Line, Tumor; Cell Survival; Flow Cytometry; HEK293 Cells; HIV Core Protein p24; HIV-1; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Nevirapine; Transfection; Zidovudine | 2016 |
Superior Effectiveness of Zidovudine Compared With Tenofovir When Combined With Nevirapine-based Antiretroviral Therapy in a Large Nigerian Cohort.
Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cohort Studies; Female; HIV Infections; Humans; Male; Nevirapine; Retrospective Studies; Tenofovir; Treatment Outcome; Viral Load; Young Adult; Zidovudine | 2016 |
The last and first frontier--emerging challenges for HIV treatment and prevention in the first week of life with emphasis on premature and low birth weight infants.
Topics: Female; HIV Infections; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Zidovudine | 2015 |
FRET-based assay to screen inhibitors of HIV-1 reverse transcriptase and nucleocapsid protein.
Topics: Anti-HIV Agents; DNA, Viral; Drug Evaluation, Preclinical; Fluorescence Resonance Energy Transfer; gag Gene Products, Human Immunodeficiency Virus; High-Throughput Screening Assays; HIV Reverse Transcriptase; HIV-1; Humans; Nevirapine; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine | 2016 |
Improved pregnancy outcomes with increasing antiretroviral coverage in South Africa.
Topics: Adolescent; Adult; Anti-Retroviral Agents; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Care; South Africa; Stavudine; Young Adult; Zidovudine | 2016 |
[Survival analysis of AIDS patients of 15 years or above years old after initiation antiretroviral treatment in Henan province during 2005 to 2014].
Topics: Acquired Immunodeficiency Syndrome; Anti-Retroviral Agents; China; Drug Therapy, Combination; Female; Humans; Lymphocyte Count; Male; Nevirapine; Proportional Hazards Models; Retrospective Studies; Risk Factors; Stavudine; Survival Analysis; Survival Rate; Zidovudine | 2015 |
Prevention of perinatal transmission of zidovudine- and nevirapine-resistant HIV.
Topics: Adolescent; Anti-HIV Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Viral Load; Zidovudine | 2016 |
Treatment of vitiligo with antiretroviral therapy in a child with HIV infection.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Drug Therapy, Combination; Follow-Up Studies; HIV-1; Humans; Lamivudine; Male; Nevirapine; Treatment Outcome; Vitiligo; Zidovudine | 2016 |
HIV-1 Drug Resistance by Ultra-Deep Sequencing Following Short Course Zidovudine, Single-Dose Nevirapine, and Single-Dose Tenofovir with Emtricitabine for Prevention of Mother-to-Child Transmission.
Topics: Anti-HIV Agents; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viral Load; Zidovudine | 2016 |
Early infant diagnosis of HIV infection using DNA-PCR at a referral center: an 8 years retrospective analysis.
Topics: Anti-HIV Agents; DNA, Viral; Early Diagnosis; Ethiopia; Female; HIV; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Nevirapine; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Risk Factors; Zidovudine | 2016 |
Adverse drug reactions associated with antiretroviral therapy in South Africa.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Dizziness; Exanthema; Female; Gynecomastia; HIV Infections; Humans; Lipodystrophy; Male; Middle Aged; Nevirapine; Peripheral Nervous System Diseases; Renal Insufficiency; Retrospective Studies; South Africa; Stavudine; Tenofovir; Zidovudine | 2016 |
Improved Adherence to Antiretroviral Therapy Observed Among HIV-Infected Children Whose Caregivers had Positive Beliefs in Medicine in Sub-Saharan Africa.
Topics: Africa South of the Sahara; Alkynes; Anti-HIV Agents; Attitude to Health; Benzoxazines; Caregivers; Child; Child, Preschool; Cyclopropanes; Dideoxynucleosides; Female; HIV Infections; Humans; Infant; Lamivudine; Linear Models; Logistic Models; Male; Medication Adherence; Multivariate Analysis; Nevirapine; Randomized Controlled Trials as Topic; Stavudine; Surveys and Questionnaires; Uganda; Zambia; Zidovudine | 2017 |
Early antiretroviral treatment (eART) limits viral diversity over time in a long-term HIV viral suppressed perinatally infected child.
Topics: Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Lamivudine; Lopinavir; Male; Nevirapine; Phylogeny; Ritonavir; Zidovudine | 2016 |
Antiretrovirals causing severe pre-eclampsia.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Delivery, Obstetric; Female; HIV Infections; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Lamivudine; Nevirapine; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Zidovudine | 2016 |
Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa.
Topics: Adult; Africa South of the Sahara; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Mutation; Nevirapine; Polymerase Chain Reaction; Retrospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Thymidine; Treatment Failure; Viral Load; Zidovudine | 2017 |
Multi-state models for the analysis of time-to-treatment modification among HIV patients under highly active antiretroviral therapy in Southwest Ethiopia.
Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Ethiopia; Female; HIV Infections; Humans; Lamivudine; Male; Models, Theoretical; Nevirapine; Pregnancy; Retrospective Studies; Stavudine; Tenofovir; Time-to-Treatment; Treatment Failure; Zidovudine | 2017 |
Accumulation of HIV-1 drug resistance in patients on a standard thymidine analogue-based first line antiretroviral therapy after virological failure: implications for the activity of next-line regimens from a longitudinal study in Mozambique.
Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Lamivudine; Longitudinal Studies; Male; Mozambique; Mutation; Nevirapine; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Failure; Viral Load; Zidovudine | 2017 |
Central nervous system-penetrating antiretrovirals impair energetic reserve in striatal nerve terminals.
Topics: Adenosine Triphosphate; Alkynes; Animals; Anti-HIV Agents; Benzoxazines; Cerebral Cortex; Corpus Striatum; Cyclohexanes; Cyclopropanes; Darunavir; Dideoxynucleosides; Dose-Response Relationship, Drug; Emtricitabine; Lopinavir; Male; Maraviroc; Mitochondria; Neurons; Nevirapine; Oxidative Phosphorylation; Permeability; Presynaptic Terminals; Raltegravir Potassium; Rats; Rats, Long-Evans; Triazoles; Zidovudine | 2017 |
Lower mitochondrial DNA and altered mitochondrial fuel metabolism in HIV-exposed uninfected infants in Cameroon.
Topics: Amino Acids, Branched-Chain; Anti-Retroviral Agents; Cameroon; Carnitine; DNA, Mitochondrial; Energy Metabolism; HIV Infections; Humans; Infant; Mitochondria; Nevirapine; Real-Time Polymerase Chain Reaction; Tandem Mass Spectrometry; Zidovudine | 2017 |
HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; CD4 Lymphocyte Count; Chemical and Drug Induced Liver Injury; Cohort Studies; Coinfection; Cyclopropanes; Female; Hepatitis B; Hepatitis C; HIV; HIV Infections; Humans; Male; Middle Aged; Nevirapine; Retrospective Studies; Treatment Outcome; Viral Load; Zidovudine | 2018 |
Motives for change of first-line antiretroviral therapy regimens in an unselected cohort of HIV/AIDS patients at a major referral centre in South-west Cameroon.
Topics: Adult; Anti-HIV Agents; Cameroon; Cohort Studies; Cross-Sectional Studies; Drug Combinations; Drug Substitution; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Referral and Consultation; Stavudine; Zidovudine | 2017 |
Long-term viral suppression and immune recovery during first-line antiretroviral therapy: a study of an HIV-infected adult cohort in Hanoi, Vietnam.
Topics: Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cohort Studies; Cyclopropanes; Female; HIV Infections; Humans; Longitudinal Studies; Male; Middle Aged; Nevirapine; Stavudine; Time Factors; Vietnam; Viral Load; Young Adult; Zidovudine | 2017 |
A prospective study of adverse events to antiretroviral therapy in HIV- infected adults in Ekiti State, Nigeria.
Topics: Abdominal Pain; Adolescent; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Drug Substitution; Drug Therapy, Combination; Female; HIV Infections; Humans; Incidence; Lamivudine; Male; Middle Aged; Nausea; Nevirapine; Nigeria; Prospective Studies; Sleep Initiation and Maintenance Disorders; Tenofovir; Young Adult; Zidovudine | 2016 |
Antiretroviral treatment Long-Term (ALT) cohort: a prospective cohort of 10 years of ART-experienced patients in Uganda.
Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Combinations; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Lamivudine; Male; Nevirapine; Prospective Studies; RNA, Viral; Time; Uganda; Viral Load; Zidovudine | 2018 |
Short Communication: Reduced Nevirapine Concentrations Among HIV-Positive Women Receiving Mefloquine for Intermittent Preventive Treatment for Malaria Control During Pregnancy.
Topics: Adult; Anti-HIV Agents; Antimalarials; Cross-Sectional Studies; Drug Interactions; Female; Fetal Blood; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Kenya; Lamivudine; Malaria; Mefloquine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Zidovudine | 2018 |
Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Anti-HIV Agents; Child; Child, Preschool; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Infant; Lamivudine; Male; Middle Aged; Nevirapine; Nigeria; Pharmacovigilance; Sex Factors; Young Adult; Zidovudine | 2018 |
Rates of HBV, HCV, HDV and HIV type 1 among pregnant women and HIV type 1 drug resistance-associated mutations in breastfeeding women on antiretroviral therapy.
Topics: Adolescent; Adult; Anti-HIV Agents; Breast Feeding; Cameroon; Coinfection; Drug Resistance, Viral; Female; Health Knowledge, Attitudes, Practice; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Vaccines; Hepatitis C; Hepatitis C Antibodies; Hepatitis D; HIV Seroprevalence; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Vaccination; Young Adult; Zidovudine | 2018 |
Rate of viral load change and adherence of HIV adult patients treated with Efavirenz or Nevirapine antiretroviral regimens at 24 and 48 weeks in Yaoundé, Cameroon: a longitudinal cohort study.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cameroon; Cohort Studies; Cyclopropanes; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Longitudinal Studies; Male; Middle Aged; Nevirapine; Patient Compliance; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Viral Load; Zidovudine | 2019 |
Incidence and types of HIV-1 drug resistance mutation among patients failing first-line antiretroviral therapy.
Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Antiviral Agents; Benzoxazines; Cyclopropanes; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Incidence; Lamivudine; Male; Middle Aged; Mutation; Nevirapine; Stavudine; Tenofovir; Treatment Failure; Viral Load; Zidovudine | 2019 |
Rates of HIV-1 virological suppression and patterns of acquired drug resistance among fisherfolk on first-line antiretroviral therapy in Uganda.
Topics: Adult; Anti-HIV Agents; Drug Resistance, Viral; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Male; Mutation; Nevirapine; Reverse Transcriptase Inhibitors; Treatment Failure; Treatment Outcome; Uganda; Viral Load; Zidovudine | 2019 |
Safety of 6-week Neonatal Triple-combination Antiretroviral Postexposure Prophylaxis in High-risk HIV-exposed Infants.
Topics: Anti-Retroviral Agents; Chemoprevention; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Nevirapine; Post-Exposure Prophylaxis; Prospective Studies; Thailand; Treatment Outcome; Zidovudine | 2019 |
Trend of HIV transmitted drug resistance before and after implementation of HAART regimen restriction in the treatment of HIV-1 infected patients in southern Taiwan.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Combinations; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Mutation; Nevirapine; Prevalence; Reverse Transcriptase Inhibitors; Taiwan; Zidovudine | 2019 |
Formulation, Development and Scale-Up of Fixed-Dose Combination Tablets Containing Zidovudine, Lamivudine and Nevirapine.
Topics: Anti-HIV Agents; Drug Combinations; Drug Compounding; Drug Development; Drug Stability; Lamivudine; Nevirapine; Tablets; Technology, Pharmaceutical; Zidovudine | 2019 |
Safety and Efficacy of Starting Antiretroviral Therapy in the First Week of Life.
Topics: Anti-HIV Agents; Botswana; Child; Child, Preschool; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Zidovudine | 2021 |
Incidence and predictors of loss to follow up among adult HIV patients on antiretroviral therapy in University of Gondar Comprehensive Specialized Hospital: A competing risk regression modeling.
Topics: Adolescent; Adult; Ambulatory Care; Anti-Retroviral Agents; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; Hospitals, Special; Humans; Incidence; Lamivudine; Lost to Follow-Up; Male; Nevirapine; Regression Analysis; Retrospective Studies; Risk Factors; Young Adult; Zidovudine | 2020 |
Perinatal Antiretroviral Intensification to Prevent Intrapartum HIV Transmission When Antenatal Antiretroviral Therapy Is Initiated Less Than 8 Weeks Before Delivery.
Topics: Adult; Anti-HIV Agents; Bayes Theorem; Drug Combinations; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Mothers; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Thailand; Viral Load; Young Adult; Zidovudine | 2020 |
Risk factors for delayed viral suppression on first-line antiretroviral therapy among persons living with HIV in Haiti, 2013-2017.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; Child, Preschool; Female; Haiti; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Risk Factors; Viral Load; Young Adult; Zidovudine | 2020 |
Mother-to-Child HIV Transmission among Pregnant Women in a City with the Highest Rates of HIV in Brazil.
Topics: Brazil; Child; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Mothers; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Retrospective Studies; Syphilis; Zidovudine | 2022 |
Adverse Reactions to Antiretrovirals in Cuban Patients Living with HIV/AIDS.
Topics: Adolescent; Adult; Anti-HIV Agents; Child; Child, Preschool; Cuba; Female; HIV Infections; Humans; Infant; Infant, Newborn; Male; Middle Aged; Nevirapine; Young Adult; Zidovudine | 2021 |
Improved Hematologic Outcomes in HIV1-Exposed Infants Receiving Nevirapine Compared With Zidovudine for Postnatal Prophylaxis in a High Resource Setting.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2022 |
Nevirapine hair and plasma concentrations and HIV-1 viral suppression among HIV infected ante-partum and post-partum women attended in a mother and child prevention program in Maputo city, Mozambique.
Topics: Adolescent; Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Drug Combinations; Female; Hair; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Logistic Models; Medication Adherence; Mozambique; Nevirapine; Postpartum Period; Pregnancy; Prospective Studies; Viral Load; Young Adult; Zidovudine | 2022 |
Serum Interleukin-6 and Weight Loss in Antiretroviral-naïve and Antiretroviral-treated Patients with HIV/AIDS: Relationships and Predictors.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Case-Control Studies; Emtricitabine; HIV Infections; Humans; Interleukin-6; Lamivudine; Middle Aged; Nevirapine; Tenofovir; Weight Loss; Zidovudine | 2022 |
Antiretroviral therapy resistance mutations among HIV infected people in Kazakhstan.
Topics: Anti-HIV Agents; Darunavir; Drug Resistance, Viral; Emtricitabine; HIV Infections; HIV-1; Humans; Kazakhstan; Mutation; Nevirapine; Viral Load; Zidovudine | 2022 |
Rate of virological failure and HIV-1 drug resistance among HIV-infected adolescents in routine follow-up on health facilities in Cameroon.
Topics: Adolescent; Anti-HIV Agents; Cameroon; Drug Resistance, Viral; Follow-Up Studies; Health Facilities; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Nevirapine; Retrospective Studies; Viral Load; Zidovudine | 2022 |